Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


Articles published in Diabetes Care

Retrieve available abstracts of 1102 articles:
HTML format



Single Articles


    May 2024
  1. HAMIDI V, Pettus JH
    Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?
    Diabetes Care. 2024;47:782-784.
    PubMed    


  2. KAYLAN KB, Philipson LH
    Werner Syndrome and Diabetes: Opportunities for Precision Medicine.
    Diabetes Care. 2024;47:785-786.
    PubMed    


  3. MOZAFFARIAN D
    Plant-Based Diets and Diabetes Risk: Which Foods, What Mechanisms?
    Diabetes Care. 2024;47:787-789.
    PubMed    


  4. BEATO-VIBORA PI, Chico A, Moreno-Fernandez J, Bellido-Castaneda V, et al
    Response to Comment on Beato-Vibora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. Diabetes Care 2024;47:216-224.
    Diabetes Care. 2024;47:e46-e47.
    PubMed    


  5. LEBBAR M, Henry Z, Thivolet C
    Comment on Beato-Vibora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-World Setting. Diabetes Care 2024;47:216-224.
    Diabetes Care. 2024;47:e44-e45.
    PubMed    


    April 2024
  6. SCHEUER SH, Andersen GS, Carstensen B, Diaz L, et al
    Trends in Incidence of Hospitalization for Hypoglycemia and Diabetic Ketoacidosis in Individuals With Type 1 or Type 2 Diabetes With and Without Severe Mental Illness in Denmark From 1996 to 2020: A Nationwide Study.
    Diabetes Care. 2024 Apr 19:dc232394. doi: 10.2337/dc23-2394.
    PubMed     Abstract available


  7. ZEITLER P, Galindo RJ, Davies MJ, Bergman BK, et al
    Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program.
    Diabetes Care. 2024 Apr 19:dc232356. doi: 10.2337/dc23-2356.
    PubMed     Abstract available


  8. LI M, Li J, Xu Y, Gao J, et al
    Effect of 5:2 Regimens: Energy-Restricted Diet or Low-Volume High-Intensity Interval Training Combined With Resistance Exercise on Glycemic Control and Cardiometabolic Health in Adults With Overweight/Obesity and Type 2 Diabetes-A Three-Arm Randomized
    Diabetes Care. 2024 Apr 18:dc240241. doi: 10.2337/dc24-0241.
    PubMed     Abstract available


  9. PASSANISI S, Salzano G, Bombaci B, Minuto N, et al
    Sustained Effectiveness of an Advanced Hybrid Closed Loop System in a Cohort of Children and Adolescents With Type 1 Diabetes: A 1-Year Real-World Study.
    Diabetes Care. 2024 Apr 16:dc232311. doi: 10.2337/dc23-2311.
    PubMed     Abstract available


  10. YAO P, Iona A, Pozarickij A, Said S, et al
    Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes.
    Diabetes Care. 2024 Apr 16:dc232145. doi: 10.2337/dc23-2145.
    PubMed     Abstract available


  11. JACOBSEN LM, Cuthbertson D, Bundy BN, Atkinson MA, et al
    Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials.
    Diabetes Care. 2024 Apr 15:dc240171. doi: 10.2337/dc24-0171.
    PubMed     Abstract available


  12. YANG PK, Jackson SL, Charest BR, Cheng YJ, et al
    Type 1 Diabetes Genetic Risk in 109,954 Veterans With Adult-Onset Diabetes: The Million Veteran Program (MVP).
    Diabetes Care. 2024 Apr 12:dc231927. doi: 10.2337/dc23-1927.
    PubMed     Abstract available


  13. SHI S, Dong Y, Wang S, Du X, et al
    Associations of Dietary Cholesterol Consumption With Incident Diabetes and Cardiovascular Disease: The Role of Genetic Variability in Cholesterol Absorption and Disease Predisposition.
    Diabetes Care. 2024 Apr 9:dc232336. doi: 10.2337/dc23-2336.
    PubMed     Abstract available


  14. DANNE T, Joubert M, Hartvig NV, Kaas A, et al
    Association Between Treatment Adherence and Continuous Glucose Monitoring Outcomes in People With Diabetes Using Smart Insulin Pens in a Real-World Setting.
    Diabetes Care. 2024 Apr 3:dc232176. doi: 10.2337/dc23-2176.
    PubMed     Abstract available


  15. RIDDLE MC
    Erratum. Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE. Diabetes Care 2024;47:556-561.
    Diabetes Care. 2024 Apr 2:dc24er06a. doi: 10.2337.
    PubMed     Abstract available


  16. JACOBSEN LM
    Prompt Recognition of New-Onset Type 1 Diabetes Is Everyone's Responsibility-Even on Weekends.
    Diabetes Care. 2024;47:646-648.
    PubMed    


  17. RIDDLE MC
    Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE.
    Diabetes Care. 2024;47:556-561.
    PubMed    


  18. NAKASONE Y, Yamashita K, Aizawa T
    Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140-143.
    Diabetes Care. 2024;47:e34.
    PubMed    


  19. KAWADA T
    Comment on Zuraikat et al. Chronic Insufficient Sleep in Women Impairs Insulin Sensitivity Independent of Adiposity Changes: Results of a Randomized Trial. Diabetes Care 2024;47:117-125.
    Diabetes Care. 2024;47:e36.
    PubMed    


  20. PAGE B
    About the Editor: Camille E. Powe, MD: Advancing Research for Diabetes and Pregnancy.
    Diabetes Care. 2024;47:518-519.
    PubMed    


  21. ST-ONGE MP, Zuraikat FM, Laferrere B, Jelic S, et al
    Response to Comment on Zuraikat et al. Chronic Insufficient Sleep in Women Impairs Insulin Sensitivity Independent of Adiposity Changes: Results of a Randomized Trial. Diabetes Care 2024;47:117-125.
    Diabetes Care. 2024;47:e37-e38.
    PubMed    


  22. MALTESE G, Sinclair AJ
    Comment on Kutz et al. Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes. Diabetes Care 2023;46:2004-2014.
    Diabetes Care. 2024;47:e32-e33.
    PubMed    


  23. NINON F, Alice L, Marie-Amelie BM, Laurence B, et al
    Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140-143.
    Diabetes Care. 2024;47:e35.
    PubMed    


  24. LORBER DL, ElSayed NA, Bannuru RR, Shah V, et al
    Diabetes Management in Detention Facilities: A Statement of the American Diabetes Association.
    Diabetes Care. 2024;47:544-555.
    PubMed     Abstract available


  25. YUAN CY, Kong YW, Amoore T, Brown K, et al
    Improved Satisfaction While Maintaining Safety and High Time in Range (TIR) With a Medtronic Investigational Enhanced Advanced Hybrid Closed-Loop (e-AHCL) System.
    Diabetes Care. 2024;47:747-755.
    PubMed     Abstract available


  26. WEISSMAN YL, Calvarysky B, Shochat T, Korotkov Z, et al
    Disparities in Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Prescription and Dispensing in the Israeli Population-A Retrospective Cohort Study.
    Diabetes Care. 2024;47:692-697.
    PubMed     Abstract available


  27. ANTHONY MS, Aroda VR, Parlett LE, Djebarri L, et al
    Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study.
    Diabetes Care. 2024;47:712-719.
    PubMed     Abstract available


  28. AL RIFAI M, Al-Mallah MH, Blaha MJ, Patel J, et al
    Epidemiology and Prognostic Implications of Coronary Artery Calcium in Asymptomatic Individuals With Prediabetes: A Multicohort Study.
    Diabetes Care. 2024;47:698-706.
    PubMed     Abstract available


  29. FOSS-FREITAS MC, Imam S, Neidert A, Gomes AD, et al
    Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy.
    Diabetes Care. 2024;47:653-659.
    PubMed     Abstract available


  30. GARVEY WT, Cohen RM, Butera NM, Kazemi EJ, et al
    Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial.
    Diabetes Care. 2024;47:562-570.
    PubMed     Abstract available


    March 2024
  31. SIMMONS D, Immanuel J, Hague WM, Teede H, et al
    Regression From Early GDM to Normal Glucose Tolerance and Adverse Pregnancy Outcomes in the Treatment of Booking Gestational Diabetes Mellitus Study.
    Diabetes Care. 2024 Mar 29:dc232215. doi: 10.2337/dc23-2215.
    PubMed     Abstract available


  32. NAGEL KE, Ramachandran R, Lipska KJ
    Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications.
    Diabetes Care. 2024 Mar 27:dci230042. doi: 10.2337/dci23-0042.
    PubMed     Abstract available


  33. ORLANDO G, Brown S, Jude E, Bowling FL, et al
    Acute Effects of Vibrating Insoles on Dynamic Balance and Gait Quality in Individuals With Diabetic Peripheral Neuropathy: A Randomized Crossover Study.
    Diabetes Care. 2024 Mar 27:dc231858. doi: 10.2337/dc23-1858.
    PubMed     Abstract available


  34. GIORGINO F, Franco DR, Nicolay C, Hemmingway A, et al
    Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials.
    Diabetes Care. 2024 Mar 26:dc232366. doi: 10.2337/dc23-2366.
    PubMed     Abstract available


  35. CALIFF RM
    Erratum. Our National Approach to Diabetes. Diabetes Care 2023;46:252-254.
    Diabetes Care. 2024 Mar 22:dc24er05b. doi: 10.2337.
    PubMed     Abstract available


  36. MAATTA LL, Andersen ST, Parkner T, Hviid CVB, et al
    Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark.
    Diabetes Care. 2024 Mar 19:dc232208. doi: 10.2337/dc23-2208.
    PubMed     Abstract available


  37. LEE CG, Ciarleglio A, Edelstein SL, Crandall JP, et al
    Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure.
    Diabetes Care. 2024 Mar 19:dc232009. doi: 10.2337/dc23-2009.
    PubMed     Abstract available


  38. SHANG Y, Grip ET, Modica A, Skroder H, et al
    Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes.
    Diabetes Care. 2024 Mar 18:dc231937. doi: 10.2337/dc23-1937.
    PubMed     Abstract available


  39. ZHAO LP, Papadopoulos GK, Skyler JS, Pugliese A, et al
    HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07).
    Diabetes Care. 2024 Mar 18:dc231947. doi: 10.2337/dc23-1947.
    PubMed     Abstract available


  40. SISKIND SM, Johnson TY, Klings ES, Modzelewski KL, et al
    Diabetes Screening Rates and Practices in Patients With Sickle Cell Disease.
    Diabetes Care. 2024 Mar 15:dc232396. doi: 10.2337/dc23-2396.
    PubMed    


  41. LIND N, Christensen MB, Hansen DL, Norgaard K, et al
    Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial.
    Diabetes Care. 2024 Mar 15:dc232194. doi: 10.2337/dc23-2194.
    PubMed     Abstract available


  42. CAHILL LE, Warren RA, Carew AS, Levy AP, et al
    Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.
    Diabetes Care. 2024 Mar 14:dc232165. doi: 10.2337/dc23-2165.
    PubMed     Abstract available


  43. HE D, Gao B, Wang J, Yang C, et al
    The Difference Between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate and Risk of Diabetic Microvascular Complications Among Adults With Diabetes: A Population-Based Cohort Study.
    Diabetes Care. 2024 Mar 12:dc232364. doi: 10.2337/dc23-2364.
    PubMed     Abstract available


  44. SUGIMOTO T, Sakurai T, Uchida K, Kuroda Y, et al
    Impact of Type 2 Diabetes and Glycated Hemoglobin Levels Within the Recommended Target Range on Mortality in Older Adults With Cognitive Impairment Receiving Care at a Memory Clinic: NCGG-STORIES.
    Diabetes Care. 2024 Mar 12:dc232324. doi: 10.2337/dc23-2324.
    PubMed     Abstract available


  45. SILVA PS, Cavallerano JD, Sun JK, Tolson AM, et al
    Disparities Between Teleretinal Imaging Findings and Patient-Reported Diabetic Retinopathy Status and Follow-Up Eye Care Interval: A 10-Year Prospective Study.
    Diabetes Care. 2024 Mar 8:dc232282. doi: 10.2337/dc23-2282.
    PubMed     Abstract available


  46. SEIFU CN, Immanuel J, Hague WM, Teede H, et al
    Association Between Immediate Treatment of Early Gestational Diabetes Mellitus and Breastfeeding Outcomes: Findings From the TOBOGM Study.
    Diabetes Care. 2024 Mar 5:dc231635. doi: 10.2337/dc23-1635.
    PubMed    


  47. NARAYAN KMV, Kondal D, Chang HH, Mohan D, et al
    Natural History of Type 2 Diabetes in Indians: Time to Progression.
    Diabetes Care. 2024 Mar 1:dc231514. doi: 10.2337/dc23-1514.
    PubMed     Abstract available


  48. MITCHELL LM, Huang ES
    Diffusion and Disparities: Rural Uptake of Continuous Glucose Monitors.
    Diabetes Care. 2024;47:344-345.
    PubMed    


  49. TOZZO V, Genco M, Omololu SO, Mow C, et al
    Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy.
    Diabetes Care. 2024;47:460-466.
    PubMed     Abstract available


  50. HENSON J, Covenant A, Hall AP, Herring L, et al
    Waking Up to the Importance of Sleep in Type 2 Diabetes Management: A Narrative Review.
    Diabetes Care. 2024;47:331-343.
    PubMed     Abstract available


  51. MURPHY HR
    A Diabetes Pregnancy Technology Roadmap: The 2023 Norbert Freinkel Award Lecture.
    Diabetes Care. 2024;47:324-330.
    PubMed     Abstract available


  52. WANG S, Gu L, Wang L
    Comment on Li et al. Association of Serum Uric Acid With All-Cause and Cardiovascular Mortality in Diabetes. Diabetes Care 2023;46:425-433.
    Diabetes Care. 2024;47:e31.
    PubMed    


    February 2024
  53. SIMMONS D, Immanuel J, Hague WM, Teede H, et al
    Perinatal Outcomes in Early and Late Gestational Diabetes Mellitus After Treatment From 24-28 Weeks' Gestation: A TOBOGM Secondary Analysis.
    Diabetes Care. 2024 Feb 29:dc231667. doi: 10.2337/dc23-1667.
    PubMed     Abstract available


  54. GONZALEZ JS, Bebu I, Krause-Steinrauf H, Hoogendoorn CJ, et al
    Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): A Randomized Clinical Trial.
    Diabetes Care. 2024 Feb 28:dc232459. doi: 10.2337/dc23-2459.
    PubMed     Abstract available


  55. SATTAR N, Presslie C, Rutter MK, McGuire DK, et al
    Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity.
    Diabetes Care. 2024 Feb 27:dci230041. doi: 10.2337/dci23-0041.
    PubMed     Abstract available


  56. SHERR JL, Bergford S, Gal RL, Clements MA, et al
    Exploring Factors That Influence Postexercise Glycemia in Youth With Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric Study (T1DEXIP).
    Diabetes Care. 2024 Feb 27:dc232212. doi: 10.2337/dc23-2212.
    PubMed     Abstract available


  57. THOMAS RL, Boeder SC, Hamidi V, Giovannetti ER, et al
    Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes.
    Diabetes Care. 2024 Feb 23:dc232501. doi: 10.2337/dc23-2501.
    PubMed    


  58. TAN L, Wang J, Han J, Sainsbury C, et al
    Socioeconomic Deprivation and the Risk of Sight-Threatening Diabetic Retinopathy (STDR): A Population-Based Cohort Study in the U.K.
    Diabetes Care. 2024 Feb 22:dc231626. doi: 10.2337/dc23-1626.
    PubMed     Abstract available


  59. EGEDE LE, Walker RJ, Campbell JA, Linde S, et al
    Historic Redlining and Impact of Structural Racism on Diabetes Prevalence in a Nationally Representative Sample of U.S. Adults.
    Diabetes Care. 2024 Feb 22:dc232184. doi: 10.2337/dc23-2184.
    PubMed     Abstract available


  60. STEIGER K, Herrin J, Swarna KS, Davis EM, et al
    Disparities in Acute and Chronic Complications of Diabetes Along the U.S. Rural-Urban Continuum.
    Diabetes Care. 2024 Feb 22:dc231552. doi: 10.2337/dc23-1552.
    PubMed     Abstract available


  61. BENEDEK T, Wieske V, Szilveszter B, Kofoed KF, et al
    Erratum. Computed Tomography Versus Invasive Coronary Angiography in Patients With Diabetes and Suspected Coronary Artery Disease. Diabetes Care 2023;46:2015-2023.
    Diabetes Care. 2024 Feb 21:dc24er05a. doi: 10.2337.
    PubMed     Abstract available


  62. BAJAJ HS, Asbjornsdottir B, Carstensen L, Laugesen C, et al
    Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-Standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4
    Diabetes Care. 2024 Feb 21:dc232136. doi: 10.2337/dc23-2136.
    PubMed     Abstract available


  63. BUCKELL J, Mitchell CA, Fryer K, Newbert C, et al
    Identifying Preferred Features of Weight Loss Programs for Adults With or at Risk of Type 2 Diabetes: A Discrete Choice Experiment With 3,960 Adults in the U.K.
    Diabetes Care. 2024 Feb 20:dc232019. doi: 10.2337/dc23-2019.
    PubMed     Abstract available


  64. BIRUKOV A, Guasch-Ferre M, Ley SH, Tobias DK, et al
    Lifetime Duration of Breastfeeding and Cardiovascular Risk in Women With Type 2 Diabetes or a History of Gestational Diabetes: Findings From Two Large Prospective Cohorts.
    Diabetes Care. 2024 Feb 20:dc231494. doi: 10.2337/dc23-1494.
    PubMed     Abstract available


  65. LINDGREN M, Norstrom F, Persson M, Larsson HE, et al
    Prevalence and Predictive Factors for Celiac Disease in Children With Type 1 Diabetes. Whom and When to Screen? A Nationwide Longitudinal Cohort Study of Swedish Children.
    Diabetes Care. 2024 Feb 16:dc231671. doi: 10.2337/dc23-1671.
    PubMed     Abstract available


  66. SULLIVAN VK, Kim H, Caulfield LE, Steffen LM, et al
    Plant-Based Dietary Patterns and Incident Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study.
    Diabetes Care. 2024 Feb 13:dc232013. doi: 10.2337/dc23-2013.
    PubMed     Abstract available


  67. KANAYA AM
    Erratum. Diabetes in South Asians: Uncovering Novel Risk Factors With Longitudinal Epidemiologic Data: Kelly West Award Lecture 2023. Diabetes Care 2024;47:7-16.
    Diabetes Care. 2024 Feb 9:dc24er04a. doi: 10.2337.
    PubMed     Abstract available


  68. STONE SI, Balasubramanyam A, Posey JE
    Atypical Diabetes: What Have We Learned and What Does the Future Hold?
    Diabetes Care. 2024 Feb 8:dci230038. doi: 10.2337/dci23-0038.
    PubMed     Abstract available


  69. LOMAX KE, Taplin CE, Abraham MB, Smith GJ, et al
    Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes.
    Diabetes Care. 2024 Feb 7:dc232033. doi: 10.2337/dc23-2033.
    PubMed     Abstract available


  70. HEDDERSON MM, Capra A, Lee C, Habel LA, et al
    Longitudinal Changes in Sex Hormone Binding Globulin (SHBG) and Risk of Incident Diabetes: The Study of Women's Health Across the Nation (SWAN).
    Diabetes Care. 2024 Feb 6:dc231630. doi: 10.2337/dc23-1630.
    PubMed     Abstract available



  71. Erratum. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2024. Diabetes Care 2024;47(Suppl. 1):S77-S110.
    Diabetes Care. 2024 Feb 5:dc24er04. doi: 10.2337.
    PubMed     Abstract available


  72. SANDY JL, Tittel SR, Rompicherla S, Karges B, et al
    Demographic, Clinical, Management, and Outcome Characteristics of 8,004 Young Children With Type 1 Diabetes.
    Diabetes Care. 2024 Feb 2:dc231317. doi: 10.2337/dc23-1317.
    PubMed     Abstract available


  73. LAM C, Wong YL, Tang Z, Hu X, et al
    Performance of Artificial Intelligence in Detecting Diabetic Macular Edema From Fundus Photography and Optical Coherence Tomography Images: A Systematic Review and Meta-analysis.
    Diabetes Care. 2024;47:304-319.
    PubMed     Abstract available


  74. GALLARDO-GOMEZ D, Salazar-Martinez E, Alfonso-Rosa RM, Ramos-Munell J, et al
    Optimal Dose and Type of Physical Activity to Improve Glycemic Control in People Diagnosed With Type 2 Diabetes: A Systematic Review and Meta-analysis.
    Diabetes Care. 2024;47:295-303.
    PubMed     Abstract available


  75. GOMES FS, Rezende LFM, Schlussel M, Lawrence M, et al
    Comment on Chen et al. Ultra-Processed Food Consumption and Risk of Type 2 Diabetes: Three Large Prospective U.S. Cohort Studies. Diabetes Care 2023;46:1335-1344.
    Diabetes Care. 2024;47:e22-e23.
    PubMed    


  76. CUROVIC VR, Persson F, Jongs N, Heerspink HJL, et al
    Response to Comment on Curovic et al. Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial. Diabetes Care 2023;46:593-601.
    Diabetes Care. 2024;47:e21.
    PubMed    


  77. ZHANG C, Yang J
    Personalizing Physical Activity for Glucose Control Among Individuals With Type 2 Diabetes: Are We There Yet?
    Diabetes Care. 2024;47:196-198.
    PubMed    


  78. CHEN Z, Khandpur N, Drouin-Chartier JP
    Response to Comment on Chen et al. Ultra-Processed Food Consumption and Risk of Type 2 Diabetes: Three Large Prospective U.S. Cohort Studies. Diabetes Care 2023;46:1335-1344.
    Diabetes Care. 2024;47:e24-e25.
    PubMed    


  79. KARAGIANNIS T, Tsapas A, Bekiari E, Toulis KA, et al
    A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes.
    Diabetes Care. 2024;47:184-192.
    PubMed     Abstract available


  80. ZELNICK LR
    Comment on Curovic et al. Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial. Diabetes Care 2023;46:593-601.
    Diabetes Care. 2024;47:e20.
    PubMed    


  81. PEARSON ER
    New Insights Into the Genetics of Glycemic Response to Metformin.
    Diabetes Care. 2024;47:193-195.
    PubMed    


  82. DAYA NR, Fang M, Mathew M, Shin JI, et al
    1,5-Anhydroglucitol: A Novel Biomarker of Adherence to Sodium-Glucose Cotransporter 2 Inhibitors.
    Diabetes Care. 2024;47:e9-e10.
    PubMed    


  83. ROSAGER EV, Helto ALK, Fox Maule CU, Friis-Hansen L, et al
    Incidence and Characteristics of the Hyperosmolar Hyperglycemic State: A Danish Cohort Study.
    Diabetes Care. 2024;47:272-279.
    PubMed     Abstract available


  84. FORTIN E, Campi B, Ferrannini E, Mari A, et al
    High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors.
    Diabetes Care. 2024;47:246-251.
    PubMed     Abstract available


  85. KLEIN KR, Clemmensen KKB, Fong E, Olsen S, et al
    Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6.
    Diabetes Care. 2024;47:280-284.
    PubMed     Abstract available


  86. SCHOUG J, Katzman P, Fagher K, Londahl M, et al
    Charcot Foot Offloading in Stage 0 Is Associated With Shorter Total Contact Cast Treatment and Lower Risk of Recurrence and Reconstructive Surgery: A Pilot Study.
    Diabetes Care. 2024;47:252-258.
    PubMed     Abstract available


  87. BEATO-VIBORA PI, Chico A, Moreno-Fernandez J, Bellido-Castaneda V, et al
    A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting.
    Diabetes Care. 2024;47:216-224.
    PubMed     Abstract available


  88. BRAFFETT BH, El Ghormli L, Albers JW, Feldman EL, et al
    Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Type 1 Diabetes.
    Diabetes Care. 2024 Feb 1:dc231749. doi: 10.2337/dc23-1749.
    PubMed     Abstract available


    January 2024
  89. SHERR JL, Laffel LM, Liu J, Wolf W, et al
    Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-Sectional Survey.
    Diabetes Care. 2024 Jan 31:dc231765. doi: 10.2337/dc23-1765.
    PubMed     Abstract available


  90. ABDELGANI S, Khattab A, Adams J, Baskoy G, et al
    Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes.
    Diabetes Care. 2024 Jan 31:dc231646. doi: 10.2337/dc23-1646.
    PubMed     Abstract available


  91. AL-SOFIANI ME, Alharthi S, Albunyan S, Alzaman N, et al
    A Real-World Prospective Study of the Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting.
    Diabetes Care. 2024 Jan 30:dc231968. doi: 10.2337/dc23-1968.
    PubMed     Abstract available


  92. BANERJI MA, Buse JB, Younes N, Krause-Steinrauf H, et al
    Mortality in Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Diabetes Care. 2024 Jan 22:dc231356. doi: 10.2337/dc23-1356.
    PubMed     Abstract available


  93. JONES AG, Shields BM, Oram RA, Dabelea DM, et al
    Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2024 Jan 22:dc231815. doi: 10.2337/dc23-1815.
    PubMed     Abstract available


  94. CHERRINGTON AL, Bebu I, Krause-Steinrauf H, Hoogendoorn CJ, et al
    Does Emotional Distress Predict Worse Glycemic Control Over Time? Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Diabetes Care. 2024 Jan 22:dc230642. doi: 10.2337/dc23-0642.
    PubMed     Abstract available


  95. TOBE SW, Mavrakanas TA, Bajaj HS, Levin A, et al
    Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE trials.
    Diabetes Care. 2024 Jan 22:dc231450. doi: 10.2337/dc23-1450.
    PubMed     Abstract available


  96. SCHMIDT BM, Huang Y, Banerjee M, Hayek SS, et al
    Residential Address Amplifies Health Disparities and Risk of Infection in Individuals With Diabetic Foot Ulcers.
    Diabetes Care. 2024 Jan 19:dc231787. doi: 10.2337/dc23-1787.
    PubMed     Abstract available


  97. BACKMAN HE, Karefylakis C, Schwarcz E, Magnuson A, et al
    Diagnosis of Gestational Diabetes Mellitus: How Should We Measure Glucose?
    Diabetes Care. 2024 Jan 19:dc231557. doi: 10.2337/dc23-1557.
    PubMed    


  98. BARMANRAY RD, Kyi M, Colman PG, Rowan L, et al
    The Specialist Treatment of Inpatients: Caring for Diabetes in Surgery (STOIC-D Surgery) Trial: A Randomized Controlled Trial of Early Intervention With an Electronic Specialist-Led Model of Diabetes Care.
    Diabetes Care. 2024 Jan 18:dc231905. doi: 10.2337/dc23-1905.
    PubMed     Abstract available


  99. LI Y, Tian J, Hou T, Gu K, et al
    Association Between Age at Diabetes Diagnosis and Subsequent Incidence of Cancer: A Longitudinal Population-Based Cohort.
    Diabetes Care. 2024 Jan 18:dc230386. doi: 10.2337/dc23-0386.
    PubMed     Abstract available


  100. PALERMO BJ, Wilkinson KS, Plante TB, Nicoli CD, et al
    Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort.
    Diabetes Care. 2024 Jan 18:dc230914. doi: 10.2337/dc23-0914.
    PubMed     Abstract available


  101. AKTURK HK, Michel K, Couts K, Karakus KE, et al
    Routine Blood Glucose Monitoring Does Not Predict Onset of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes.
    Diabetes Care. 2024 Jan 17:dc231964. doi: 10.2337/dc23-1964.
    PubMed    


  102. WANG Y, Zhang P, Zhou X, Rolka D, et al
    Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged >/=67 Years With Diabetes.
    Diabetes Care. 2024 Jan 16:dc231679. doi: 10.2337/dc23-1679.
    PubMed     Abstract available


  103. HOOGENDOORN CJ, Krause-Steinrauf H, Uschner D, Wen H, et al
    Emotional Distress Predicts Reduced Type 2 Diabetes Treatment Adherence in Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Diabetes Care. 2024 Jan 16:dc231401. doi: 10.2337/dc23-1401.
    PubMed     Abstract available


  104. DAVIS TME, Drinkwater JJ, Davis WA
    Pulmonary Function Trajectories Over 6 Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
    Diabetes Care. 2024 Jan 11:dc231726. doi: 10.2337/dc23-1726.
    PubMed     Abstract available


  105. RASOULI N, Younes N, Ghosh A, Albu J, et al
    Longitudinal Effects of Glucose-Lowering Medications on beta-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
    Diabetes Care. 2024 Jan 11:dc231070. doi: 10.2337/dc23-1070.
    PubMed     Abstract available


  106. CHENG R, Taleb N, Wu Z, Bouchard D, et al
    Managing Impending Nonsevere Hypoglycemia With Oral Carbohydrates in Type 1 Diabetes: The REVERSIBLE Trial.
    Diabetes Care. 2024 Jan 9:dc231328. doi: 10.2337/dc23-1328.
    PubMed     Abstract available


  107. KIRKMAN MS, Tripputi M, Krause-Steinrauf H, Bebu I, et al
    Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
    Diabetes Care. 2024 Jan 9:dc231332. doi: 10.2337/dc23-1332.
    PubMed     Abstract available


  108. CHERRINGTON AL, Tripputi MT, Younes N, Herman WH, et al
    Impact of Glucose-Lowering Medications on Health-Related Quality of Life in Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Diabetes Care. 2024 Jan 8:dc231648. doi: 10.2337/dc23-1648.
    PubMed     Abstract available


  109. UTZSCHNEIDER KM, Younes N, Butera NM, Balasubramanyam A, et al
    Impact of Insulin Sensitivity and beta-Cell Function Over Time on Glycemic Outcomes in GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study): Differential Treatment Effects of Dual Therapy.
    Diabetes Care. 2024 Jan 8:dc231059. doi: 10.2337/dc23-1059.
    PubMed     Abstract available


  110. FETER N, de Paula D, Dos Reis RCP, Raichlen D, et al
    Leisure-Time Physical Activity May Attenuate the Impact of Diabetes on Cognitive Decline in Middle-Aged and Older Adults: Findings From the ELSA-Brasil Study.
    Diabetes Care. 2024 Jan 5:dc231524. doi: 10.2337/dc23-1524.
    PubMed     Abstract available


  111. ZHU K, Qian F, Lu Q, Li R, et al
    Modifiable Lifestyle Factors, Genetic Risk, and Incident Peripheral Artery Disease Among Individuals With Type 2 Diabetes: A Prospective Study.
    Diabetes Care. 2024 Jan 5:dc231503. doi: 10.2337/dc23-1503.
    PubMed     Abstract available


  112. ROUBILLE F, Bouabdallaoui N, Kouz S, Waters DD, et al
    Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT).
    Diabetes Care. 2024 Jan 5:dc231825. doi: 10.2337/dc23-1825.
    PubMed     Abstract available


  113. FOLON L, Baron M, Scherrer V, Toussaint B, et al
    Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes.
    Diabetes Care. 2024 Jan 3:dc231851. doi: 10.2337/dc23-1851.
    PubMed     Abstract available


  114. FU T, Sun Y, Lu S, Zhao J, et al
    Risk Assessment for Gastrointestinal Diseases via Clinical Dimension and Genome-Wide Polygenic Risk Scores of Type 2 Diabetes: A Population-Based Cohort Study.
    Diabetes Care. 2024 Jan 2:dc230978. doi: 10.2337/dc23-0978.
    PubMed     Abstract available



  115. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  116. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  117. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  118. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  119. 17. Diabetes Advocacy: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  120. Introduction and Methodology: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed    



  121. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  122. 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  123. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  124. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  125. 14. Children and Adolescents: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  126. 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  127. 13. Older Adults: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  128. Summary of Revisions: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed    



  129. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  130. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  131. Disclosures: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed    



  132. 7. Diabetes Technology: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  133. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available



  134. 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available


  135. FEIG DS, Scott EM
    Optimizing Patient Outcomes in Pregnancy: What Continuous Glucose Monitoring Metrics Should We Be Aiming For?
    Diabetes Care. 2024;47:54-55.
    PubMed    


  136. AGUILAR D, Davis BR
    Aspirin Dosing in Cardiovascular Disease and Diabetes: Insights From ADAPTABLE.
    Diabetes Care. 2024;47:52-53.
    PubMed    


  137. TAHERI S
    Type 2 Diabetes Remission: A New Mission in Diabetes Care.
    Diabetes Care. 2024;47:47-49.
    PubMed    


  138. GIACCARI A
    Expanding the Use of SGLT2i in Diabetes Beyond Type 2.
    Diabetes Care. 2024;47:50-51.
    PubMed    


  139. JOSEFSON JL
    It's All About Fat, Baby: Is Infant Adiposity Associated With Later Adverse Metabolic Health?
    Diabetes Care. 2024;47:44-46.
    PubMed    


  140. ZHANG Y, Giovannucci EL
    Comment on Zaccardi et al. Duration of Type 2 Diabetes and Incidence of Cancer: An Observational Study in England. Diabetes Care 2023;46:1923-1930.
    Diabetes Care. 2024;47:e6.
    PubMed    


  141. ZACCARDI F, Ling S, Brown K, Davies M, et al
    Response to Comment on Zaccardi et al. Duration of Type 2 Diabetes and Incidence of Cancer: An Observational Study in England. Diabetes Care 2023;46:1923-1930.
    Diabetes Care. 2024;47:e7-e8.
    PubMed    


  142. SEIDU S, Kunutsor SK, Ajjan RA, Choudhary P, et al
    Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.
    Diabetes Care. 2024;47:169-179.
    PubMed     Abstract available


  143. KANAYA AM
    Diabetes in South Asians: Uncovering Novel Risk Factors With Longitudinal Epidemiologic Data: Kelly West Award Lecture 2023.
    Diabetes Care. 2024;47:7-16.
    PubMed     Abstract available


  144. POUWER F, Mizokami-Stout K, Reeves ND, Pop-Busui R, et al
    Psychosocial Care for People With Diabetic Neuropathy: Time for Action.
    Diabetes Care. 2024;47:17-25.
    PubMed     Abstract available


  145. KAHN SE, Anderson CAM, Buse JB, Selvin E, et al
    Reflecting on a Year at the Helm of Diabetes Care.
    Diabetes Care. 2024;47:4-6.
    PubMed    


  146. GOODRICH JA, Wang H, Walker DI, Lin X, et al
    Postprandial Metabolite Profiles and Risk of Prediabetes in Young People: A Longitudinal Multicohort Study.
    Diabetes Care. 2024;47:151-159.
    PubMed     Abstract available


  147. BAEKDAL M, Nielsen SW, Hansen CP, Storkholm JH, et al
    Empagliflozin Normalizes Fasting Hyperglycemia and Improves Postprandial Glucose Tolerance in Totally Pancreatectomized Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
    Diabetes Care. 2024;47:71-80.
    PubMed     Abstract available


    December 2023
  148. WANDER PL, Bammler TK, MacDonald JW, Srinouanprachanh S, et al
    Plasma miRNAs and Treatment Failure in Participants in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
    Diabetes Care. 2023 Dec 28:dc231540. doi: 10.2337/dc23-1540.
    PubMed     Abstract available


  149. BJORNSTAD P, Choi YJ, Platnick C, Gross S, et al
    Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes.
    Diabetes Care. 2023 Dec 28:dc231818. doi: 10.2337/dc23-1818.
    PubMed     Abstract available


  150. VIROSTKO J, Wright JJ, Williams JM, Hilmes MA, et al
    Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes.
    Diabetes Care. 2023 Dec 27:dc231681. doi: 10.2337/dc23-1681.
    PubMed     Abstract available


  151. EBERT T, Anker SD, Ruilope LM, Fioretto P, et al
    Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance.
    Diabetes Care. 2023 Dec 27:dc231420. doi: 10.2337/dc23-1420.
    PubMed     Abstract available


  152. THORIUS IH, Husemoen LLN, Nordsborg RB, Alibegovic AC, et al
    Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort.
    Diabetes Care. 2023 Dec 21:dc231281. doi: 10.2337/dc23-1281.
    PubMed     Abstract available


  153. KAMRATH C, Sindichakis M, Auzanneau M, Schmid S, et al
    Association of Diabetic Ketoacidosis in Childhood New-Onset Type 1 Diabetes With Day of Presentation in Germany.
    Diabetes Care. 2023 Dec 21:dc231643. doi: 10.2337/dc23-1643.
    PubMed     Abstract available


  154. FOSTER TP, Jacobsen LM, Bruggeman B, Salmon C, et al
    Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes.
    Diabetes Care. 2023 Dec 20:dc231750. doi: 10.2337/dc23-1750.
    PubMed     Abstract available


  155. CASTANEDA J, Arrieta A, van den Heuvel T, Battelino T, et al
    Time in Tight Glucose Range in Type 1 Diabetes: Predictive Factors and Achievable Targets in Real-World Users of the MiniMed 780G System.
    Diabetes Care. 2023 Dec 19:dc231581. doi: 10.2337/dc23-1581.
    PubMed     Abstract available


  156. BERTHON W, McGurnaghan SJ, Blackbourn LAK, Bath LE, et al
    Incidence of Type 1 Diabetes in Children Has Fallen to Pre-COVID-19 Pandemic Levels: A Population-Wide Analysis From Scotland.
    Diabetes Care. 2023 Dec 19:dc232068. doi: 10.2337/dc23-2068.
    PubMed    


  157. SHULMAN R, Cohen E, Stukel TA, Diong C, et al
    Disruption to Pattern but No Overall Increase in the Expected Incidence of Pediatric Diabetes During the First Three Years of the COVID-19 Pandemic in Ontario, Canada (March 2020-March 2023).
    Diabetes Care. 2023 Dec 18:dc231794. doi: 10.2337/dc23-1794.
    PubMed    


  158. CHRISTENSEN MH, Bistrup C, Rubin KH, Nohr EA, et al
    Kidney Disease in Women With Previous Gestational Diabetes Mellitus: A Nationwide Register-Based Cohort Study.
    Diabetes Care. 2023 Dec 15:dc231092. doi: 10.2337/dc23-1092.
    PubMed     Abstract available


  159. SHI X, Su W, Wang J, Huang P, et al
    Serum Low C-Peptide Levels Correlate With Low Muscle Mass in Patients With Type 2 Diabetes Mellitus.
    Diabetes Care. 2023 Dec 13:dc231168. doi: 10.2337/dc23-1168.
    PubMed    


  160. CHAUDHARY RS, Turner MB, Mehta LS, Al-Roub NM, et al
    Low Awareness of Diabetes as a Major Risk Factor for Cardiovascular Disease in Middle- and High-Income Countries.
    Diabetes Care. 2023 Dec 13:dc231731. doi: 10.2337/dc23-1731.
    PubMed     Abstract available


  161. BESSER REJ, Long AE, Owen KR, Law R, et al
    Transdermal Blood Sampling for C-Peptide Is a Minimally Invasive, Reliable Alternative to Venous Sampling in Children and Adults With Type 1 Diabetes.
    Diabetes Care. 2023 Dec 13:dc231379. doi: 10.2337/dc23-1379.
    PubMed     Abstract available


  162. KAMINSKI CY, Galindo RJ, Navarrete JE, Zabala Z, et al
    Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Diabetes Care. 2023 Dec 12:dc231276. doi: 10.2337/dc23-1276.
    PubMed     Abstract available


  163. ZU C, Liu M, Su X, Wei Y, et al
    Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus.
    Diabetes Care. 2023 Dec 11:dc231727. doi: 10.2337/dc23-1727.
    PubMed     Abstract available


  164. VISARIA A, Huang SP, Su CC, Robinson D, et al
    Ambient Heat and Risk of Serious Hypoglycemia in Older Adults With Diabetes Using Insulin in the U.S. and Taiwan: A Cross-National Case-Crossover Study.
    Diabetes Care. 2023 Dec 7:dc231189. doi: 10.2337/dc23-1189.
    PubMed     Abstract available


  165. WANG HH, Chong M, Perrot N, Feiner J, et al
    Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk.
    Diabetes Care. 2023 Dec 6:dc231488. doi: 10.2337/dc23-1488.
    PubMed     Abstract available


  166. SINGH LG, Ntelis S, Siddiqui T, Seliger SL, et al
    Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study.
    Diabetes Care. 2023 Dec 5:dc231129. doi: 10.2337/dc23-1129.
    PubMed     Abstract available


  167. EITEL KB, Roberts AJ, D'Agostino R Jr, Barrett CE, et al
    Diabetes Stigma and Psychosocial Outcomes in Adolescents and Young Adults: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2023 Dec 5:dc231453. doi: 10.2337/dc23-1453.
    PubMed     Abstract available


  168. WANG Y, Jiao T, Muschett MR, Brown JD, et al
    Associations Between Postdischarge Care and Cognitive Impairment-Related Hospital Readmissions for Ketoacidosis and Severe Hypoglycemia in Adults With Diabetes.
    Diabetes Care. 2023 Dec 4:dca230013. doi: 10.2337/dca23-0013.
    PubMed     Abstract available


  169. WHITE SL, Poston L
    Another Mechanistic Piece of the Gestational Diabetes Puzzle.
    Diabetes Care. 2023;46:2120-2122.
    PubMed    


  170. KAHN SE, Anderson CAM, Benoit SR, Bullard KM, et al
    A New Partnership: Bringing Novel Aspects of CDC Data to Diabetes Care.
    Diabetes Care. 2023;46:2091.
    PubMed    


  171. THIRUNAVUKKARASU S
    Comment on Rooney et al. Global Prevalence of Prediabetes. Diabetes Care 2023;46:1388-1394.
    Diabetes Care. 2023;46:e219.
    PubMed    


  172. SHINDE SA
    Comment on Rooney et al. Global Prevalence of Prediabetes. Diabetes Care 2023;46:1388-1394.
    Diabetes Care. 2023;46:e221.
    PubMed    


  173. ADDALA A
    Making a Good Thing Even Better: Expanding Access and Applicability of Automated Insulin Delivery Systems to Benefit All Youth With Type 1 Diabetes.
    Diabetes Care. 2023;46:2126-2128.
    PubMed    


  174. MOHAN V, Unnikrishnan R, Anjana RM
    Comment on Rooney et al. Global Prevalence of Prediabetes. Diabetes Care 2023;46:1388-1394.
    Diabetes Care. 2023;46:e220.
    PubMed    


  175. KHUNTI K, Chudasama YV, Gregg EW, Kamkuemah M, et al
    Diabetes and Multiple Long-term Conditions: A Review of Our Current Global Health Challenge.
    Diabetes Care. 2023;46:2092-2101.
    PubMed     Abstract available


  176. ROONEY MR, Fang M, Selvin E
    Response to Comment on Rooney et al. Global Prevalence of Prediabetes. Diabetes Care 2023;46:1388-1394.
    Diabetes Care. 2023;46:e222.
    PubMed    


  177. KOYAMA AK, Bullard KM, Onufrak S, Xu F, et al
    Risk Factors Amenable to Primary Prevention of Type 2 Diabetes Among Disaggregated Racial and Ethnic Subgroups in the U.S.
    Diabetes Care. 2023;46:2112-2119.
    PubMed     Abstract available


  178. ZENG B, Gao L, Yang Q, Jia H, et al
    Automated Insulin Delivery Systems in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-analysis of Outpatient Randomized Controlled Trials.
    Diabetes Care. 2023;46:2300-2307.
    PubMed     Abstract available


  179. SHIN J, Patel Y, Parker N, Paus T, et al
    Prediabetic HbA1c and Cortical Atrophy: Underlying Neurobiology.
    Diabetes Care. 2023;46:2267-2272.
    PubMed     Abstract available


  180. COUCH CA, Piccinini F, Fowler LA, Garvey WT, et al
    Proinsulin-to-C-Peptide Ratio as a Marker of beta-Cell Function in African American and European American Adults.
    Diabetes Care. 2023;46:2129-2136.
    PubMed     Abstract available


    November 2023
  181. SINHA GREGORY N, Burghardt AJ, Backlund JC, Rubin MR, et al
    Diabetes Risk Factors and Bone Microarchitecture as Assessed by High-Resolution Peripheral Quantitative Computed Tomography in Adults With Long-Standing Type 1 Diabetes.
    Diabetes Care. 2023 Nov 29:dc230839. doi: 10.2337/dc23-0839.
    PubMed     Abstract available


  182. UMAPATHYSIVAM MM, Gunton J, Stranks SN, Jesudason D, et al
    Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction.
    Diabetes Care. 2023 Nov 21:dc231163. doi: 10.2337/dc23-1163.
    PubMed     Abstract available


  183. HAYES AG, Raven LM, Viardot A, Kotlyar E, et al
    SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes.
    Diabetes Care. 2023 Nov 14:dc231903. doi: 10.2337/dc23-1903.
    PubMed    


  184. DAI J, Niu X, Bullock A, Manson SM, et al
    Prevalence of Diagnosed Type 1 and Type 2 Diabetes Among American Indian and Alaska Native Peoples in 2012-2013.
    Diabetes Care. 2023 Nov 13:dc230930. doi: 10.2337/dc23-0930.
    PubMed    


  185. ZURAIKAT FM, Laferrere B, Cheng B, Scaccia SE, et al
    Chronic Insufficient Sleep in Women Impairs Insulin Sensitivity Independent of Adiposity Changes: Results of a Randomized Trial.
    Diabetes Care. 2023 Nov 13:dc231156. doi: 10.2337/dc23-1156.
    PubMed     Abstract available


  186. ZHANG B, Cheng Z, Chen J, Zhang X, et al
    Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
    Diabetes Care. 2023 Nov 9:dc231287. doi: 10.2337/dc23-1287.
    PubMed     Abstract available


  187. RIDDELL MC, Gal RL, Bergford S, Patton SR, et al
    The Acute Effects of Real-World Physical Activity on Glycemia in Adolescents With Type 1 Diabetes: The Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) Study.
    Diabetes Care. 2023 Nov 3:dc231548. doi: 10.2337/dc23-1548.
    PubMed     Abstract available


  188. HERNAR I, Cooper JG, Nilsen RM, Skinner TC, et al
    Diabetes Distress and Associations With Demographic and Clinical Variables: A Nationwide Population-Based Registry Study of 10,186 Adults With Type 1 Diabetes in Norway.
    Diabetes Care. 2023 Nov 3:dc231001. doi: 10.2337/dc23-1001.
    PubMed     Abstract available


  189. AVDIC T, Carlsen HK, Isaksson R, Gudbjornsdottir S, et al
    Risk Factors for and Risk of Peripheral Artery Disease in Swedish Individuals With Type 2 Diabetes: A Nationwide Register-Based Study.
    Diabetes Care. 2023 Nov 2:dc231198. doi: 10.2337/dc23-1198.
    PubMed     Abstract available


  190. PARKER ED, Lin J, Mahoney T, Ume N, et al
    Economic Costs of Diabetes in the U.S. in 2022.
    Diabetes Care. 2023 Nov 1:dci230085. doi: 10.2337/dci23-0085.
    PubMed     Abstract available


  191. HERMAN WH, Ye W
    Precision Prevention of Diabetes.
    Diabetes Care. 2023;46:1894-1896.
    PubMed    


  192. CAMPAGNA D
    Comment on Elsayed et al. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S68-S96.
    Diabetes Care. 2023;46:e212-e213.
    PubMed    


  193. DARVILLE A, Hilliard M, ElSayed NA, Bannuru RR, et al
    Response to Comment on Elsayed et al. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S68-S96.
    Diabetes Care. 2023;46:e214.
    PubMed    


  194. LLAMOSAS-FALCON L, Rehm J, Bright S, Buckley C, et al
    The Relationship Between Alcohol Consumption, BMI, and Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis.
    Diabetes Care. 2023;46:2076-2083.
    PubMed     Abstract available


  195. PINHEIRO MM, Pinheiro FMM
    Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013.
    Diabetes Care. 2023;46:e209.
    PubMed    


  196. RUSSELL WE, Moore DJ, Herold KC
    Response to Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013.
    Diabetes Care. 2023;46:e210-e211.
    PubMed    


  197. TOBIAS DK, Papatheodorou S, Yamamoto JM, Hu FB, et al
    A Primer on Systematic Review and Meta-analysis in Diabetes Research.
    Diabetes Care. 2023;46:1882-1893.
    PubMed     Abstract available


  198. ROSENSTOCK J, Vazquez L, Del Prato S, Franco DR, et al
    Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1-4 Trials.
    Diabetes Care. 2023;46:1986-1992.
    PubMed     Abstract available


  199. LONNROT M, Lynch KF, Rewers M, Lernmark A, et al
    Gastrointestinal Infections Modulate the Risk for Insulin Autoantibodies as the First-Appearing Autoantibody in the TEDDY Study.
    Diabetes Care. 2023;46:1908-1915.
    PubMed     Abstract available


    October 2023
  200. TILDEN DR, French B, Datye KA, Jaser SS, et al
    Disparities in Continuous Glucose Monitor Use Between Children With Type 1 Diabetes Living in Urban and Rural Areas.
    Diabetes Care. 2023 Oct 31:dc231564. doi: 10.2337/dc23-1564.
    PubMed     Abstract available


  201. MARCH C, Sherman J, Bannuru RR, Fischer A, et al
    Care of Young Children With Diabetes in the Childcare and Community Setting: A Statement of the American Diabetes Association.
    Diabetes Care. 2023 Oct 30:dci230083. doi: 10.2337/dci23-0083.
    PubMed     Abstract available


  202. ZOU X, Hu M, Huang X, Zhou L, et al
    Rare Variant in Metallothionein 1E Increases the Risk of Type 2 Diabetes in a Chinese Population.
    Diabetes Care. 2023 Oct 25:dc222031. doi: 10.2337/dc22-2031.
    PubMed     Abstract available


  203. SHERWOOD JS, Castellanos LE, O'Connor MY, Balliro CA, et al
    Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes.
    Diabetes Care. 2023 Oct 24:dc231411. doi: 10.2337/dc23-1411.
    PubMed     Abstract available


  204. ZAHARIA OP, Antoniou S, Bobrov P, Karusheva Y, et al
    Reduced Insulin Clearance Differently Relates to Increased Liver Lipid Content and Worse Glycemic Control in Recent-Onset Type 2 and Type 1 Diabetes.
    Diabetes Care. 2023 Oct 24:dc231267. doi: 10.2337/dc23-1267.
    PubMed     Abstract available


  205. TSATSARIS G, Rajamand Ekberg N, Fall T, Catrina SB, et al
    Prevalence of Charcot Foot in Subjects With Diabetes: A Nationwide Cohort Study.
    Diabetes Care. 2023 Oct 24:dc230628. doi: 10.2337/dc23-0628.
    PubMed    


  206. PARVIAINEN A, But A, Sund R, Arffman M, et al
    Incidence of Type 1 Diabetes in Relation to Exposure to Rotavirus Infections in Pre- and Postvaccine Birth Cohorts in Finland.
    Diabetes Care. 2023 Oct 20:dc231203. doi: 10.2337/dc23-1203.
    PubMed     Abstract available


  207. HARTMANN-BOYCE J, Rees K, Onakpoya I, Otunla A, et al
    An Update to the Overview of Reviews: Risks of and From SARS-COV-2 Infection and COVID-19 in People With Diabetes.
    Diabetes Care. 2023 Oct 19:dc231365. doi: 10.2337/dc23-1365.
    PubMed    


  208. HSIEH TYJ, Chang R, Yong SB, Liao PL, et al
    COVID-19 Vaccination Prior to SARS-CoV-2 Infection Reduced Risk of Subsequent Diabetes Mellitus: A Real-World Investigation Using U.S. Electronic Health Records.
    Diabetes Care. 2023 Oct 18:dc230936. doi: 10.2337/dc23-0936.
    PubMed     Abstract available


  209. KWON S, Lee SR, Choi EK, Ahn HJ, et al
    Association Between Atrial Fibrillation and Diabetes-Related Complications: A Nationwide Cohort Study.
    Diabetes Care. 2023 Oct 18:dc230931. doi: 10.2337/dc23-0931.
    PubMed     Abstract available


  210. MULUK P, Zhu J, Thoma F, Hay E, et al
    Impact of Guideline-Directed Statin Intervention for Primary Prevention in Patients With Diabetes.
    Diabetes Care. 2023 Oct 18:dc230816. doi: 10.2337/dc23-0816.
    PubMed     Abstract available


  211. WITTMAN JT, Bullard KM, Benoit SR
    Trends in Preventive Care Services Among U.S. Adults With Diagnosed Diabetes, 2008-2020.
    Diabetes Care. 2023 Oct 16:dc231119. doi: 10.2337/dc23-1119.
    PubMed     Abstract available


  212. HOCKING SL, Markovic TP, Lee CMY, Picone TJ, et al
    Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australia: DiRECT-Aus.
    Diabetes Care. 2023 Oct 16:dc230781. doi: 10.2337/dc23-0781.
    PubMed     Abstract available


  213. MALECKI MT, Batterham RL, Sattar N, Levine JA, et al
    Predictors of >/=15% Weight Reduction and Associated Changes in Cardiometabolic Risk Factors With Tirzepatide in Adults With Type 2 Diabetes in SURPASS 1-4.
    Diabetes Care. 2023 Oct 12:dc231135. doi: 10.2337/dc23-1135.
    PubMed     Abstract available


  214. DONOVAN LE, Feig DS, Lemieux P, Murphy HR, et al
    A Randomized Trial of Closed-Loop Insulin Delivery Postpartum in Type 1 Diabetes.
    Diabetes Care. 2023 Oct 12:dc230882. doi: 10.2337/dc23-0882.
    PubMed     Abstract available


  215. LI J, Sesso HD, Kim E, Manson JE, et al
    Cocoa Extract Supplementation and Risk of Type 2 Diabetes: The Cocoa Supplement and Multivitamin Outcomes Study (COSMOS) Randomized Clinical Trial.
    Diabetes Care. 2023 Oct 10:dc231012. doi: 10.2337/dc23-1012.
    PubMed     Abstract available


  216. LIU JJ, Ching J, Wee HN, Liu S, et al
    Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes.
    Diabetes Care. 2023 Oct 5:dc231147. doi: 10.2337/dc23-1147.
    PubMed     Abstract available


  217. SANUSI AA, Xue Y, McIlwraith C, Howard H, et al
    Association of Continuous Glucose Monitoring Metrics With Pregnancy Outcomes in Patients With Preexisting Diabetes.
    Diabetes Care. 2023 Oct 2:dc230636. doi: 10.2337/dc23-0636.
    PubMed     Abstract available


  218. LIMBERT C, von dem Berge T, Danne T
    Personalizing Early-Stage Type 1 Diabetes in Children.
    Diabetes Care. 2023;46:1747-1749.
    PubMed    


  219. NAIK AD
    Pragmatic Evidence for Theory-Based Innovations in Diabetes Primary Care.
    Diabetes Care. 2023;46:1750-1752.
    PubMed    


  220. SPEKSNIJDER EM, Ten Noever de Brauw GV, Malekzadeh A, Bisschop PH, et al
    Effect of Postmenopausal Hormone Therapy on Glucose Regulation in Women With Type 1 or Type 2 Diabetes: A Systematic Review and Meta-analysis.
    Diabetes Care. 2023;46:1866-1875.
    PubMed     Abstract available


  221. HUH JH, Kang JG
    Response to Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.
    Diabetes Care. 2023;46:e205-e206.
    PubMed    


  222. RAJESH AE, Davidson OQ, Lee CS, Lee AY, et al
    Artificial Intelligence and Diabetic Retinopathy: AI Framework, Prospective Studies, Head-to-head Validation, and Cost-effectiveness.
    Diabetes Care. 2023;46:1728-1739.
    PubMed     Abstract available


  223. HEGELE RA
    Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.
    Diabetes Care. 2023;46:e204.
    PubMed    


  224. CANYELLES M, Blanco-Vaca F, Perez A, Escola-Gil JC, et al
    Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.
    Diabetes Care. 2023;46:e203.
    PubMed    


  225. BLERVAQUE J, Lablanche S, Romero-Ugalde H, Adenis A, et al
    Comment on Haidar et al. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes. Diabetes Care 2023;46:1372-1378.
    Diabetes Care. 2023;46:e207-e208.
    PubMed    


  226. UUSITALO U, Mramba LK, Aronsson CA, Vehik K, et al
    HLA Genotype and Probiotics Modify the Association Between Timing of Solid Food Introduction and Islet Autoimmunity in the TEDDY Study.
    Diabetes Care. 2023;46:1839-1847.
    PubMed     Abstract available


    September 2023
  227. DURU OK, Mangione CM, Turk N, Chon J, et al
    The Effectiveness of Shared Decision Making for Diabetes Prevention: 24- and 36-Month Results From the Prediabetes Informed Decision and Education (PRIDE) Trial.
    Diabetes Care. 2023 Sep 28:dc230829. doi: 10.2337/dc23-0829.
    PubMed     Abstract available


  228. TOBIAS DK, Manning AK, Wessel J, Raghavan S, et al
    Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
    Diabetes Care. 2023 Sep 27:dc230805. doi: 10.2337/dc23-0805.
    PubMed     Abstract available


  229. SATTAR N, Taheri S, Astling DP, Chadwick J, et al
    Prediction of Cardiometabolic Health Through Changes in Plasma Proteins With Intentional Weight Loss in the DiRECT and DIADEM-I Randomized Clinical Trials of Type 2 Diabetes Remission.
    Diabetes Care. 2023 Sep 26:dc230602. doi: 10.2337/dc23-0602.
    PubMed     Abstract available


  230. HOLLANDER PA, Krause-Steinrauf H, Butera NM, Kazemi EJ, et al
    The Use of Rescue Insulin in the Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study (GRADE).
    Diabetes Care. 2023 Sep 26:dc230516. doi: 10.2337/dc23-0516.
    PubMed     Abstract available


  231. DRAKE C, Alfaro JM, Blalock DV, Ito K, et al
    Association of Unmet Social Needs With Metformin Use Among Patients With Type 2 Diabetes.
    Diabetes Care. 2023 Sep 26:dc230448. doi: 10.2337/dc23-0448.
    PubMed     Abstract available


  232. CHUNG HF, Dobson AJ, Hayashi K, Hardy R, et al
    Ethnic Differences in the Association Between Age at Natural Menopause and Risk of Type 2 Diabetes Among Postmenopausal Women: A Pooled Analysis of Individual Data From 13 Cohort Studies.
    Diabetes Care. 2023 Sep 26:dc231209. doi: 10.2337/dc23-1209.
    PubMed     Abstract available


  233. STEPANOVA M, Kumar A, Brandt P, Gundurao N, et al
    Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplantations in the U.S.: Data From a National Registry.
    Diabetes Care. 2023 Sep 25:dc231085. doi: 10.2337/dc23-1085.
    PubMed     Abstract available


  234. OLSON RM, Nolan CP, Limaye N, Osei M, et al
    National Prevalence of Diabetes and Barriers to Care Among U.S. Farmworkers and Association With Migrant Worker Status.
    Diabetes Care. 2023 Sep 22:dc230960. doi: 10.2337/dc23-0960.
    PubMed     Abstract available


  235. XIAO Q, Durbin J, Bauer C, Yeung CHC, et al
    Alignment Between 24-h Light-Dark and Activity-Rest Rhythms Is Associated With Diabetes and Glucose Metabolism in a Nationally Representative Sample of American Adults.
    Diabetes Care. 2023 Sep 21:dc231034. doi: 10.2337/dc23-1034.
    PubMed     Abstract available


  236. RENARD E, Joubert M, Villard O, Dreves B, et al
    Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial.
    Diabetes Care. 2023 Sep 20:dc230685. doi: 10.2337/dc23-0685.
    PubMed     Abstract available


  237. BENEDEK T, Wieske V, Szilveszter B, Kofoed KF, et al
    Computed Tomography Versus Invasive Coronary Angiography in Patients With Diabetes and Suspected Coronary Artery Disease.
    Diabetes Care. 2023 Sep 19:dc230710. doi: 10.2337/dc23-0710.
    PubMed     Abstract available


  238. NARCISSE DI, Kim H, Wruck LM, Stebbins AL, et al
    Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial.
    Diabetes Care. 2023 Sep 15:dc230749. doi: 10.2337/dc23-0749.
    PubMed     Abstract available


  239. MAYBERRY LS, Zhao S, Roddy MK, Spieker AJ, et al
    Family Typology for Adults With Type 2 Diabetes: Longitudinal Stability and Validity for Diabetes Management and Well-Being.
    Diabetes Care. 2023 Sep 14:dc230827. doi: 10.2337/dc23-0827.
    PubMed     Abstract available


  240. LIBMAN I, Bingley PJ, Becker D, Buckner JH, et al
    Hydroxychloroquine in Stage 1 Type 1 Diabetes.
    Diabetes Care. 2023 Sep 14:dc231096. doi: 10.2337/dc23-1096.
    PubMed     Abstract available


  241. TOJJAR J, Cervin M, Hedlund E, Brahimi Q, et al
    Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes.
    Diabetes Care. 2023 Sep 12:dc230124. doi: 10.2337/dc23-0124.
    PubMed     Abstract available


  242. KUTZ A, Kim DH, Wexler DJ, Liu J, et al
    Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes.
    Diabetes Care. 2023 Sep 7:dc230671. doi: 10.2337/dc23-0671.
    PubMed     Abstract available


  243. O'DONNELL HK, Rasmussen CG, Dong F, Simmons KM, et al
    Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High Risk for Type 1 Diabetes.
    Diabetes Care. 2023 Sep 6:dc230350. doi: 10.2337/dc23-0350.
    PubMed     Abstract available


  244. NAAMAN SC, Bakris GL
    Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression.
    Diabetes Care. 2023;46:1574-1586.
    PubMed     Abstract available


  245. ANDERSON CAM, Fitzpatrick SL, Buse JB, Kahn SE, et al
    Felicia Hill-Briggs: A Tireless Worker for Better Outcomes and Social Justice in Diabetes.
    Diabetes Care. 2023;46:1572-1573.
    PubMed    


  246. ARTZ O, Meacock L, Elias DA, Edmonds ME, et al
    Grading Fractures on Foot and Ankle X-rays and MRI Scans in the Active Charcot Foot in Diabetes: How Strong Is the Agreement Between Modalities?
    Diabetes Care. 2023;46:1668-1672.
    PubMed     Abstract available


    August 2023
  247. SATHISH T, Khunti K, Narayan KMV, Mohan V, et al
    Effect of Conventional Lifestyle Interventions on Type 2 Diabetes Incidence by Glucose-Defined Prediabetes Phenotype: An Individual-Participant Data Meta-analysis of Randomized Controlled Trials.
    Diabetes Care. 2023 Aug 31:dc230696. doi: 10.2337/dc23-0696.
    PubMed     Abstract available


  248. MIZRAK HI, Hansen TW, Rossing P, Curovic VR, et al
    Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes.
    Diabetes Care. 2023 Aug 30:dc230312. doi: 10.2337/dc23-0312.
    PubMed     Abstract available


  249. SAWICKI CM, Haslam DE, Braun KVE, Drouin-Chartier JP, et al
    Methyl Donor Nutrient Intake and Incidence of Type 2 Diabetes: Results From Three Large U.S. Cohorts.
    Diabetes Care. 2023 Aug 29:dc230662. doi: 10.2337/dc23-0662.
    PubMed     Abstract available


  250. HERNANDEZ TL, Farabi SS, Fosdick BK, Hirsch N, et al
    Randomization to a Provided Higher-Complex-Carbohydrate Versus Conventional Diet in Gestational Diabetes Results in Similar Maternal 24-Hour Glycemia and Newborn Adiposity.
    Diabetes Care. 2023 Aug 29:dc230617. doi: 10.2337/dc23-0617.
    PubMed     Abstract available


  251. MANERKAR K, Crowther CA, Harding JE, Meyer MP, et al
    Impact of Gestational Diabetes Detection Thresholds on Infant Growth and Body Composition: A Prospective Cohort Study Within a Randomized Trial.
    Diabetes Care. 2023 Aug 29:dc230464. doi: 10.2337/dc23-0464.
    PubMed     Abstract available


  252. WU B, Yee SW, Xiao S, Xu F, et al
    Genome-Wide Association Study Identifies Pharmacogenomic Variants Associated With Metformin Glycemic Response in African American Patients With Type 2 Diabetes.
    Diabetes Care. 2023 Aug 28:dc222494. doi: 10.2337/dc22-2494.
    PubMed     Abstract available


  253. ZACCARDI F, Ling S, Brown K, Davies M, et al
    Duration of Type 2 Diabetes and Incidence of Cancer: An Observational Study in England.
    Diabetes Care. 2023 Aug 28:dc231013. doi: 10.2337/dc23-1013.
    PubMed     Abstract available


  254. WEI Y, Herzog K, Ahlqvist E, Andersson T, et al
    All-Cause Mortality and Cardiovascular and Microvascular Diseases in Latent Autoimmune Diabetes in Adults.
    Diabetes Care. 2023 Aug 28:dc230739. doi: 10.2337/dc23-0739.
    PubMed     Abstract available


  255. BARKER MM, Davies MJ, Sargeant JA, Chan JCN, et al
    Age at Type 2 Diabetes Diagnosis and Cause-Specific Mortality: Observational Study of Primary Care Patients in England.
    Diabetes Care. 2023 Aug 25:dc230834. doi: 10.2337/dc23-0834.
    PubMed     Abstract available


  256. BOUGHTON CK, Hartnell S, Lakshman R, Nwokolo M, et al
    Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover Study.
    Diabetes Care. 2023 Aug 24:dc230728. doi: 10.2337/dc23-0728.
    PubMed     Abstract available


  257. SONG C, Dhaliwal S, Bapat P, Scarr D, et al
    Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 Diabetes.
    Diabetes Care. 2023 Aug 24:dc230840. doi: 10.2337/dc23-0840.
    PubMed     Abstract available


  258. NORGAARD K, Ranjan AG, Laugesen C, Tidemand KG, et al
    Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study.
    Diabetes Care. 2023 Aug 23:dc231137. doi: 10.2337/dc23-1137.
    PubMed     Abstract available


  259. HEROLD KC, Gitelman SE, Gottlieb PA, Knecht LA, et al
    Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves beta-Cell Function.
    Diabetes Care. 2023 Aug 22:dc230675. doi: 10.2337/dc23-0675.
    PubMed     Abstract available


  260. HARDING JL, Wander PL, Zhang X, Li X, et al
    Erratum. The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions. Diabetes Care 2022;45:994-1006.
    Diabetes Care. 2023 Aug 21:dc23er11. doi: 10.2337.
    PubMed    


  261. HUH JH, Roh E, Lee SJ, Ihm SH, et al
    Erratum. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.
    Diabetes Care. 2023 Aug 21:dc23er10. doi: 10.2337.
    PubMed    


  262. KE C, Lipscombe LL, Weisman A, Zhou L, et al
    Change in the Relation Between Age and Cardiovascular Events Among Men and Women With Diabetes Compared With Those Without Diabetes in 1994-1999 and 2014-2019: A Population-Based Cohort Study.
    Diabetes Care. 2023 Aug 21:dc230952. doi: 10.2337/dc23-0952.
    PubMed    


  263. CRABTREE TSJ, Griffin TP, Yap YW, Narendran P, et al
    Hybrid Closed Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-World Observational Study.
    Diabetes Care. 2023 Aug 11:dc230635. doi: 10.2337/dc23-0635.
    PubMed     Abstract available


  264. AHMED A, Amin H, Drenos F, Sattar N, et al
    Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes.
    Diabetes Care. 2023 Aug 9:dc230855. doi: 10.2337/dc23-0855.
    PubMed     Abstract available


  265. MOURA FA, Berg DD, Bellavia A, Dwyer JP, et al
    Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes.
    Diabetes Care. 2023 Aug 9:dc230492. doi: 10.2337/dc23-0492.
    PubMed     Abstract available


  266. KRISTENSEN FPB, Sanchez-Lastra MA, Dalene KE, Del Pozo Cruz B, et al
    Leisure-Time Physical Activity and Risk of Microvascular Complications in Individuals With Type 2 Diabetes: A UK Biobank Study.
    Diabetes Care. 2023 Aug 7:dc230937. doi: 10.2337/dc23-0937.
    PubMed     Abstract available


  267. FUHRI SNETHLAGE CM, McDonald TJ, Oram RD, de Groen P, et al
    Residual beta-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.
    Diabetes Care. 2023 Aug 3:dc230776. doi: 10.2337/dc23-0776.
    PubMed     Abstract available


  268. HUANG ES, Sinclair A, Conlin PR, Cukierman-Yaffe T, et al
    The Growing Role of Technology in the Care of Older Adults With Diabetes.
    Diabetes Care. 2023;46:1455-1463.
    PubMed     Abstract available


  269. LITTMAN AJ, Timmons AK, Korpak A, Chan KCG, et al
    Evaluation of the Effectiveness of Remote Foot Temperature Monitoring for Prevention of Amputation in a Large Integrated Health Care System.
    Diabetes Care. 2023;46:1464-1468.
    PubMed     Abstract available


  270. LEVEK N, Faruge-Hadiga R, Pinhas-Hamiel O
    Insulin Omission for Weight Loss in a Female Adolescent Treated With Advanced Hybrid Closed-Loop System: A Word of Caution.
    Diabetes Care. 2023;46:e143-e145.
    PubMed    


  271. HEERSPINK HJL, Sattar N, Pavo I, Haupt A, et al
    Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis.
    Diabetes Care. 2023;46:1501-1506.
    PubMed     Abstract available


  272. HUGHES MS, Kingman RS, Hsu L, Lal RA, et al
    Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water.
    Diabetes Care. 2023;46:e148-e150.
    PubMed    


    July 2023
  273. QIU Z, Lu Q, Wan Z, Geng T, et al
    Associations of Habitual Calcium Supplementation With Risk of Cardiovascular Disease and Mortality in Individuals With and Without Diabetes.
    Diabetes Care. 2023 Jul 28:dc230109. doi: 10.2337/dc23-0109.
    PubMed     Abstract available


  274. OSAFEHINTI D, Mulukutla SN, Hampe CS, Gaba R, et al
    Type 1 Diabetes Genetic Risk Score Differentiates Subgroups of Ketosis-Prone Diabetes.
    Diabetes Care. 2023 Jul 28:dc230622. doi: 10.2337/dc23-0622.
    PubMed     Abstract available


  275. MAINA JG, Balkhiyarova Z, Nouwen A, Pupko I, et al
    Bidirectional Mendelian Randomization and Multiphenotype GWAS Show Causality and Shared Pathophysiology Between Depression and Type 2 Diabetes.
    Diabetes Care. 2023 Jul 26:dc222373. doi: 10.2337/dc22-2373.
    PubMed     Abstract available


  276. KRAAL AZ, Ellingrod VL, Zahodne LB
    Depressive Symptoms Longitudinally Mediate the Effect of Hyperglycemia on Memory Decline in Type 2 Diabetes.
    Diabetes Care. 2023 Jul 25:dc230656. doi: 10.2337/dc23-0656.
    PubMed     Abstract available


  277. DEBRAS C, Deschasaux-Tanguy M, Chazelas E, Sellem L, et al
    Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Sante Cohort.
    Diabetes Care. 2023 Jul 25:dc230206. doi: 10.2337/dc23-0206.
    PubMed     Abstract available


  278. BERG AK, Grauslund AC, Sorensen F, Thorsen SU, et al
    A Skin Care Program to Prevent Skin Problems due to Diabetes Devices in Children and Adolescents: A Cluster-Controlled Intervention Study.
    Diabetes Care. 2023 Jul 21:dc230462. doi: 10.2337/dc23-0462.
    PubMed     Abstract available


  279. GARCIA-TIRADO J, Colmegna P, Villard O, Diaz JL, et al
    Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes.
    Diabetes Care. 2023 Jul 21:dc230119. doi: 10.2337/dc23-0119.
    PubMed     Abstract available


  280. SACKS DB, Arnold M, Bakris GL, Bruns DE, et al
    Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
    Diabetes Care. 2023 Jul 20:dci230036. doi: 10.2337/dci23-0036.
    PubMed     Abstract available


  281. SACKS DB, Arnold M, Bakris GL, Bruns DE, et al
    Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
    Diabetes Care. 2023 Jul 20:dci230048. doi: 10.2337/dci23-0048.
    PubMed     Abstract available


  282. HUH JH, Kwon S, Kim GO, Kim BY, et al
    Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea.
    Diabetes Care. 2023 Jul 20:dc230444. doi: 10.2337/dc23-0444.
    PubMed     Abstract available


  283. LUO Y, Sun L, Wu Q, Song B, et al
    Diet-Related Lipidomic Signatures and Changed Type 2 Diabetes Risk in a Randomized Controlled Feeding Study With Mediterranean Diet and Traditional Chinese or Transitional Diets.
    Diabetes Care. 2023 Jul 18:dc230314. doi: 10.2337/dc23-0314.
    PubMed     Abstract available


  284. GALINDO RJ, Moazzami B, Scioscia MF, Zambrano C, et al
    A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c >/=9-15%: DUAL HIGH Trial.
    Diabetes Care. 2023 Jul 17:dc222426. doi: 10.2337/dc22-2426.
    PubMed     Abstract available


  285. KARAKUS KE, Akturk HK, Alonso GT, Snell-Bergeon JK, et al
    Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade.
    Diabetes Care. 2023 Jul 17:dc230495. doi: 10.2337/dc23-0495.
    PubMed     Abstract available


  286. KALUS A, Shinohara MM, Wang R, Baran JD, et al
    Evaluation of Insulin Pump Infusion Sites in Type 1 Diabetes: The DERMIS Study.
    Diabetes Care. 2023 Jul 14:dc230426. doi: 10.2337/dc23-0426.
    PubMed     Abstract available


  287. VAZQUEZ L, Vazquez Arreola E, Hanson RL, Sinha M, et al
    Glycemic Measures in Childhood as Predictors of Future Diabetes-Related Microvascular Complications in an Indigenous American Population.
    Diabetes Care. 2023 Jul 11:dc230343. doi: 10.2337/dc23-0343.
    PubMed     Abstract available


  288. STOUGAARD EB, Amadid H, Sondergaard E, Carstensen B, et al
    Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes-A Nationwide Danish Register Study.
    Diabetes Care. 2023 Jul 11:dc230475. doi: 10.2337/dc23-0475.
    PubMed     Abstract available


  289. SIMO R, Franch-Nadal J, Vlacho B, Real J, et al
    Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-World Population-Based Study in Subjects With Type 2 Diabetes.
    Diabetes Care. 2023 Jul 10:dc222521. doi: 10.2337/dc22-2521.
    PubMed     Abstract available


  290. GERMINE LT, Han SD, Chaytor NS
    New Methods Permit a Science of Everyday Functioning in Type 1 Diabetes.
    Diabetes Care. 2023;46:1330-1331.
    PubMed    


  291. SCODITTI E, Marchesini G, Gastaldelli A
    Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!
    Diabetes Care. 2023;46:1332-1334.
    PubMed    


  292. VADIVELOO MK, Gardner CD
    Not All Ultra-Processed Foods Are Created Equal: A Case for Advancing Research and Policy That Balances Health and Nutrition Security.
    Diabetes Care. 2023;46:1327-1329.
    PubMed    


  293. GREGG EW, Patorno E, Karter AJ, Mehta R, et al
    Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes.
    Diabetes Care. 2023;46:1316-1326.
    PubMed     Abstract available


  294. FELDMAN-BILLARD S, Massin P, Creuzot-Garcher C
    Comment on Lundeen et al. Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years. Diabetes Care 2023;46:687-696.
    Diabetes Care. 2023;46:e138-e139.
    PubMed    


  295. ROONEY MR, Fang M, Ogurtsova K, Ozkan B, et al
    Global Prevalence of Prediabetes.
    Diabetes Care. 2023;46:1388-1394.
    PubMed     Abstract available


  296. THIOYE EMM, Vicaut E, Larger E, Sal M, et al
    GAD Antibodies in Women With Hyperglycemia in Pregnancy: No Association With Large-for-Gestational-Age Birth Weight.
    Diabetes Care. 2023;46:e136-e137.
    PubMed    


    June 2023

  297. Effect of Early Glycemic Control in Youth-Onset Type 2 Diabetes on Longer-Term Glycemic Control and beta-Cell Function: Results From the TODAY Study.
    Diabetes Care. 2023 Jun 28:dc230560. doi: 10.2337/dc23-0560.
    PubMed     Abstract available


  298. BROWN OI, Drozd M, McGowan H, Giannoudi M, et al
    Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study.
    Diabetes Care. 2023 Jun 27:dc230294. doi: 10.2337/dc23-0294.
    PubMed     Abstract available


  299. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.
    Diabetes Care. 2023 Jun 25:dc23ad08. doi: 10.2337.
    PubMed     Abstract available


  300. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S41-S48.
    Diabetes Care. 2023 Jun 25:dc23ad08a. doi: 10.2337.
    PubMed     Abstract available


  301. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    Addendum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S49-S67.
    Diabetes Care. 2023 Jun 25:dc23ad09. doi: 10.2337.
    PubMed     Abstract available


  302. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    Erratum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S49-S67.
    Diabetes Care. 2023 Jun 25:dc23er09a. doi: 10.2337.
    PubMed     Abstract available


  303. LEVI R, Bleich SN, Seligman HK
    Food Insecurity and Diabetes: Overview of Intersections and Potential Dual Solutions.
    Diabetes Care. 2023 Jun 24:dci230002. doi: 10.2337/dci23-0002.
    PubMed     Abstract available


  304. HILL-BRIGGS F, Fitzpatrick SL
    Overview of Social Determinants of Health in the Development of Diabetes.
    Diabetes Care. 2023 Jun 24:dci230001. doi: 10.2337/dci23-0001.
    PubMed     Abstract available


  305. MUJAHID MS, Maddali SR, Gao X, Oo KH, et al
    The Impact of Neighborhoods on Diabetes Risk and Outcomes: Centering Health Equity.
    Diabetes Care. 2023 Jun 24:dci230003. doi: 10.2337/dci23-0003.
    PubMed     Abstract available


  306. BERKOWITZ SA, Orr CJ
    Three Lessons About Diabetes and the Social Determinants of Health.
    Diabetes Care. 2023 Jun 24:dci230045. doi: 10.2337/dci23-0045.
    PubMed    


  307. DEUTSCH AJ, Schroeder PH, Mandla R, Kang S, et al
    Type 2 Diabetes Polygenic Score Predicts the Risk of Glucocorticoid-Induced Hyperglycemia in Patients Without Diabetes.
    Diabetes Care. 2023 Jun 23:dc230353. doi: 10.2337/dc23-0353.
    PubMed     Abstract available


  308. BOTROS FT, Gerstein HC, Malik R, Nicolay C, et al
    Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis.
    Diabetes Care. 2023 Jun 21:dc230231. doi: 10.2337/dc23-0231.
    PubMed     Abstract available


  309. KJERPESETH LJ, Cesta CE, Furu K, Engeland A, et al
    Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study.
    Diabetes Care. 2023 Jun 21:dc230256. doi: 10.2337/dc23-0256.
    PubMed     Abstract available


  310. NYGAARD M, Willaing I, Joensen LE, Lindgreen P, et al
    A Short-Form Measure of Diabetes Distress Among Adults With Type 1 Diabetes for Use in Clinical Practice: Development and Validation of the T1-DDS-7.
    Diabetes Care. 2023 Jun 21:dc230460. doi: 10.2337/dc23-0460.
    PubMed     Abstract available


  311. MCCARTHY KJ, Liu SH, Huynh M, Kennedy J, et al
    Influence of Gestational Diabetes Mellitus on Diabetes Risk and Glycemic Control in a Retrospective Population-Based Cohort.
    Diabetes Care. 2023 Jun 21:dc221676. doi: 10.2337/dc22-1676.
    PubMed     Abstract available


  312. KRISTENSEN FPB, Christensen DH, Callaghan BC, Stidsen JV, et al
    The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of beta-Cell Function and Insulin Sensitivity.
    Diabetes Care. 2023 Jun 19:dc230079. doi: 10.2337/dc23-0079.
    PubMed     Abstract available


  313. ALKABBANI W, Maxwell CJ, Marrie RA, Tyas SL, et al
    Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study.
    Diabetes Care. 2023 Jun 14:dc230222. doi: 10.2337/dc23-0222.
    PubMed     Abstract available


  314. ROSSING P, Burgess E, Agarwal R, Anker SD, et al
    Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888-897.
    Diabetes Care. 2023 Jun 13:dc23er09. doi: 10.2337.
    PubMed     Abstract available


  315. SRINIVASAN S, Liju S, Sathish N, Siddiqui MK, et al
    Common and Distinct Genetic Architecture of Age at Diagnosis of Diabetes in South Indian and European Populations.
    Diabetes Care. 2023 Jun 12:dc230243. doi: 10.2337/dc23-0243.
    PubMed     Abstract available


  316. PAN Y, Zhong X, Qiu W, Zhao F, et al
    New-Onset Fulminant Type 1 Diabetes After SARS-CoV-2 Infection.
    Diabetes Care. 2023 Jun 12:dc230536. doi: 10.2337/dc23-0536.
    PubMed    


  317. WANDER PL, Lowy E, Beste LA, Tulloch-Palomino L, et al
    Erratum. The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection. Diabetes Care 2022;45:782-788.
    Diabetes Care. 2023 Jun 8:dc23er08. doi: 10.2337.
    PubMed     Abstract available


  318. ZHOU C, He P, Ye Z, Zhang Y, et al
    Erratum. Relationships of Serum 25-Hydroxyvitamin D Concentrations, Diabetes, Genetic Susceptibility, and New-Onset Chronic Kidney Disease. Diabetes Care 2022;45:2518-2525.
    Diabetes Care. 2023 Jun 6:dc23er08a. doi: 10.2337.
    PubMed     Abstract available


  319. SHARAN R, Wiens K, Ronksley PE, Hwang SW, et al
    The Association of Homelessness With Rates of Diabetes Complications: A Population-Based Cohort Study.
    Diabetes Care. 2023 Jun 5:dc230211. doi: 10.2337/dc23-0211.
    PubMed     Abstract available


  320. ZAREINI B, Sorensen KK, Eiken PA, Fischer TK, et al
    Association of Coronavirus Disease 2019 and Development of Type 1 Diabetes: A Danish Nationwide Register Study.
    Diabetes Care. 2023 Jun 5:dc230428. doi: 10.2337/dc23-0428.
    PubMed     Abstract available


  321. ALEXOPOULOS AS, Crowley MJ, Kahkoska AR
    Diabetes Medication Changes in Older Adults With Type 2 Diabetes: Insights Into Physician Factors and Questions Ahead.
    Diabetes Care. 2023;46:1137-1139.
    PubMed    


  322. REDONDO MJ, van Raalte DH
    Age Ain't Nothing But a Number . . . or Is It?
    Diabetes Care. 2023;46:1135-1136.
    PubMed    


  323. CHANG AR, Bailey-Davis L
    Food Is Medicine, but Are Produce Prescriptions?
    Diabetes Care. 2023;46:1140-1142.
    PubMed    


  324. ARSENAULT BJ, Despres JP
    Physical Activity for Type 2 Diabetes Prevention: Some Is Better Than None, More Is Better, and Earliest Is Best.
    Diabetes Care. 2023;46:1132-1134.
    PubMed    


  325. RODRIGUEZ-VALADEZ JM, Tahsin M, Fleischmann KE, Masharani U, et al
    Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression.
    Diabetes Care. 2023;46:1300-1310.
    PubMed     Abstract available


  326. WU L, Tsang V, Menzies AM, Sasson SC, et al
    Risk Factors and Characteristics of Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus (CIADM): A Systematic Review and Delineation From Type 1 Diabetes.
    Diabetes Care. 2023;46:1292-1299.
    PubMed     Abstract available


  327. VAN POPPEL MNM, Damm P, Mathiesen ER, Ringholm L, et al
    Is the Biphasic Effect of Diabetes and Obesity on Fetal Growth a Risk Factor for Childhood Obesity?
    Diabetes Care. 2023;46:1124-1131.
    PubMed     Abstract available


  328. ALONSO GT, Triolo TM, Akturk HK, Pauley ME, et al
    Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population.
    Diabetes Care. 2023;46:1218-1222.
    PubMed     Abstract available


  329. MITTENDORFER B, Patterson BW, Haire-Joshu D, Cahill AG, et al
    Insulin Sensitivity and beta-Cell Function During Early and Late Pregnancy in Women With and Without Gestational Diabetes Mellitus.
    Diabetes Care. 2023 Jun 1:dc221894. doi: 10.2337/dc22-1894.
    PubMed     Abstract available


    May 2023
  330. PETERSON KA, Carlin CS, Solberg LI, Normington J, et al
    Care Management Processes Important for High-Quality Diabetes Care.
    Diabetes Care. 2023 May 31:dc222372. doi: 10.2337/dc22-2372.
    PubMed     Abstract available


  331. QIAN J, Xiao Q, Walkup MP, Coday M, et al
    Association of Timing of Moderate-to-Vigorous Physical Activity With Changes in Glycemic Control Over 4 Years in Adults With Type 2 Diabetes From the Look AHEAD Trial.
    Diabetes Care. 2023 May 25:dc222413. doi: 10.2337/dc22-2413.
    PubMed     Abstract available


  332. HOLMAN N, Woch E, Dayan C, Warner J, et al
    National Trends in Hyperglycemia and Diabetic Ketoacidosis in Children, Adolescents, and Young Adults With Type 1 Diabetes: A Challenge Due to Age or Stage of Development, or Is New Thinking About Service Provision Needed?
    Diabetes Care. 2023 May 22:dc230180. doi: 10.2337/dc23-0180.
    PubMed     Abstract available


  333. LEVY CJ, Kudva YC, Ozaslan B, Castorino K, et al
    At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter Study.
    Diabetes Care. 2023 May 17:dc230173. doi: 10.2337/dc23-0173.
    PubMed     Abstract available


  334. SRIDHAR VS, Heerspink HJL, Davies MJ, Banks P, et al
    The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3.
    Diabetes Care. 2023 May 12:dc230129. doi: 10.2337/dc23-0129.
    PubMed    


  335. GALINDO RJ, Inselman SA, Umpierrez GE, Moazzami B, et al
    National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017.
    Diabetes Care. 2023 May 11:dc230554. doi: 10.2337/dc23-0554.
    PubMed    


  336. LI X, van Giessen A, Altunkaya J, Slieker RC, et al
    Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups.
    Diabetes Care. 2023 May 5:dc222170. doi: 10.2337/dc22-2170.
    PubMed     Abstract available


  337. LIU X, Johnson SB, Lynch KF, Cordan K, et al
    Physical Activity and the Development of Islet Autoimmunity and Type 1 Diabetes in 5-15-Year-Old Children Followed in the TEDDY Study.
    Diabetes Care. 2023 May 4:dc230036. doi: 10.2337/dc23-0036.
    PubMed     Abstract available


  338. DENZER C, Rosenbauer J, Klose D, Korner A, et al
    Is COVID-19 to Blame? Trends of Incidence and Sex Ratio in Youth-Onset Type 2 Diabetes in Germany.
    Diabetes Care. 2023 May 4:dc222257. doi: 10.2337/dc22-2257.
    PubMed     Abstract available


  339. HAIDAR A, Legault L, Raffray M, Gouchie-Provencher N, et al
    A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.
    Diabetes Care. 2023 May 3:dc222297. doi: 10.2337/dc22-2297.
    PubMed     Abstract available


  340. FLEETWOOD KJ, Wild SH, Licence KAM, Mercer SW, et al
    Severe Mental Illness and Type 2 Diabetes Outcomes and Complications: A Nationwide Cohort Study.
    Diabetes Care. 2023 May 2:dc230177. doi: 10.2337/dc23-0177.
    PubMed     Abstract available


  341. THAWEETHAI T, Soetan Z, James K, Florez JC, et al
    Distinct Insulin Physiology Trajectories in Euglycemic Pregnancy and Gestational Diabetes Mellitus.
    Diabetes Care. 2023 May 1:dc222226. doi: 10.2337/dc22-2226.
    PubMed     Abstract available


  342. TAM CHT, Lim CKP, Luk AOY, Shi M, et al
    Identification of a Common Variant for Coronary Heart Disease at PDE1A Contributes to Individualized Treatment Goals and Risk Stratification of Cardiovascular Complications in Chinese Patients With Type 2 Diabetes.
    Diabetes Care. 2023 May 1:dc222331. doi: 10.2337/dc22-2331.
    PubMed     Abstract available


  343. PUTMAN MS, Norris AW, Hull RL, Rickels MR, et al
    Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
    Diabetes Care. 2023 May 1:dc230380. doi: 10.2337/dc23-0380.
    PubMed     Abstract available


  344. KAHKOSKA AR, Cristello Sarteau A, Crowley MJ
    Delivering on the Promise of Technology to Augment Behavioral Interventions in Type 2 Diabetes.
    Diabetes Care. 2023;46:918-920.
    PubMed    


  345. CEFALU WT
    COVID-19 and Rising Incidence of Diabetes: Despite Evolving Data, an Enigma Still to Be Solved.
    Diabetes Care. 2023;46:913-915.
    PubMed    


  346. FRANKS PW
    Socioeconomic Disparities Across the Spectrum of Genetic Burden in Type 2 Diabetes and Obesity Risk.
    Diabetes Care. 2023;46:916-917.
    PubMed    


  347. MANAS-MARTINEZ AB, Gimeno-Orna JA
    Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
    Diabetes Care. 2023;46:e119.
    PubMed    


  348. TANG M, Kalim S
    Response to Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130-137.
    Diabetes Care. 2023;46:e116.
    PubMed    


  349. BEZIN J, Mathieu C, Faillie JL, Pariente A, et al
    Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
    Diabetes Care. 2023;46:e121-e122.
    PubMed    


  350. SMITS MM, van Raalte DH
    Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
    Diabetes Care. 2023;46:e120.
    PubMed    


  351. ENDO M, Roth MY, Tylee TS, DeSantis A, et al
    Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
    Diabetes Care. 2023;46:e118.
    PubMed    


  352. DUARTE RV, Nevitt S, Copley S, Maden M, et al
    Response to Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466-2475.
    Diabetes Care. 2023;46:e113-e114.
    PubMed    


  353. SADEGHIRAD B, Wang X, Busse JW
    Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466-2475.
    Diabetes Care. 2023;46:e112.
    PubMed    


  354. YANG J, Rana J, Yang A
    Comment on Galvez-Fernandez et al. Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study. Diabetes Care 2022;45:2561-2569.
    Diabetes Care. 2023;46:e108.
    PubMed    


  355. SHARAN AD, Hatheway JA, Murphy M, Dann T, et al
    Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466-2475.
    Diabetes Care. 2023;46:e110-e111.
    PubMed    


  356. FOUSSARD N, Larroumet A, Ferriere A, Blanco L, et al
    Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130-137.
    Diabetes Care. 2023;46:e115.
    PubMed    


  357. CELIS-MORALES CA, Eliasson B, Sattar N
    Response to Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care 2022;45:634-641.
    Diabetes Care. 2023;46:e107.
    PubMed    


  358. YU OHY, Suissa S
    Metformin and Cancer: Solutions to a Real-World Evidence Failure.
    Diabetes Care. 2023;46:904-912.
    PubMed     Abstract available


  359. GOLDENBERG RM, Jain AB
    Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
    Diabetes Care. 2023;46:e117.
    PubMed    


  360. GALVEZ-FERNANDEZ M, Navas-Acien A
    Response to Comment on Galvez-Fernandez et al. Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study. Diabetes Care 2022;45:2561-2569.
    Diabetes Care. 2023;46:e109.
    PubMed    


  361. MENG X, Wang Y
    Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care 2022;45:634-641.
    Diabetes Care. 2023;46:e106.
    PubMed    


  362. SOSENKO JM, Cuthbertson D, Sims EK, Ismail HM, et al
    Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies.
    Diabetes Care. 2023;46:1098-1105.
    PubMed     Abstract available


  363. GERSTEIN HC, Lee SF, Pare G, Bethel MA, et al
    Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis.
    Diabetes Care. 2023;46:1046-1051.
    PubMed     Abstract available


  364. ABDELGANI S, Khattab A, Adams J, Abu-Farha M, et al
    Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients.
    Diabetes Care. 2023;46:978-984.
    PubMed     Abstract available


    April 2023

  365. The Rare and Atypical Diabetes Network (RADIANT) Study: Design and Early Results.
    Diabetes Care. 2023 Apr 27:dc222440. doi: 10.2337/dc22-2440.
    PubMed     Abstract available


  366. MULLIGAN K, Kim J, Tysinger B, Blim J, et al
    The Broader Economic Value of Treatment for Diabetic Macular Edema.
    Diabetes Care. 2023 Apr 26:dc222527. doi: 10.2337/dc22-2527.
    PubMed     Abstract available


  367. RITCHIE ND, Sauder KA, Perreault L
    Glycemic Improvement and Health Equity in the National Diabetes Prevention Program.
    Diabetes Care. 2023 Apr 21:dc230552. doi: 10.2337/dc23-0552.
    PubMed    


  368. FAN B, Lim CKP, Poon EWM, Lau ESH, et al
    Differential Associations of GAD Antibodies (GADA) and C-Peptide With Insulin Initiation, Glycemic Responses, and Severe Hypoglycemia in Patients Diagnosed With Type 2 Diabetes.
    Diabetes Care. 2023 Apr 19:dc222301. doi: 10.2337/dc22-2301.
    PubMed     Abstract available


  369. TORNESE G, Carletti C, Lanzetta MA, Tamaro G, et al
    Safety of Real-life Usage of Advanced Hybrid Closed Loop System MiniMed 780G in Children With Type 1 Diabetes Younger Than Seven Years Old.
    Diabetes Care. 2023 Apr 17:dc222046. doi: 10.2337/dc22-2046.
    PubMed    


  370. SCARTON L, Nelson T, Yao Y, DeVaughan-Circles A, et al
    Association of Medication Adherence With HbA1c Control Among American Indian Adults With Type 2 Diabetes Using Tribal Health Services.
    Diabetes Care. 2023 Apr 17:dc221885. doi: 10.2337/dc22-1885.
    PubMed     Abstract available


  371. MANGELIS A, Wijewickrama P, Nirmalakumaran A, Fountoulakis N, et al
    People With Type 1 Diabetes of African Caribbean Ethnicity Are at Increased Risk of Developing Sight-Threatening Diabetic Retinopathy.
    Diabetes Care. 2023 Apr 16:dc222118. doi: 10.2337/dc22-2118.
    PubMed     Abstract available


  372. NOORZAE R, Junker TG, Hviid AP, Wohlfahrt J, et al
    Risk of Type 1 Diabetes in Children Is Not Increased After SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark.
    Diabetes Care. 2023 Apr 14:dc222351. doi: 10.2337/dc22-2351.
    PubMed     Abstract available


  373. BARZILAY JI, Tressel W, Biggs ML, Stein PK, et al
    Erratum. The Association of Measures of Cardiovascular Autonomic Function, Heart Rate, and Orthostatic Hypotension With Incident Glucose Disorders: The Cardiovascular Health Study. Diabetes Care 2022;45:2376-2382.
    Diabetes Care. 2023 Apr 13:dc23er06a. doi: 10.2337.
    PubMed     Abstract available


  374. JENSEN ET, Rigdon J, Rezaei KA, Saaddine J, et al
    Prevalence, Progression, and Modifiable Risk Factors for Diabetic Retinopathy in Youth and Young Adults With Youth-Onset Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2023 Apr 12:dc222503. doi: 10.2337/dc22-2503.
    PubMed     Abstract available


  375. WANG G, Buckley JP, Bartell TR, Hong X, et al
    Gestational Diabetes Mellitus, Postpartum Lipidomic Signatures, and Subsequent Risk of Type 2 Diabetes: A Lipidome-Wide Association Study.
    Diabetes Care. 2023 Apr 12:dc221841. doi: 10.2337/dc22-1841.
    PubMed     Abstract available


  376. CASTERA L, Laouenan C, Vallet-Pichard A, Vidal-Trecan T, et al
    High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold.
    Diabetes Care. 2023 Apr 12:dc222048. doi: 10.2337/dc22-2048.
    PubMed     Abstract available


  377. CAREY IM, Critchley JA, Chaudhry UAR, DeWilde S, et al
    Evaluating Ethnic Variations in the Risk of Infections in People With Prediabetes and Type 2 Diabetes: A Matched Cohort Study.
    Diabetes Care. 2023 Apr 12:dc222394. doi: 10.2337/dc22-2394.
    PubMed     Abstract available


  378. NG JKC, Ling J, Luk AOY, Lau ESH, et al
    Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis.
    Diabetes Care. 2023 Apr 12:dc222348. doi: 10.2337/dc22-2348.
    PubMed     Abstract available


  379. WENZL FA, Mengozzi A, Mohammed SA, Pugliese NR, et al
    Circulating Long Noncoding RNA Signatures Associate With Incident Diabetes in Older Adults: a Prospective Analysis From the VITA Cohort Study.
    Diabetes Care. 2023 Apr 11:dc230012. doi: 10.2337/dc23-0012.
    PubMed     Abstract available


  380. LEE JJ, Khan T, Sievenpiper JL
    Response to Comment on Lee et al. Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies. Diabetes Care 2022;45:1917-1930.
    Diabetes Care. 2023;46:e99-e100.
    PubMed    


  381. CHEW EY
    The Clinical Significance and Implications of Developing Diabetic Retinopathy During the 5 Years Following the Diagnosis of Type 1 Diabetes.
    Diabetes Care. 2023;46:678-679.
    PubMed    


  382. KAHN SE, Anderson CAM, Atkinson MA, Bakris GL, et al
    Reducing Bias in Academic Publishing: The Diabetes Care Approach.
    Diabetes Care. 2023;46:665-666.
    PubMed    


  383. EGEDE LE, Campbell JA, Walker RJ, Linde S, et al
    Structural Racism as an Upstream Social Determinant of Diabetes Outcomes: A Scoping Review.
    Diabetes Care. 2023;46:667-677.
    PubMed     Abstract available


  384. BUZIAU AM, Blokland GAM, Schalkwijk CG, Scheijen JLJM, et al
    Comment on Lee et al. Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies. Diabetes Care 2022;45:1917-1930.
    Diabetes Care. 2023;46:e97-e98.
    PubMed    


  385. HERZIG D, Vettoretti M, Guensch DP, Melmer A, et al
    Performance of the Dexcom G6 Continuous Glucose Monitoring System During Cardiac Surgery Using Hypothermic Extracorporeal Circulation.
    Diabetes Care. 2023;46:864-867.
    PubMed     Abstract available


  386. WRIGHT JJ, Williams JM, Letourneau-Freiberg LR, Kandasamy B, et al
    Insulin Deficiency From Insulin Gene Mutation Leads to Smaller Pancreas.
    Diabetes Care. 2023;46:773-776.
    PubMed     Abstract available


    March 2023
  387. WAGNER S, Norgaard K, Willaing I, Olesen K, et al
    Upper-Extremity Impairments in Type 1 Diabetes: Results From a Controlled Nationwide Study.
    Diabetes Care. 2023 Mar 31:dc230063. doi: 10.2337/dc23-0063.
    PubMed     Abstract available


  388. CASTELLANOS LE, Russell SJ, Damiano ER, Beck RW, et al
    The Insulin-Only Bionic Pancreas Improves Glycemic Control in Non-Hispanic White and Minority Adults and Children With Type 1 Diabetes.
    Diabetes Care. 2023 Mar 31:dc221478. doi: 10.2337/dc22-1478.
    PubMed     Abstract available


  389. DEN BRAVER NR, Beulens JWJ, Wu CF, Fazli GS, et al
    Higher Neighborhood Drivability Is Associated With a Higher Diabetes Risk in Younger Adults: A Population-Based Cohort Study in Toronto, Canada.
    Diabetes Care. 2023 Mar 23:dc221549. doi: 10.2337/dc22-1549.
    PubMed     Abstract available


  390. WANG H, Cordiner RLM, Huang Y, Donnelly L, et al
    Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-Line Drugs: A Nation-Wide Population-Based Comparative Safety Study.
    Diabetes Care. 2023 Mar 21:dc221238. doi: 10.2337/dc22-1238.
    PubMed     Abstract available


  391. BUE-VALLESKEY JM, Kazda CM, Ma C, Chien J, et al
    Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial.
    Diabetes Care. 2023 Mar 21:dc222396. doi: 10.2337/dc22-2396.
    PubMed     Abstract available


  392. LEE H, Choi J, Kim NY, Kim JI, et al
    Earlier Age at Type 2 Diabetes Diagnosis Is Associated With Increased Genetic Risk of Cardiovascular Disease.
    Diabetes Care. 2023 Mar 20:dc222144. doi: 10.2337/dc22-2144.
    PubMed     Abstract available


  393. TARASEWICZ D, Karter AJ, Pimentel N, Moffet HH, et al
    Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm.
    Diabetes Care. 2023 Mar 17:dc221168. doi: 10.2337/dc22-1168.
    PubMed     Abstract available


  394. GEDEBJERG A, Bjerre M, Kjaergaard AD, Nielsen JS, et al
    CRP, C-Peptide, and Risk of First-Time Cardiovascular Events and Mortality in Early Type 2 Diabetes: A Danish Cohort Study.
    Diabetes Care. 2023 Mar 17:dc221353. doi: 10.2337/dc22-1353.
    PubMed     Abstract available


  395. CHRISTENSEN MH, Andersen MS, Rubin KH, Nohr EA, et al
    Psychiatric Morbidity in Women With Previous Gestational Diabetes Mellitus: A Nationwide Register-Based Cohort Study.
    Diabetes Care. 2023 Mar 16:dc221961. doi: 10.2337/dc22-1961.
    PubMed     Abstract available


  396. KAZDA CM, Bue-Valleskey JM, Chien J, Zhang Q, et al
    Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes.
    Diabetes Care. 2023 Mar 15:dc222395. doi: 10.2337/dc22-2395.
    PubMed     Abstract available


  397. SNG GGR, Tung JYM, Lim DYZ, Bee YM, et al
    Potential and Pitfalls of ChatGPT and Natural-Language Artificial Intelligence Models for Diabetes Education.
    Diabetes Care. 2023 Mar 15:dc230197. doi: 10.2337/dc23-0197.
    PubMed    


  398. REDDY S, Wu CC, Jose A, Hsieh JL, et al
    Personalized Virtual Care Using Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Less Intensive Therapies.
    Diabetes Care. 2023 Mar 15:cd220128. doi: 10.2337/cd22-0128.
    PubMed    


  399. RUSSELL WE, Bundy BN, Anderson MS, Cooney LA, et al
    Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.
    Diabetes Care. 2023 Mar 15:dc222200. doi: 10.2337/dc22-2200.
    PubMed     Abstract available


  400. MARTINEZ-MONTORO JI, Picon-Cesar MJ, Simon-Frapolli VJ, Pinzon-Martin JL, et al
    Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study.
    Diabetes Care. 2023 Mar 8:dc230083. doi: 10.2337/dc23-0083.
    PubMed    


  401. EITEL KB, Roberts AJ, D'Agostino R, Barrett CE, et al
    Diabetes Stigma and Clinical Outcomes in Adolescents and Young Adults: the SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2023 Mar 8:dc221749. doi: 10.2337/dc22-1749.
    PubMed     Abstract available


  402. EDSTORP J, Ahlqvist E, Alfredsson L, Aly DM, et al
    Incidence of LADA and Type 2 Diabetes in Relation to Tobacco Use and Genetic Susceptibility to Type 2 Diabetes and Related Traits: Findings From a Swedish Case-Control Study and the Norwegian HUNT Study.
    Diabetes Care. 2023 Mar 3:dc222284. doi: 10.2337/dc22-2284.
    PubMed     Abstract available


  403. THORSEN SU, Liu X, Kataria Y, Mandrup-Poulsen T, et al
    Interaction Between Dietary Iron Intake and Genetically Determined Iron Overload: Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in the TEDDY Study.
    Diabetes Care. 2023 Mar 3:dc221359. doi: 10.2337/dc22-1359.
    PubMed     Abstract available


  404. FROHNERT BI, Ghalwash M, Li Y, Ng K, et al
    Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity.
    Diabetes Care. 2023 Mar 2:dc221960. doi: 10.2337/dc22-1960.
    PubMed     Abstract available


  405. PYATAK EA, Spruijt-Metz D, Schneider S, Hernandez R, et al
    Impact of Overnight Glucose on Next-Day Functioning in Adults With Type 1 Diabetes: An Exploratory Intensive Longitudinal Study.
    Diabetes Care. 2023 Mar 2:dc222008. doi: 10.2337/dc22-2008.
    PubMed     Abstract available


  406. SERES-NORIEGA T, Boswell L, Perea V, Amor AJ, et al
    Response to Comment on Seres-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412-2421.
    Diabetes Care. 2023;46:e87-e88.
    PubMed    


  407. PERNG W, Conway R, Mayer-Davis E, Dabelea D, et al
    Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic.
    Diabetes Care. 2023;46:490-499.
    PubMed     Abstract available


  408. KHAN TA, Field D, Chen V, Ahmad S, et al
    Combination of Multiple Low-Risk Lifestyle Behaviors and Incident Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies.
    Diabetes Care. 2023;46:643-656.
    PubMed     Abstract available


  409. GONZALEZ-CLEMENTE JM, Llaurado G, Cano A, Gimenez-Palop O, et al
    Comment on Seres-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412-2421.
    Diabetes Care. 2023;46:e85-e86.
    PubMed    


  410. HEISE T, DeVries JH, Urva S, Li J, et al
    Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.
    Diabetes Care. 2023 Mar 1:dc221710. doi: 10.2337/dc22-1710.
    PubMed     Abstract available


  411. WILSON DM, Pietropaolo SL, Acevedo-Calado M, Huang S, et al
    CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.
    Diabetes Care. 2023;46:526-534.
    PubMed     Abstract available


  412. NABILA S, Kim JE, Choi J, Park J, et al
    Associations Between Modifiable Risk Factors and Changes in Glycemic Status Among Individuals With Prediabetes.
    Diabetes Care. 2023;46:535-543.
    PubMed     Abstract available


  413. SUZUKI S, Kokumai T, Furuya A, Takahashi S, et al
    SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY.
    Diabetes Care. 2023;46:e74-e75.
    PubMed    


  414. RIGBY MR, Hayes B, Li Y, Vercruysse F, et al
    Two-Year Follow-up From the T1GER Study: Continued Off-Therapy Metabolic Improvements in Children and Young Adults With New-Onset T1D Treated With Golimumab and Characterization of Responders.
    Diabetes Care. 2023;46:561-569.
    PubMed     Abstract available


  415. XIANG AH
    Diabetes in Pregnancy for Mothers and Offspring: Reflection on 30 Years of Clinical and Translational Research: The 2022 Norbert Freinkel Award Lecture.
    Diabetes Care. 2023;46:482-489.
    PubMed     Abstract available


    February 2023
  416. CHEN Z, Khandpur N, Desjardins C, Wang L, et al
    Ultra-Processed Food Consumption and Risk of Type 2 Diabetes: Three Large Prospective U.S. Cohort Studies.
    Diabetes Care. 2023 Feb 28:dc221993. doi: 10.2337/dc22-1993.
    PubMed     Abstract available


  417. LI R, Shen M, Yang Q, Fairley CK, et al
    Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19- Related Severity and Mortality: A Systematic Review and Meta-analysis.
    Diabetes Care. 2023 Feb 24:dc221943. doi: 10.2337/dc22-1943.
    PubMed     Abstract available


  418. LEE YB, Kim G, Jun JE, Park H, et al
    An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial.
    Diabetes Care. 2023 Feb 23:dc221929. doi: 10.2337/dc22-1929.
    PubMed     Abstract available


  419. HAGER K, Shi P, Li Z, Chui K, et al
    Evaluation of a Produce Prescription Program for Patients With Diabetes: A Longitudinal Analysis of Glycemic Control.
    Diabetes Care. 2023 Feb 22:dc221645. doi: 10.2337/dc22-1645.
    PubMed     Abstract available


  420. THOMAS NJ, Hill AV, Dayan CM, Oram RA, et al
    Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes.
    Diabetes Care. 2023 Feb 21:dc222159. doi: 10.2337/dc22-2159.
    PubMed     Abstract available


  421. PILLA SJ, Jalalzai R, Tang O, Schoenborn NL, et al
    A National Physician Survey of Deintensifying Diabetes Medications for Older Adults With Type 2 Diabetes.
    Diabetes Care. 2023 Feb 17:dc222146. doi: 10.2337/dc22-2146.
    PubMed     Abstract available


  422. CHEN J, Yuan S, Fu T, Ruan X, et al
    Gastrointestinal Consequences of Type 2 Diabetes Mellitus and Impaired Glycemic Homeostasis: A Mendelian Randomization Study.
    Diabetes Care. 2023 Feb 17:dc221385. doi: 10.2337/dc22-1385.
    PubMed     Abstract available


  423. REAVEN PD, Newell M, Rivas S, Zhou X, et al
    Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration.
    Diabetes Care. 2023 Feb 17:dc222189. doi: 10.2337/dc22-2189.
    PubMed     Abstract available


  424. LEHMANN V, Foll S, Maritsch M, van Weenen E, et al
    Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data.
    Diabetes Care. 2023 Feb 17:dc222290. doi: 10.2337/dc22-2290.
    PubMed     Abstract available


  425. HEERSPINK HJL, Apperloo E, Davies M, Dicker D, et al
    Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials.
    Diabetes Care. 2023 Feb 17:dc221889. doi: 10.2337/dc22-1889.
    PubMed     Abstract available


  426. MORICONI D, Sacchetta L, Chiriaco M, Nesti L, et al
    Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study.
    Diabetes Care. 2023 Feb 14:dc222003. doi: 10.2337/dc22-2003.
    PubMed     Abstract available


  427. PRADA M, Eichelmann F, Wittenbecher C, Kuxhaus O, et al
    Plasma Lipidomic n-6 Polyunsaturated Fatty Acids and Type 2 Diabetes Risk in the EPIC-Potsdam Prospective Cohort Study.
    Diabetes Care. 2023 Feb 14:dc221435. doi: 10.2337/dc22-1435.
    PubMed     Abstract available


  428. CROMER SJ, Lakhani CM, Mercader JM, Majarian TD, et al
    Association and Interaction of Genetics and Area-Level Socioeconomic Factors on the Prevalence of Type 2 Diabetes and Obesity.
    Diabetes Care. 2023 Feb 14:dc221954. doi: 10.2337/dc22-1954.
    PubMed     Abstract available


  429. TAWFIK YMK, Van Tassell BW, Dixon DL, Baker WL, et al
    Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
    Diabetes Care. 2023 Feb 14:dc222040. doi: 10.2337/dc22-2040.
    PubMed     Abstract available


  430. HU Y, Liu G, Yu E, Wang B, et al
    Low-Carbohydrate Diet Scores and Mortality Among Adults With Incident Type 2 Diabetes.
    Diabetes Care. 2023 Feb 14:dc222310. doi: 10.2337/dc22-2310.
    PubMed     Abstract available


  431. DAVIS GM, Peters AL, Bode BW, Carlson AL, et al
    Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.
    Diabetes Care. 2023 Feb 14:dc221915. doi: 10.2337/dc22-1915.
    PubMed     Abstract available


  432. ADESOBA TP, Brown CC
    Trends in the Prevalence of Lean Diabetes Among U.S. Adults, 2015-2020.
    Diabetes Care. 2023 Feb 10:dc221847. doi: 10.2337/dc22-1847.
    PubMed     Abstract available


  433. JING J, Liu C, Zhu W, Pan Y, et al
    Increased Resting-State Functional Connectivity as a Compensatory Mechanism for Reduced Brain Volume in Prediabetes and Type 2 Diabetes.
    Diabetes Care. 2023 Feb 7:dc221998. doi: 10.2337/dc22-1998.
    PubMed     Abstract available


  434. SELVARAJAH D, Sloan G, Teh K, Wilkinson ID, et al
    Structural Brain Alterations in Key Somatosensory and Nociceptive Regions in Diabetic Peripheral Neuropathy.
    Diabetes Care. 2023 Feb 7:dc221123. doi: 10.2337/dc22-1123.
    PubMed     Abstract available


  435. RIDDELL MC, Li Z, Gal RL, Calhoun P, et al
    Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI).
    Diabetes Care. 2023 Feb 7:dc221721. doi: 10.2337/dc22-1721.
    PubMed     Abstract available


  436. DEUTSCH AJ, Stalbow L, Majarian TD, Mercader JM, et al
    Polygenic Scores Help Reduce Racial Disparities in Predictive Accuracy of Automated Type 1 Diabetes Classification Algorithms.
    Diabetes Care. 2023 Feb 6:dc221833. doi: 10.2337/dc22-1833.
    PubMed     Abstract available


  437. WANDELL P, Li X, Saleh Stattin N, Carlsson AC, et al
    Diabetes During Pregnancy Among Immigrants in Sweden: A National Cohort Study of All Pregnant Women in Sweden.
    Diabetes Care. 2023 Feb 6:dc222180. doi: 10.2337/dc22-2180.
    PubMed    


  438. NWOSU UA, Darbinian JA, Chen KK, Zeng B, et al
    Prevalence of Albuminuria Among Adults With Diabetes and Preserved Estimated Glomerular Filtration Rate by Race and Ethnicity.
    Diabetes Care. 2023 Feb 6:dc221871. doi: 10.2337/dc22-1871.
    PubMed    


  439. URBINA EM, Isom S, Dabelea D, D'Agostino R, et al
    Association of Elevated Arterial Stiffness With Cardiac Target Organ Damage and Cardiac Autonomic Neuropathy in Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2023 Feb 2:dc221703. doi: 10.2337/dc22-1703.
    PubMed     Abstract available


  440. CALIFF RM
    Our National Approach to Diabetes.
    Diabetes Care. 2023;46:252-254.
    PubMed    


  441. WYLIE-ROSETT J, DiMeglio LA
    Strategies to Reduce Food Insecurity for People With Diabetes: A Call to Action.
    Diabetes Care. 2023;46:245-248.
    PubMed    


  442. BARBARESKO J, Lang A, Szczerba E, Baechle C, et al
    Dietary Factors and All-Cause Mortality in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Prospective Observational Studies.
    Diabetes Care. 2023;46:469-477.
    PubMed     Abstract available


  443. KAHN SE, Anderson CAM, Buse JB, Selvin E, et al
    The Art of Diabetes Care.
    Diabetes Care. 2023;46:227.
    PubMed    


  444. SCHILLINGER D, Bullock A, Powell C, Fukagawa NK, et al
    The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs for Population-Level Diabetes Prevention and Control: Recommendations From the National Clinical Care Commission.
    Diabetes Care. 2023;46:e24-e38.
    PubMed     Abstract available


  445. GREENLEE MC, Bolen S, Chong W, Dokun A, et al
    The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Improve Diabetes Treatment and Reduce Complications.
    Diabetes Care. 2023;46:e51-e59.
    PubMed     Abstract available


  446. HERMAN WH, Schillinger D, Bolen S, Boltri JM, et al
    The National Clinical Care Commission Report to Congress: Recommendations to Better Leverage Federal Policies and Programs to Prevent and Control Diabetes.
    Diabetes Care. 2023;46:255-261.
    PubMed     Abstract available


  447. BOLTRI JM, Tracer H, Strogatz D, Idzik S, et al
    The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes.
    Diabetes Care. 2023;46:e39-e50.
    PubMed     Abstract available


  448. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    Erratum. 2. Classification and diagnosis of diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.
    Diabetes Care. 2023 Feb 1:dc23er05. doi: 10.2337.
    PubMed     Abstract available


  449. SCHWARTZ MW, Krinsley JS, Faber CL, Hirsch IB, et al
    Brain Glucose Sensing and the Problem of Relative Hypoglycemia.
    Diabetes Care. 2023;46:237-244.
    PubMed     Abstract available


  450. HERMAN WH, Bullock A, Boltri JM, Conlin PR, et al
    The National Clinical Care Commission Report to Congress: Background, Methods, and Foundational Recommendations.
    Diabetes Care. 2023;46:e14-e23.
    PubMed     Abstract available


  451. CONLIN PR, Boltri JM, Bullock A, Greenlee MC, et al
    The National Clinical Care Commission Report to Congress: Summary and Next Steps.
    Diabetes Care. 2023;46:e60-e63.
    PubMed     Abstract available


  452. HE L, Wang J, Li Z, Li Y, et al
    Dipeptidyl Peptidase 4 Inhibitors and Gallbladder or Biliary Diseases: Data From the U.S. Food and Drug Administration Adverse Event Reporting System.
    Diabetes Care. 2023;46:e72-e73.
    PubMed    


  453. THOMPSON CA, Sturmer T
    Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts.
    Diabetes Care. 2023;46:249-251.
    PubMed    


  454. WALLACE AS, Rooney MR, Fang M, Echouffo-Tcheugui JB, et al
    Natural History of Prediabetes and Long-term Risk of Clinical Outcomes in Middle-aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study.
    Diabetes Care. 2023;46:e67-e68.
    PubMed    


  455. WU CY, Iskander C, Wang C, Xiong LY, et al
    Association of Sodium-Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study.
    Diabetes Care. 2023;46:297-304.
    PubMed     Abstract available


  456. ENGSTROM A, Wintzell V, Melbye M, Hviid A, et al
    Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study.
    Diabetes Care. 2023;46:351-360.
    PubMed     Abstract available


  457. BEZIN J, Gouverneur A, Penichon M, Mathieu C, et al
    GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.
    Diabetes Care. 2023;46:384-390.
    PubMed     Abstract available


    January 2023
  458. SHAH BR, Austin PC, Ke C, Lipscombe LL, et al
    Growing Income-Related Disparities in Cardiovascular Hospitalizations Among People With Diabetes, 1995 to 2019: Population-Based Study.
    Diabetes Care. 2023 Jan 31:dc221936. doi: 10.2337/dc22-1936.
    PubMed     Abstract available


  459. RYDER REJ, Laubner K, Benes M, Haluzik M, et al
    Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.
    Diabetes Care. 2023 Jan 30:dc221952. doi: 10.2337/dc22-1952.
    PubMed    


  460. SVEHLIKOVA E, Ashcroft NL, Gatschelhofer C, Gerring D, et al
    Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes.
    Diabetes Care. 2023 Jan 30:dc221054. doi: 10.2337/dc22-1054.
    PubMed     Abstract available


  461. ROONEY MR, Chen J, Echouffo-Tcheugui JB, Walker KA, et al
    Proteomic Predictors of Incident Diabetes: Results From the Atherosclerosis Risk in Communities (ARIC) Study.
    Diabetes Care. 2023 Jan 27:dc221830. doi: 10.2337/dc22-1830.
    PubMed     Abstract available


  462. SAUNDERS AL, Bodine C, Snell-Bergeon J, Forlenza GP, et al
    Higher Prevalence of Hypoglycemia and Unsafe Driving Practices in Adults With Type 1 Diabetes.
    Diabetes Care. 2023 Jan 27:dc222035. doi: 10.2337/dc22-2035.
    PubMed    


  463. YANG J, Wu J, Tekola-Ayele F, Li LJ, et al
    Plasma Amino Acids in Early Pregnancy and Midpregnancy and Their Interplay With Phospholipid Fatty Acids in Association With the Risk of Gestational Diabetes Mellitus: Results From a Longitudinal Prospective Cohort.
    Diabetes Care. 2023 Jan 26:dc221892. doi: 10.2337/dc22-1892.
    PubMed     Abstract available


  464. PARENTE EB, Mutter S, Thorn LM, Harjutsalo V, et al
    Relationship Between Abdominal Fatness and Onset and Progression of Albuminuria in Type 1 Diabetes.
    Diabetes Care. 2023 Jan 26:dc221935. doi: 10.2337/dc22-1935.
    PubMed    


  465. BAKINOWSKA L, Vartak T, Phuthego T, Taylor M, et al
    Exocrine Proteins Including Trypsin(ogen) as a Key Biomarker in Type 1 Diabetes.
    Diabetes Care. 2023 Jan 26:dc221317. doi: 10.2337/dc22-1317.
    PubMed     Abstract available


  466. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    Erratum. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S158-S190.
    Diabetes Care. 2023 Jan 26:dc23er04. doi: 10.2337.
    PubMed     Abstract available


  467. KVIST AV, Nasser MI, Vestergaard P, Frost M, et al
    Site-Specific Fracture Incidence Rates Among Patients With Type 1 Diabetes, Type 2 Diabetes or Without Diabetes in Denmark (1997-2017).
    Diabetes Care. 2023 Jan 25:dc221004. doi: 10.2337/dc22-1004.
    PubMed     Abstract available


  468. STRAIN T, Dempsey PC, Wijndaele K, Sharp SJ, et al
    Quantifying the Relationship Between Physical Activity Energy Expenditure and Incident Type 2 Diabetes: A Prospective Cohort Study of Device-Measured Activity in 90,096 Adults.
    Diabetes Care. 2023 Jan 24:dc221467. doi: 10.2337/dc22-1467.
    PubMed     Abstract available


  469. ARONSON R, Riddell MC, Conoscenti V, Junaidi MK, et al
    Effect of Mini-Dose Ready-to-Use Liquid Glucagon on Preventing Exercise-Associated Hypoglycemia in Adults With Type 1 Diabetes.
    Diabetes Care. 2023 Jan 23:dc221145. doi: 10.2337/dc22-1145.
    PubMed     Abstract available


  470. BOUCSEIN A, Watson AS, Frewen CM, Sanders OJ, et al
    Impact of Advanced Hybrid Closed Loop on Youth With High-Risk Type 1 Diabetes Using Multiple Daily Injections.
    Diabetes Care. 2023 Jan 23:dc221971. doi: 10.2337/dc22-1971.
    PubMed     Abstract available


  471. BEERNINK JM, Persson F, Jongs N, Laverman GD, et al
    Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study.
    Diabetes Care. 2023 Jan 20:dc221514. doi: 10.2337/dc22-1514.
    PubMed     Abstract available


  472. CUROVIC VR, Jongs N, Kroonen MYAM, Zobel EH, et al
    Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial.
    Diabetes Care. 2023 Jan 18:dc221699. doi: 10.2337/dc22-1699.
    PubMed     Abstract available


  473. RETNAKARAN R, Pu J, Emery A, Kramer CK, et al
    Concordance of A1C, Fasting Glucose, and Oral Glucose Tolerance Test Criteria for Defining Remission of Diabetes.
    Diabetes Care. 2023 Jan 18:dc222406. doi: 10.2337/dc22-2406.
    PubMed    


  474. BAIDAL DA, Ballou CM, Rickels MR, Berney T, et al
    Predictive Value of C-Peptide Measures for Clinical Outcomes of beta-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).
    Diabetes Care. 2023 Jan 17:dc221155. doi: 10.2337/dc22-1155.
    PubMed     Abstract available


  475. HOLMAN N, Barron E, Young B, Gregg EW, et al
    Comparative Incidence of Diabetes Following Hospital Admission for COVID-19 and Pneumonia: A Cohort Study.
    Diabetes Care. 2023 Jan 17:dc220670. doi: 10.2337/dc22-0670.
    PubMed     Abstract available


  476. AROSEMENA M, Salguero MV, Naylor RN, Wroblewski K, et al
    Objective and Subjective Sleep Patterns in Adults With Maturity-Onset Diabetes of the Young (MODY).
    Diabetes Care. 2023 Jan 13:dc221343. doi: 10.2337/dc22-1343.
    PubMed     Abstract available


  477. LUNDEEN EA, Kim M, Rein DB, Wittenborn JS, et al
    Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years.
    Diabetes Care. 2023 Jan 13:dc221834. doi: 10.2337/dc22-1834.
    PubMed     Abstract available


  478. NAGY DK, Bresee LC, Eurich DT, Simpson SH, et al
    Rural Residence Is Associated With a Delayed Trend Away From Sulfonylurea Use for Treatment Intensification of Type 2 Diabetes.
    Diabetes Care. 2023 Jan 13:dc221223. doi: 10.2337/dc22-1223.
    PubMed     Abstract available


  479. SASIDHARAN PILLAI S, Has P, Quintos JB, Serrano Gonzalez M, et al
    Incidence, Severity, and Presentation of Type 2 Diabetes in Youth During the First and Second Year of the COVID-19 Pandemic.
    Diabetes Care. 2023 Jan 13:dc221702. doi: 10.2337/dc22-1702.
    PubMed     Abstract available


  480. BARKER MM, Davies MJ, Zaccardi F, Brady EM, et al
    Age at Diagnosis of Type 2 Diabetes and Depressive Symptoms, Diabetes-Specific Distress, and Self-Compassion.
    Diabetes Care. 2023 Jan 11:dc221237. doi: 10.2337/dc22-1237.
    PubMed     Abstract available


  481. MCPHERSON AR, Bancks MP
    Assessment for Gender Differences in Trend in Age at Diagnosis of Diabetes Among U.S. Adults, 1999-2020.
    Diabetes Care. 2023 Jan 11:dc221572. doi: 10.2337/dc22-1572.
    PubMed    


  482. HERGES JR, Galindo RJ, Neumiller JJ, Heien HC, et al
    Glucagon Prescribing and Costs Among U.S. Adults With Diabetes, 2011-2021.
    Diabetes Care. 2023 Jan 11:dc221564. doi: 10.2337/dc22-1564.
    PubMed     Abstract available


  483. EDQVIST J, Lundberg C, Andreasson K, Bjorck L, et al
    Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden.
    Diabetes Care. 2023 Jan 6:dc221760. doi: 10.2337/dc22-1760.
    PubMed     Abstract available


  484. RETNAKARAN R, Ye C, Hanley AJ, Connelly PW, et al
    Treatment of Gestational Diabetes Mellitus and Maternal Risk of Diabetes After Pregnancy.
    Diabetes Care. 2023 Jan 5:dc221786. doi: 10.2337/dc22-1786.
    PubMed     Abstract available


  485. PETROVSKI G, Campbell J, Pasha M, Day E, et al
    Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents With Type 1 Diabetes Using the MiniMed 780G Advanced Hybrid Closed Loop System: A Randomized Controlled Trial Comparing Glucose Control.
    Diabetes Care. 2023 Jan 4:dc221692. doi: 10.2337/dc22-1692.
    PubMed     Abstract available


  486. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  487. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  488. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  489. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  490. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    Introduction and Methodology: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed    


  491. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    6. Glycemic Targets: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  492. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  493. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  494. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    17. Diabetes Advocacy: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available



  495. Disclosures: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed    


  496. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    Summary of Revisions: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed    


  497. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    14. Children and Adolescents: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  498. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  499. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    13. Older Adults: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  500. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  501. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  502. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    7. Diabetes Technology: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  503. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  504. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  505. ELSAYED NA, Aleppo G, Aroda VR, Bannuru RR, et al
    10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023.
    Diabetes Care. 2023;46.
    PubMed     Abstract available


  506. MCDERMOTT K, Fang M, Boulton AJM, Selvin E, et al
    Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers.
    Diabetes Care. 2023;46:209-221.
    PubMed     Abstract available


  507. CERIELLO A, Prattichizzo F
    Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448.
    Diabetes Care. 2023;46:e12.
    PubMed    


  508. LACHIN JM, Bebu I, Gao X, Nathan DM, et al
    Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448.
    Diabetes Care. 2023;46:e13.
    PubMed    


  509. SCHLESINGER S
    Diet and Diabetes Prevention: Is a Plant-Based Diet the Solution?
    Diabetes Care. 2023;46:6-8.
    PubMed    


  510. KAHN SE, Anderson CAM, Buse JB, Selvin E, et al
    "The Times They Are A-Changin'" at Diabetes Care.
    Diabetes Care. 2023;46:3-5.
    PubMed    


  511. HOOGWERF BJ
    Prediabetes, Atrial Fibrillation, and Heart Failure: An Intersection of Comorbidities.
    Diabetes Care. 2023;46:9-10.
    PubMed    


  512. POLLACK R, Raz I, Wiviott SD, Goodrich EL, et al
    Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58.
    Diabetes Care. 2023;46:156-164.
    PubMed     Abstract available


  513. LEE JY, Nguyen JT, Arroyo J, Tran T, et al
    Feasibility and Acceptability of Using Flash Glucose Monitoring System Sensors to Empower Lifestyle Changes in People With Prediabetes.
    Diabetes Care. 2023;46:e10-e11.
    PubMed    


  514. CROMER SJ, Lauffenburger JC, Levin R, Patorno E, et al
    Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure.
    Diabetes Care. 2023;46:65-74.
    PubMed     Abstract available


  515. PARK JH, Hong JY, Han K, Shen JJ, et al
    Association Between Glycemic Status and the Risk of Kidney Cancer in Men and Women: A Nationwide Cohort Study.
    Diabetes Care. 2023;46:38-45.
    PubMed     Abstract available


  516. CHIOU TT, Ge Y, Romley JA
    Trends in Metformin Use Among Patients With Prediabetes: 2008-2020.
    Diabetes Care. 2023;46:e1-e2.
    PubMed    


  517. HUANG JY, Tse YK, Li HL, Chen C, et al
    Prediabetes Is Associated With Increased Risk of Heart Failure Among Patients With Atrial Fibrillation.
    Diabetes Care. 2023;46:190-196.
    PubMed     Abstract available


    December 2022
  518. JONAS RA, Earls JP, Marques H, Katz RJ, et al
    Diabetes, Atherosclerosis, and Stenosis by AI.
    Diabetes Care. 2022 Dec 28:dc211663. doi: 10.2337/dc21-1663.
    PubMed     Abstract available


  519. GIANNELLA A, Castelblanco E, Zambon CF, Basso D, et al
    Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes.
    Diabetes Care. 2022 Dec 28:dc221441. doi: 10.2337/dc22-1441.
    PubMed     Abstract available


  520. WENDEU-FOYET G, Bellicha A, Chajes V, Huybrechts I, et al
    Different Types of Industry-Produced and Ruminant Trans Fatty Acid Intake and Risk of Type 2 Diabetes: Findings From the NutriNet-Sante Prospective Cohort.
    Diabetes Care. 2022 Dec 21:dc220900. doi: 10.2337/dc22-0900.
    PubMed     Abstract available


  521. SIMPSON FR, Justice JN, Pilla SJ, Kritchevsky SB, et al
    An Examination of Whether Diabetes Control and Treatments Are Associated With Change in Frailty Index Across 8 Years: An Ancillary Exploratory Study From the Action for Health in Diabetes (Look AHEAD) Trial.
    Diabetes Care. 2022 Dec 21:dc221728. doi: 10.2337/dc22-1728.
    PubMed     Abstract available


  522. VAJRAVELU ME, Mani I, Malik S, Hewitt B, et al
    Race and Neighborhood-Related Disparities Spanning the COVID-19 Pandemic: Trajectories of Combined Glycemic Control and Body Mass Index in Youth With Diabetes.
    Diabetes Care. 2022 Dec 19:dc221439. doi: 10.2337/dc22-1439.
    PubMed     Abstract available


  523. GASTON SA, Riley NM, Parks CG, Woo JMP, et al
    Racial/Ethnic Differences in Associations Between Traumatic Childhood Experiences and Both Metabolic Syndrome Prevalence and Type 2 Diabetes Mellitus Risk Among a Cohort of US Women.
    Diabetes Care. 2022 Dec 16:dc221486. doi: 10.2337/dc22-1486.
    PubMed     Abstract available


  524. DIMAKOS J, Cui Y, Platt RW, Renoux C, et al
    Concomitant Use of Sulfonylureas and beta-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study.
    Diabetes Care. 2022 Dec 16:dc221584. doi: 10.2337/dc22-1584.
    PubMed     Abstract available


  525. TONNIES T, Brinks R, Isom S, Dabelea D, et al
    Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years Through 2060: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2022 Dec 16:dc220945. doi: 10.2337/dc22-0945.
    PubMed     Abstract available


  526. BEBU I, Braffett BH, de Boer IH, Aiello LP, et al
    Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: the DCCT/EDIC Study.
    Diabetes Care. 2022 Dec 15:dc221744. doi: 10.2337/dc22-1744.
    PubMed     Abstract available


  527. MCCOY RG, Herrin J, Galindo RJ, Swarna KS, et al
    Rates of Hypoglycemic and Hyperglycemic Emergencies Among U.S. Adults With Diabetes, 2011-2020.
    Diabetes Care. 2022 Dec 15:dc221673. doi: 10.2337/dc22-1673.
    PubMed    


  528. CHAMBERS EC, Hua S, Lin J, Kim RS, et al
    Doubled-Up Households, Self-Management Behaviors, Diabetes Preventive Care Services, and Hospital Use in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) 2015-2020.
    Diabetes Care. 2022 Dec 14:dc221477. doi: 10.2337/dc22-1477.
    PubMed     Abstract available


  529. LIU JJ, Liu S, Wang J, Pek SLT, et al
    Urine Leucine-Rich alpha-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes.
    Diabetes Care. 2022 Dec 14:dc221611. doi: 10.2337/dc22-1611.
    PubMed     Abstract available


  530. ALKABBANI W, Maxwell CJ, Marrie RA, Tyas SL, et al
    Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study.
    Diabetes Care. 2022 Dec 14:dc221496. doi: 10.2337/dc22-1496.
    PubMed     Abstract available


  531. AJJAN RA, Heller SR, Everett CC, Vargas-Palacios A, et al
    Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
    Diabetes Care. 2022 Dec 14:dc221219. doi: 10.2337/dc22-1219.
    PubMed     Abstract available


  532. MALONE JI, Gao X, Lorenzi GM, Raskin P, et al
    Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced Retinopathy.
    Diabetes Care. 2022 Dec 13:dc221711. doi: 10.2337/dc22-1711.
    PubMed     Abstract available


  533. OBERMAYER A, Tripolt NJ, Pferschy PN, Kojzar H, et al
    Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.
    Diabetes Care. 2022 Dec 12:dc221622. doi: 10.2337/dc22-1622.
    PubMed     Abstract available


  534. LI B, Chen L, Hu X, Tan T, et al
    Association of Serum Uric Acid With All-Cause and Cardiovascular Mortality in Diabetes.
    Diabetes Care. 2022 Dec 9:dc221339. doi: 10.2337/dc22-1339.
    PubMed     Abstract available


  535. NI K, Tampe CA, Sol K, Richardson DB, et al
    Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes.
    Diabetes Care. 2022 Dec 8:dc221287. doi: 10.2337/dc22-1287.
    PubMed     Abstract available


  536. SELEN DJ, Thaweethai T, Schulte CCM, Hsu S, et al
    Gestational Glucose Intolerance and Risk of Future Diabetes.
    Diabetes Care. 2022 Dec 6:dc221390. doi: 10.2337/dc22-1390.
    PubMed     Abstract available


  537. PARK CS, Choi EK, Han KD, Yoo J, et al
    Physical Activity Changes and the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: A Nationwide Longitudinal Follow-up Cohort Study of 1.8 Million Subjects.
    Diabetes Care. 2022 Dec 5:dc221655. doi: 10.2337/dc22-1655.
    PubMed     Abstract available


  538. CROOSU SS, Roikjer J, Morch CD, Ejskjaer N, et al
    Alterations in Functional Connectivity of Thalamus and Primary Somatosensory Cortex in Painful and Painless Diabetic Peripheral Neuropathy.
    Diabetes Care. 2022 Dec 5:dc220587. doi: 10.2337/dc22-0587.
    PubMed     Abstract available


  539. HUH JH, Roh E, Lee SJ, Ihm SH, et al
    Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
    Diabetes Care. 2022 Dec 5:dc221550. doi: 10.2337/dc22-1550.
    PubMed     Abstract available


  540. LIU SL, Gonder JR, Owrangi E, Klar NS, et al
    Effectiveness of Nonmydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease: A Randomized Controlled Trial (Clearsight).
    Diabetes Care. 2022 Dec 5:dc220713. doi: 10.2337/dc22-0713.
    PubMed     Abstract available


  541. POKHAREL P, Kyro C, Olsen A, Tjonneland A, et al
    Vegetable, But Not Potato, Intake is Associated With a Lower Risk of Type 2 Diabetes in the Danish Diet, Cancer and Health Cohort.
    Diabetes Care. 2022 Dec 5:dc220974. doi: 10.2337/dc22-0974.
    PubMed     Abstract available


  542. WILLEY VJ, Crowley MJ
    Observational Evaluations of Disease Management Programs for Diabetes: The Proof Is in the Concept.
    Diabetes Care. 2022;45:2808-2810.
    PubMed    


  543. TRIMARCO B, Barbato E, Izzo R, Morisco C, et al
    Microvascular Disease and the Pathogenesis of Heart Failure in Diabetes: A Tiny Piece of the Tricky Puzzle.
    Diabetes Care. 2022;45:2817-2819.
    PubMed    


  544. GIACCARI A
    What Is the Best Medicine for Chronic Kidney Disease in Diabetes?
    Diabetes Care. 2022;45:2814-2816.
    PubMed    


  545. YANG YS, Hu KC, Kao CH
    Response to Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184-1192.
    Diabetes Care. 2022;45:e182-e183.
    PubMed    


  546. NOLAN CJ
    Gestational Diabetes Mellitus and the Maternal Heart.
    Diabetes Care. 2022;45:2820-2822.
    PubMed    


  547. ALLEN DW, Craig ME, Donaghue KC
    Response to Comment on Allen et al. Thirty-Year Time Trends in Diabetic Retinopathy and Macular Edema in Youth With Type 1 Diabetes. Diabetes Care 2022;45:2247-2254.
    Diabetes Care. 2022;45:e185-e186.
    PubMed    


  548. YANG Z, Qu Y, Chen K, Wang J, et al
    Comment on Park et al. U-Shaped Associations Between Body Weight Changes and Major Cardiovascular Events in Type 2 Diabetes Mellitus: A Longitudinal Follow-up Study of a Nationwide Cohort of Over 1.5 Million. Diabetes Care 2022;45:1239-1246.
    Diabetes Care. 2022;45:e187.
    PubMed    


  549. KWON Y, Lee S, Kim D, ALRomi A, et al
    Biliopancreatic Limb Length as a Potential Key Factor in Superior Glycemic Outcomes After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes: A Meta-Analysis.
    Diabetes Care. 2022;45:3091-3100.
    PubMed     Abstract available


  550. XU M, Li X
    Comment on Allen et al. Thirty-Year Time Trends in Diabetic Retinopathy and Macular Edema in Youth With Type 1 Diabetes. Diabetes Care 2022;45:2247-2254.
    Diabetes Care. 2022;45:e184.
    PubMed    


  551. PARK CS, Han KD, Kim HK
    Response to Comment on Park et al. U-Shaped Associations Between Body Weight Changes and Major Cardiovascular Events in Type 2 Diabetes Mellitus: A Longitudinal Follow-up Study of a Nationwide Cohort of Over 1.5 Million. Diabetes Care 2022;45:1239-124
    Diabetes Care. 2022;45:e188-e189.
    PubMed    


  552. HUNG CH, Yen FS, Wei JC
    Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184-1192.
    Diabetes Care. 2022;45:e181.
    PubMed    


  553. SEAQUIST ER, Teff K, Heller SR
    Impaired Awareness of Hypoglycemia in Type 1 Diabetes: A Report of An NIDDK Workshop in October 2021.
    Diabetes Care. 2022;45:2799-2805.
    PubMed     Abstract available


  554. RIETZ M, Lehr A, Mino E, Lang A, et al
    Physical Activity and Risk of Major Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review and Meta-Analysis of Observational Studies.
    Diabetes Care. 2022;45:3101-3111.
    PubMed     Abstract available


  555. FOROUHI NG
    Nutrition and Type 2 Diabetes: Computational Optimization Modeling to Expand the Evidence Base for South Asians.
    Diabetes Care. 2022;45:2811-2813.
    PubMed    


  556. KAUL S
    Pursuit of Myocardial Ischemia for Therapeutic Decision-Making in Patients With Diabetes and Stable Ischemic Heart Disease: Reconciling Randomized Controlled Trials and Observational Studies.
    Diabetes Care. 2022;45:2823-2827.
    PubMed    


  557. FRENCH R, Kneale D, Warner JT, Robinson H, et al
    Educational Attainment and Childhood-Onset Type 1 Diabetes.
    Diabetes Care. 2022;45:2852-2861.
    PubMed     Abstract available


  558. SIMS EK, Cuthbertson D, Felton JL, Ismail HM, et al
    Persistence of beta-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening.
    Diabetes Care. 2022;45:2982-2990.
    PubMed     Abstract available


  559. CLAPIN HF, Earnest A, Colman PG, Davis EA, et al
    Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Long-term HbA1c in 7,961 Children and Young Adults in the Australasian Diabetes Data Network.
    Diabetes Care. 2022;45:2918-2925.
    PubMed     Abstract available


    November 2022
  560. GOMEZ-PERALTA F, Abreu C, Fernandez-Rubio E, Cotovad L, et al
    Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial.
    Diabetes Care. 2022 Nov 30:dc220525. doi: 10.2337/dc22-0525.
    PubMed     Abstract available


  561. LEE DH, Luo X, Rezende LFM, Joh HK, et al
    Long-term Weight Training and Mortality in U.S. Male Health Professionals With and Without Type 2 Diabetes.
    Diabetes Care. 2022 Nov 21:dc212420. doi: 10.2337/dc21-2420.
    PubMed     Abstract available


  562. ZHANG Y, Song M, Cao Y, Eliassen AH, et al
    Incident Early- and Later-Onset Type 2 Diabetes and Risk of Early- and Later-Onset Cancer: Prospective Cohort Study.
    Diabetes Care. 2022 Nov 18. pii: 147946. doi: 10.2337/dc22-1575.
    PubMed     Abstract available


  563. HANAI K, Mori T, Yamamoto Y, Yoshida N, et al
    Association of Estimated Glomerular Filtration Rate With Progression of Albuminuria in Individuals With Type 2 Diabetes.
    Diabetes Care. 2022 Nov 18. pii: 147943. doi: 10.2337/dc22-1582.
    PubMed     Abstract available


  564. TANG M, Berg A, Rhee EP, Allegretti AS, et al
    The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease.
    Diabetes Care. 2022 Nov 18. pii: 147949. doi: 10.2337/dc22-1399.
    PubMed     Abstract available


  565. SMIDTSLUND P, Jansson Sigfrids F, Ylinen A, Elonen N, et al
    Prognosis After First-Ever Myocardial Infarction in Type 1 Diabetes Is Strongly Affected by Chronic Kidney Disease.
    Diabetes Care. 2022 Nov 18. pii: 147944. doi: 10.2337/dc22-1586.
    PubMed     Abstract available


  566. CHEN S, Lu J, Peng D, Liu F, et al
    Effect of a Mobile Health Technology-Based Diabetes Education Program on Glucose Control in Patients With Type 2 Diabetes Initiating Premixed Insulin: A Prospective, Multicenter, Observational Study.
    Diabetes Care. 2022 Nov 18. pii: 147947. doi: 10.2337/dc22-0510.
    PubMed    


  567. WANG Y, Zhang P, Shao H, Andes LJ, et al
    Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 1 Diabetes.
    Diabetes Care. 2022 Nov 18. pii: 147945. doi: 10.2337/dc21-2538.
    PubMed     Abstract available


  568. AKHTARI FS, Lloyd D, Burkholder A, Tong X, et al
    Questionnaire-Based Polyexposure Assessment Outperforms Polygenic Scores for Classification of Type 2 Diabetes in a Multiancestry Cohort.
    Diabetes Care. 2022 Nov 16. pii: 147936. doi: 10.2337/dc22-0295.
    PubMed     Abstract available


  569. EMMERT-FEES KMF, Laxy M, Patel SA, Singh K, et al
    Cost-Effectiveness of a Collaborative Care Model Among Patients With Type 2 Diabetes and Depression in India.
    Diabetes Care. 2022 Nov 16. pii: 147934. doi: 10.2337/dc21-2533.
    PubMed     Abstract available


  570. HAN H, Wang Y, Li T, Feng C, et al
    Sleep Duration and Risks of Incident Cardiovascular Disease and Mortality Among People With Type 2 Diabetes.
    Diabetes Care. 2022 Nov 16. pii: 147933. doi: 10.2337/dc22-1127.
    PubMed     Abstract available


  571. LI S, Guo B, Jiang Y, Wang X, et al
    Long-term Exposure to Ambient PM2.5 and Its Components Associated With Diabetes: Evidence From a Large Population-Based Cohort From China.
    Diabetes Care. 2022 Nov 16. pii: 147938. doi: 10.2337/dc22-1585.
    PubMed     Abstract available


  572. JEON C, Hart PA, Li L, Yang Y, et al
    Development of a Clinical Prediction Model for Diabetes in Chronic Pancreatitis: The PREDICT3c Study.
    Diabetes Care. 2022 Nov 16. pii: 147837. doi: 10.2337/dc22-1414.
    PubMed     Abstract available


  573. JI X, Gao H, Sun D, Zhuang J, et al
    Trajectories of Cognition and Daily Functioning Before and After Incident Diabetes.
    Diabetes Care. 2022 Nov 15. pii: 147836. doi: 10.2337/dc22-1190.
    PubMed     Abstract available


  574. KANBOUR S, Jones M, Abusamaan MS, Nass C, et al
    Racial Disparities in Access and Use of Diabetes Technology Among Adult Patients With Type 1 Diabetes in a U.S. Academic Medical Center.
    Diabetes Care. 2022 Nov 15. pii: 147841. doi: 10.2337/dc22-1055.
    PubMed     Abstract available


  575. YEN FS, Hou MC, Pan CW, Liu JS, et al
    The Risk of Severe Hypoglycemia and Mortality in Patients With Type 2 Diabetes and Discharged With Acute Liver Injury.
    Diabetes Care. 2022 Nov 15. pii: 147937. doi: 10.2337/dc22-1349.
    PubMed     Abstract available


  576. DICEMBRINI I, Scoccimarro D, Del Vescovo GG, Marinelli C, et al
    Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study).
    Diabetes Care. 2022 Nov 14. pii: 147932. doi: 10.2337/dc22-0868.
    PubMed    


  577. LEE HS, Park JC, Chung I, Liu J, et al
    Sustained Low Income, Income Changes, and Risk of All-Cause Mortality in Individuals With Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
    Diabetes Care. 2022 Nov 11. pii: 147891. doi: 10.2337/dc21-2305.
    PubMed     Abstract available


  578. MATHIAS P, Mahali LP, Agarwal S
    Erratum. Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors. Diabetes Care 2022;45:2231-2237.
    Diabetes Care. 2022 Nov 10. pii: 147884. doi: 10.2337.
    PubMed    


  579. PASQUA MR, Jafar A, Kobayati A, Tsoukas MA, et al
    Low-Dose Empagliflozin as Adjunct to Hybrid Closed-Loop Insulin Therapy in Adults With Suboptimally Controlled Type 1 Diabetes: A Randomized Crossover Controlled Trial.
    Diabetes Care. 2022 Nov 4. pii: 147853. doi: 10.2337/dc22-0490.
    PubMed     Abstract available


  580. BRINCK J, Hagstrom E, Natman J, Franzen S, et al
    Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study.
    Diabetes Care. 2022 Nov 3. pii: 147832. doi: 10.2337/dc22-1025.
    PubMed     Abstract available


  581. JENKINS DJA, Chiavaroli L, Mirrahimi A, Mitchell S, et al
    Glycemic Index Versus Wheat Fiber on Arterial Wall Damage in Diabetes: A Randomized Controlled Trial.
    Diabetes Care. 2022 Nov 3. pii: 147833. doi: 10.2337/dc22-1028.
    PubMed     Abstract available


  582. PERKINS BA, Bebu I, de Boer IH, Molitch M, et al
    Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes.
    Diabetes Care. 2022 Nov 2. pii: 147720. doi: 10.2337/dc22-1420.
    PubMed     Abstract available


  583. COTE-CORRIVEAU G, Marcoux S, Leduc V, Healy-Profitos J, et al
    Response to Comment on Marcoux et al. Varying Impact of Gestational Diabetes Mellitus on Incidence of Childhood Cancers: An Age-Stratified Retrospective Cohort Study. Diabetes Care 2022;45:1177-1183.
    Diabetes Care. 2022;45:e155-e156.
    PubMed    


  584. LONTCHI-YIMAGOU E, Anoop S, Kurian ME, Ye K, et al
    Response to Comment on Lontchi-Yimagou et al. An Atypical Form of Diabetes Among Individuals With Low BMI. Diabetes Care 2022;45:1428-1437.
    Diabetes Care. 2022;45:e159-e160.
    PubMed    


  585. YIN M, Zhang Y, Wang J, Li X, et al
    Comment on Marcoux et al. Varying Impact of Gestational Diabetes Mellitus on Incidence of Childhood Cancers: An Age-Stratified Retrospective Cohort Study. Diabetes Care 2022;45:1177-1183.
    Diabetes Care. 2022;45:e153-e154.
    PubMed    


  586. ZUCATTI KP, Teixeira PP, Wayerbacher LF, Piccoli GF, et al
    Long-term Effect of Lifestyle Interventions on the Cardiovascular and All-Cause Mortality of Subjects With Prediabetes and Type 2 Diabetes: A Systematic Review and Meta-analysis.
    Diabetes Care. 2022;45:2787-2795.
    PubMed     Abstract available


  587. UNNIKRISHNAN R, Anjana RM, Mukhopadhyay S, Kesavadev J, et al
    Comment on Lontchi-Yimagou et al. An Atypical Form of Diabetes Among Individuals With Low BMI. Diabetes Care 2022;45:1428-1437.
    Diabetes Care. 2022;45:e157-e158.
    PubMed    


  588. PEASE AJ, Zoungas S, Callander E, Jones TW, et al
    Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis.
    Diabetes Care. 2022;45:2611-2619.
    PubMed     Abstract available


  589. XU M, Zheng J, Hou T, Lin H, et al
    SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study.
    Diabetes Care. 2022;45:2718-2728.
    PubMed     Abstract available


  590. KOVATCHEV BP, Singh H, Mueller L, Gonder-Frederick LA, et al
    Biobehavioral Changes Following Transition to Automated Insulin Delivery: A Large Real-life Database Analysis.
    Diabetes Care. 2022;45:2636-2643.
    PubMed     Abstract available


  591. PICHARDO-LOWDEN AR, Haidet P, Umpierrez GE, Lehman EB, et al
    Clinical Decision Support for Glycemic Management Reduces Hospital Length of Stay.
    Diabetes Care. 2022;45:2526-2534.
    PubMed     Abstract available


  592. LOMBARDI A, Agarwal S, Schechter C, Tomer Y, et al
    In-Hospital Hyperglycemia Is Associated With Worse Outcomes in Patients Admitted With COVID-19.
    Diabetes Care. 2022;45:2683-2688.
    PubMed     Abstract available


  593. YATES T, Sargeant JA, King JA, Henson J, et al
    Initiation of New Glucose-Lowering Therapies May Act to Reduce Physical Activity Levels: Pooled Analysis From Three Randomized Trials.
    Diabetes Care. 2022;45:2749-2752.
    PubMed     Abstract available


  594. MATEJKO B, Juza A, Kiec-Wilk B, Cyranka K, et al
    Transitioning of People With Type 1 Diabetes From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to MiniMed 780G Advanced Hybrid Closed-Loop System: A Two-Center, Randomized, Controlled Study.
    Diabetes Care. 2022;45:2628-2635.
    PubMed     Abstract available


  595. ZHU R, Jalo E, Silvestre MP, Poppitt SD, et al
    Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.
    Diabetes Care. 2022;45:2698-2708.
    PubMed     Abstract available


    October 2022
  596. SIDDIQUI MK, Hall C, Cunningham SG, McCrimmon R, et al
    Using Data to Improve the Management of Diabetes: The Tayside Experience.
    Diabetes Care. 2022 Oct 26. pii: 147835. doi: 10.2337/dci22-0003.
    PubMed     Abstract available


  597. BELLO-CHAVOLLA OY, Antonio-Villa NE, Fermin-Martinez CA, Fernandez-Chirino L, et al
    Diabetes-Related Excess Mortality in Mexico: A Comparative Analysis of National Death Registries Between 2017-2019 and 2020.
    Diabetes Care. 2022 Oct 26. pii: 147830. doi: 10.2337/dc22-0616.
    PubMed     Abstract available


  598. LYU B, Sang Y, Selvin E, Chang AR, et al
    Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel.
    Diabetes Care. 2022 Oct 25. pii: 147781. doi: 10.2337/dc22-1253.
    PubMed     Abstract available


  599. DEO SV, McAllister DA, Al-Kindi S, Elgudin Y, et al
    Trends in Prescriptions of Cardioprotective Diabetic Agents After Coronary Artery Bypass Grafting Among U.S. Veterans.
    Diabetes Care. 2022 Oct 18. pii: 147774. doi: 10.2337/dc22-0570.
    PubMed     Abstract available


  600. KUWAHARA K, Sawada SS, Noma H, Honda T, et al
    Commuter Cycling and Risk of Type 2 Diabetes: A Cohort Study in Japan.
    Diabetes Care. 2022 Oct 17. pii: 147724. doi: 10.2337/dc22-1267.
    PubMed    


  601. LIU S, Leone M, Ludvigsson JF, Lichtenstein P, et al
    Early-Onset Type 2 Diabetes and Mood, Anxiety, and Stress-Related Disorders: A Genetically Informative Register-Based Cohort Study.
    Diabetes Care. 2022 Oct 17. pii: 147745. doi: 10.2337/dc22-1053.
    PubMed     Abstract available


  602. RICKELS MR, Eggerman TL, Bayman L, Qidwai JC, et al
    Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study.
    Diabetes Care. 2022 Oct 17. pii: 147713. doi: 10.2337/dc21-2688.
    PubMed     Abstract available


  603. MORGAN NG, Richardson SJ, Powers AC, Saunders DC, et al
    Images From the Exeter Archival Diabetes Biobank Now Accessible via Pancreatlas.
    Diabetes Care. 2022 Oct 14. pii: 147618. doi: 10.2337/dc22-1613.
    PubMed    


  604. ANDERSON RL, DiMeglio LA, Mander AP, Dayan CM, et al
    Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201.
    Diabetes Care. 2022 Oct 11. pii: 147725. doi: 10.2337.
    PubMed     Abstract available


  605. BOJER AS, Sorensen MH, Gaede P, Madsen PL, et al
    Myocardial Extracellular Volume Expansion in Type 2 Diabetes Is Associated With Ischemic Heart Disease, Autonomic Neuropathy, and Active Smoking.
    Diabetes Care. 2022 Oct 10. pii: 147721. doi: 10.2337/dc22-0942.
    PubMed     Abstract available


  606. EASON RJ, Thomas NJ, Hill AV, Knight BA, et al
    Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation.
    Diabetes Care. 2022 Oct 7. pii: 147718. doi: 10.2337/dc22-0623.
    PubMed     Abstract available


  607. BOGAR K, Brensinger CM, Hennessy S, Flory JH, et al
    Climate Change and Ambient Temperature Extremes: Association With Serious Hypoglycemia, Diabetic Ketoacidosis, and Sudden Cardiac Arrest/Ventricular Arrhythmia in People With Type 2 Diabetes.
    Diabetes Care. 2022 Oct 7. pii: 147672. doi: 10.2337/dc22-1161.
    PubMed    


  608. SHERR JL, Heinemann L, Fleming GA, Bergenstal RM, et al
    Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
    Diabetes Care. 2022 Oct 6. pii: 147674. doi: 10.2337/dci22-0018.
    PubMed     Abstract available


  609. VIRGILIO E, Trevisan C, Abbatecola A, Malara A, et al
    Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-Term Care Facilities: Data From the GeroCovid Vax Study.
    Diabetes Care. 2022 Oct 6. pii: 147714. doi: 10.2337/dc22-1255.
    PubMed     Abstract available


  610. CHOWDHARY A, Javed W, Thirunavukarasu S, Jex N, et al
    Cardiac Adaptations to Acute Hemodynamic Stress in Function, Perfusion, and Energetics in Type 2 Diabetes With Overweight and Obesity.
    Diabetes Care. 2022 Oct 4. pii: 147712. doi: 10.2337/dc22-0887.
    PubMed    



  611. Long-Term Outcomes Among Young Adults With Type 2 Diabetes, Based on Durability of Glycemic Control: Results From the TODAY Cohort Study.
    Diabetes Care. 2022 Oct 3. pii: 147704. doi: 10.2337/dc22-0784.
    PubMed     Abstract available


  612. DE BOER IH, Khunti K, Sadusky T, Tuttle KR, et al
    Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
    Diabetes Care. 2022 Oct 3. pii: 147614. doi: 10.2337/dci22-0027.
    PubMed     Abstract available


  613. NAHRA R, Wang T, Gadde KM, Oscarsson J, et al
    Erratum. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care 2021;44:1433-1442.
    Diabetes Care. 2022 Oct 3. pii: 147708. doi: 10.2337.
    PubMed     Abstract available


  614. DUNGAN KM
    A New Bar for Pharmacologic Weight Loss: Type 2 Diabetes Prevention.
    Diabetes Care. 2022;45:2204-2206.
    PubMed    


  615. ANDERSON RL, DiMeglio LA, Mander AP, Dayan CM, et al
    Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes.
    Diabetes Care. 2022;45:2189-2201.
    PubMed     Abstract available


  616. LIANG B, Gu N
    Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251.
    Diabetes Care. 2022;45:e150.
    PubMed    


  617. DUARTE RV, Nevitt S, Copley S, Maden M, et al
    Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy.
    Diabetes Care. 2022;45:2466-2475.
    PubMed     Abstract available


  618. SANTULLI G, Frullone S, Morgante M, Macina G, et al
    Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251.
    Diabetes Care. 2022;45:e151-e152.
    PubMed    


  619. VEHIK K, Boulware D, Killian M, Rewers M, et al
    Rising Hemoglobin A1c in the Nondiabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests.
    Diabetes Care. 2022;45:2342-2349.
    PubMed     Abstract available


  620. KRISCHER JP, Liu X, Lernmark A, Hagopian WA, et al
    Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study.
    Diabetes Care. 2022;45:2271-2281.
    PubMed     Abstract available


  621. FERRANNINI G, Mellbin LG, Kirabo F, Ramasundarahettige C, et al
    Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis.
    Diabetes Care. 2022;45:e146-e147.
    PubMed    


  622. DIMAKOS J, Cui Y, Platt RW, Renoux C, et al
    Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: Population-Based Cohort Study.
    Diabetes Care. 2022;45:e131-e133.
    PubMed    


  623. MCEWEN LN, Hurst TE, Joiner KL, Herman WH, et al
    Health Beliefs Associated With Metformin Use Among Insured Adults With Prediabetes.
    Diabetes Care. 2022;45:2282-2288.
    PubMed     Abstract available


  624. BARZILAY JI, Tressel W, Biggs ML, Stein PK, et al
    The Association of Measures of Cardiovascular Autonomic Function, Heart Rate, and Orthostatic Hypotension With Incident Glucose Disorders: The Cardiovascular Health Study.
    Diabetes Care. 2022;45:2376-2382.
    PubMed     Abstract available


  625. PERREAULT L, Davies M, Frias JP, Laursen PN, et al
    Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program.
    Diabetes Care. 2022;45:2396-2405.
    PubMed     Abstract available


  626. HSIA J, Guthrie NL, Lupinacci P, Gubbi A, et al
    Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes.
    Diabetes Care. 2022 Oct 1. pii: 147620. doi: 10.2337/dc22-1099.
    PubMed     Abstract available


    September 2022
  627. ASLAM AA, Baksh RA, Pape SE, Strydom A, et al
    Diabetes and Obesity in Down Syndrome Across the Lifespan: A Retrospective Cohort Study Using U.K. Electronic Health Records.
    Diabetes Care. 2022 Sep 30. pii: 147691. doi: 10.2337/dc22-0482.
    PubMed     Abstract available


  628. HOU W, Han T, Sun X, Chen Y, et al
    Relationship Between Carbohydrate Intake (Quantity, Quality, and Time Eaten) and Mortality (Total, Cardiovascular, and Diabetes): Assessment of 2003-2014 National Health and Nutrition Examination Survey Participants.
    Diabetes Care. 2022 Sep 29. pii: 147696. doi: 10.2337/dc22-0462.
    PubMed     Abstract available


  629. BIRUKOV A, Plavsa B, Eichelmann F, Kuxhaus O, et al
    Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease.
    Diabetes Care. 2022 Sep 29. pii: 147697. doi: 10.2337/dc22-0833.
    PubMed     Abstract available


  630. CHEN X, Wan Z, Geng T, Zhu K, et al
    Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes: A Prospective Study.
    Diabetes Care. 2022 Sep 28. pii: 147520. doi: 10.2337/dc22-0513.
    PubMed     Abstract available


  631. ABRAHAMI D, Tesfaye H, Yin H, Vine S, et al
    Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study.
    Diabetes Care. 2022 Sep 28. pii: 147692. doi: 10.2337/dc22-1174.
    PubMed     Abstract available


  632. RESCHKE F, Lanzinger S, Herczeg V, Prahalad P, et al
    The COVID-19 Pandemic Affects Seasonality, With Increasing Cases of New-Onset Type 1 Diabetes in Children, From the Worldwide SWEET Registry.
    Diabetes Care. 2022 Sep 27. pii: 147675. doi: 10.2337/dc22-0278.
    PubMed     Abstract available


  633. GLENN AJ, Li J, Lo K, Jenkins DJA, et al
    The Portfolio Diet and Incident Type 2 Diabetes: Findings From the Women's Health Initiative Prospective Cohort Study.
    Diabetes Care. 2022 Sep 26. pii: 147679. doi: 10.2337/dc22-1029.
    PubMed     Abstract available


  634. ANDERSEN JA, Rasmussen A, Engberg S, Bencke J, et al
    Flexor Tendon Tenotomy Treatment of the Diabetic Foot: A Multicenter Randomized Controlled Trial.
    Diabetes Care. 2022 Sep 24. pii: 147160. doi: 10.2337/dc22-0085.
    PubMed     Abstract available


  635. DAVIES MJ, Aroda VR, Collins BS, Gabbay RA, et al
    Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetes Care. 2022 Sep 23. pii: 147671. doi: 10.2337/dci22-0034.
    PubMed     Abstract available


  636. LAMPREA-MONTEALEGRE JA, Madden E, Tummalapalli SL, Chu CD, et al
    Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease.
    Diabetes Care. 2022 Sep 23. pii: 147676. doi: 10.2337/dc22-0614.
    PubMed     Abstract available


  637. POIRRIER JE, Meyers JL, Nagar SP, Patterson BJ, et al
    Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis.
    Diabetes Care. 2022 Sep 22. pii: 147673. doi: 10.2337/dc21-2053.
    PubMed     Abstract available


  638. GALVEZ-FERNANDEZ M, Powers M, Grau-Perez M, Domingo-Relloso A, et al
    Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study.
    Diabetes Care. 2022 Sep 22. pii: 147601. doi: 10.2337/dc22-1152.
    PubMed     Abstract available


  639. LUI DTW, Man Tang EH, Au ICH, Wu T, et al
    Evaluation of Fracture Risk Among Patients With Type 2 Diabetes and Nonvalvular Atrial Fibrillation Receiving Different Oral Anticoagulants.
    Diabetes Care. 2022 Sep 20. pii: 147615. doi: 10.2337/dc22-0664.
    PubMed     Abstract available


  640. TISON SE, Shikany JM, Long DL, Carson AP, et al
    Differences in the Association of Select Dietary Measures With Risk of Incident Type 2 Diabetes.
    Diabetes Care. 2022 Sep 20. pii: 147564. doi: 10.2337/dc22-0217.
    PubMed     Abstract available


  641. DE BEAUFORT C, Schierloh U, Thankamony A, Ware J, et al
    Cambridge Hybrid Closed-Loop System in Very Young Children With Type 1 Diabetes Reduces Caregivers' Fear of Hypoglycemia and Improves Their Well-Being.
    Diabetes Care. 2022 Sep 16. pii: 147613. doi: 10.2337/dc22-0693.
    PubMed     Abstract available


  642. SUN LY, Zghebi SS, Eddeen AB, Liu PP, et al
    Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes.
    Diabetes Care. 2022 Sep 15. pii: 147606. doi: 10.2337/dc22-0894.
    PubMed     Abstract available


  643. LUSK JB, Hoffman MN, Clark AG, Bae J, et al
    Neighborhood Socioeconomic Deprivation and 30-Day Mortality and Readmission for Patients Admitted for Diabetes Management.
    Diabetes Care. 2022 Sep 15. pii: 147605. doi: 10.2337/dc22-0913.
    PubMed    


  644. IKRAM A, Ikram S, Inam M
    Is Son Preference a Potential Risk Factor for Diabetes?
    Diabetes Care. 2022 Sep 14. pii: 147602. doi: 10.2337/dc22-1413.
    PubMed    


  645. ZHOU C, He P, Ye Z, Zhang Y, et al
    Relationships of Serum 25-Hydroxyvitamin D Concentrations, Diabetes, Genetic Susceptibility, and New-Onset Chronic Kidney Disease.
    Diabetes Care. 2022 Sep 13. pii: 147596. doi: 10.2337/dc22-1194.
    PubMed     Abstract available


  646. WANG Y, Zhang P, Shao H, Andes LJ, et al
    Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 2 Diabetes.
    Diabetes Care. 2022 Sep 13. pii: 147597. doi: 10.2337/dc21-2151.
    PubMed     Abstract available


  647. THIRUNAVUKARASU S, Ansari F, Cubbon R, Forbes K, et al
    Maternal Cardiac Changes in Women With Obesity and Gestational Diabetes Mellitus.
    Diabetes Care. 2022 Sep 12. pii: 147592. doi: 10.2337/dc22-0401.
    PubMed     Abstract available


  648. ARNQVIST HJ, Westerlund MC, Fredrikson M, Ludvigsson J, et al
    Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study.
    Diabetes Care. 2022 Sep 12. pii: 147518. doi: 10.2337/dc22-0239.
    PubMed     Abstract available


  649. TOUGAARD NH, Moller AL, Ronn PF, Hansen TW, et al
    Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort.
    Diabetes Care. 2022 Sep 12. pii: 147213. doi: 10.2337/dc22-0852.
    PubMed     Abstract available


  650. KHUNTI K, Ruan Y, Davies J, Field BCT, et al
    Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.
    Diabetes Care. 2022 Sep 8. pii: 147558. doi: 10.2337/dc22-0357.
    PubMed     Abstract available


  651. MILLER TA, Campbell JH, Bloom N, Wurdeman SR, et al
    Racial Disparities in Health Care With Timing to Amputation Following Diabetic Foot Ulcer.
    Diabetes Care. 2022 Sep 7. pii: 147454. doi: 10.2337/dc21-2693.
    PubMed     Abstract available


  652. MATHIAS P, Mahali LP, Agarwal S
    Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors.
    Diabetes Care. 2022 Sep 2. pii: 147540. doi: 10.2337/dc22-0555.
    PubMed     Abstract available


  653. PARK J, Bigman E, Zhang P
    Productivity Loss and Medical Costs Associated With Type 2 Diabetes Among Employees Aged 18-64 Years With Large Employer-Sponsored Insurance.
    Diabetes Care. 2022 Sep 1. pii: 147546. doi: 10.2337/dc22-0445.
    PubMed     Abstract available


  654. PATEL MR, Zhang G, Heisler M, Song PXK, et al
    Measurement and Validation of the COmprehensive Score for financial Toxicity (COST) in a Population With Diabetes.
    Diabetes Care. 2022 Sep 1. pii: 147547. doi: 10.2337/dc22-0494.
    PubMed     Abstract available


  655. WHIPPLE MO, Pinto AJ, Abushamat LA, Bergouignan A, et al
    Sex Differences in Physical Activity Among Individuals With Type 2 Diabetes Across the Life Span: A Systematic Review and Meta-analysis.
    Diabetes Care. 2022;45:2163-2177.
    PubMed     Abstract available


  656. MANGELIS A, Fountoulakis N, Corcillo A, Collins J, et al
    African Caribbean Ethnicity Is an Independent Predictor of Significant Decline in Kidney Function in People With Type 1 Diabetes.
    Diabetes Care. 2022;45:2095-2102.
    PubMed     Abstract available


  657. HE Y, Ma RCW, McIntyre HD, Sacks DA, et al
    Comparing IADPSG and NICE Diagnostic Criteria for GDM in Predicting Adverse Pregnancy Outcomes.
    Diabetes Care. 2022;45:2046-2054.
    PubMed     Abstract available


  658. HERZIG D, Suhner S, Roos J, Schurch D, et al
    Perioperative Fully Closed-Loop Insulin Delivery in Patients Undergoing Elective Surgery: An Open-Label, Randomized Controlled Trial.
    Diabetes Care. 2022;45:2076-2083.
    PubMed     Abstract available


  659. YISAHAK SF, Hinkle SN, Mumford SL, Gleason JL, et al
    Periconceptional and First Trimester Ultraprocessed Food Intake and Maternal Cardiometabolic Outcomes.
    Diabetes Care. 2022;45:2028-2036.
    PubMed     Abstract available


  660. PEASE A, Callander E, Zomer E, Abraham MB, et al
    The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth.
    Diabetes Care. 2022;45:1971-1980.
    PubMed     Abstract available


  661. FERRANNINI G, De Bacquer D, Erlund I, Gyberg V, et al
    Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population.
    Diabetes Care. 2022;45:2111-2117.
    PubMed     Abstract available


    August 2022
  662. WONG R, Vaddavalli R, Hall MA, Patel MV, et al
    Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes.
    Diabetes Care. 2022 Aug 31. pii: 147549. doi: 10.2337/dc22-0730.
    PubMed     Abstract available


  663. LITKOWSKI EM, Logue MW, Zhang R, Charest BR, et al
    A Diabetes Genetic Risk Score Is Associated With All-Cause Dementia and Clinically Diagnosed Vascular Dementia in the Million Veteran Program.
    Diabetes Care. 2022 Aug 30. pii: 147543. doi: 10.2337/dc22-0105.
    PubMed     Abstract available


  664. MILLER CK, Nagaraja HN, Cheavens J, Fujita K, et al
    Impact of a Novel Diabetes Prevention Intervention for Early Slow Weight Loss Responders Among Adults With Prediabetes: An Adaptive Trial.
    Diabetes Care. 2022 Aug 30. pii: 147541. doi: 10.2337/dc22-0824.
    PubMed     Abstract available


  665. ESCOLANO-LOZANO F, Buehling-Schindowski F, Kramer HH, Birklein F, et al
    Painful Diabetic Neuropathy: Myofascial Pain Makes the Difference.
    Diabetes Care. 2022 Aug 30. pii: 147477. doi: 10.2337/dc22-1023.
    PubMed    


  666. WHITE NH, Pan Q, Knowler WC, Schroeder EB, et al
    Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience.
    Diabetes Care. 2022 Aug 30. pii: 147545. doi: 10.2337/dc22-0860.
    PubMed     Abstract available


  667. KOSHINO A, Schechter M, Sen T, Vart P, et al
    Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.
    Diabetes Care. 2022 Aug 30. pii: 147542. doi: 10.2337/dc22-0866.
    PubMed     Abstract available


  668. PIERI BA, Bergin-Cartwright GAI, Simpson A, Collins J, et al
    Symptoms of Anxiety and Depression Are Independently Associated With Impaired Awareness of Hypoglycemia in Type 1 Diabetes.
    Diabetes Care. 2022 Aug 25. pii: 147525. doi: 10.2337/dc21-2482.
    PubMed     Abstract available


  669. RYDBERG M, Zimmerman M, Gottsater A, Eeg-Olofsson K, et al
    High HbA1c Levels Are Associated With Development of Trigger Finger in Type 1 and Type 2 Diabetes: An Observational Register-Based Study From Sweden.
    Diabetes Care. 2022 Aug 25. pii: 147524. doi: 10.2337/dc22-0829.
    PubMed     Abstract available


  670. KURONUMA K, Han D, Miller RJH, Rozanski A, et al
    Long-term Survival Benefit From Revascularization Compared With Medical Therapy in Patients With or Without Diabetes Undergoing Myocardial Perfusion Single Photon Emission Computed Tomography.
    Diabetes Care. 2022 Aug 24. pii: 147521. doi: 10.2337/dc22-0454.
    PubMed     Abstract available


  671. GARVEY KC, Finkelstein JA, Zhang F, LeCates R, et al
    Health Care Utilization Trends Across the Transition Period in a National Cohort of Adolescents and Young Adults With Type 1 Diabetes.
    Diabetes Care. 2022 Aug 24. pii: 147519. doi: 10.2337/dc22-0152.
    PubMed     Abstract available


  672. CUROVIC RV, Eickhoff MK, Ronkko T, Frimodt-Moller M, et al
    Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria - a Randomized Clinical Trial.
    Diabetes Care. 2022 Aug 23. pii: 147478. doi: 10.2337/dc22-1157.
    PubMed     Abstract available


  673. ISMAIL HM, Cuthbertson D, Gitelman SE, Skyler JS, et al
    The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk.
    Diabetes Care. 2022 Aug 23. pii: 147463. doi: 10.2337/dc22-0167.
    PubMed     Abstract available


  674. MOSENZON O, Raz I, Wiviott SD, Schechter M, et al
    Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes-Post Hoc Analyses From the DECLARE-TIMI 58 Trial.
    Diabetes Care. 2022 Aug 23. pii: 147474. doi: 10.2337/dc22-0382.
    PubMed     Abstract available


  675. VELAYUTHAM V, Benitez-Aguirre P, Craig M, Cho YH, et al
    Cardiac Autonomic Nerve Dysfunction Predicts Incident Retinopathy and Early Kidney Dysfunction in Adolescents With Type 1 Diabetes.
    Diabetes Care. 2022 Aug 23. pii: 147475. doi: 10.2337/dc22-0349.
    PubMed     Abstract available


  676. NAAMAN SH, Mizrak HI, Lind N, Laursen JC, et al
    Cardiovascular Autonomic Neuropathy Is Associated With Increased Glucose Variability in People With Type 1 Diabetes.
    Diabetes Care. 2022 Aug 23. pii: 147473. doi: 10.2337/dc22-0117.
    PubMed     Abstract available


  677. HILLIARD ME, Tully C, Monaghan M, Hildebrandt T, et al
    First STEPS: Primary Outcomes of a Randomized, Stepped-Care Behavioral Clinical Trial for Parents of Young Children With New-Onset Type 1 Diabetes.
    Diabetes Care. 2022 Aug 23. pii: 147476. doi: 10.2337/dc21-2704.
    PubMed     Abstract available


  678. POLLE OG, Delfosse A, Martin M, Louis J, et al
    Glycemic Variability Patterns Strongly Correlate With Partial Remission Status in Children With Newly Diagnosed Type 1 Diabetes.
    Diabetes Care. 2022 Aug 22. pii: 147335. doi: 10.2337/dc21-2543.
    PubMed     Abstract available


  679. CHOE HJ, Rhee EJ, Won JC, Park KS, et al
    Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study.
    Diabetes Care. 2022 Aug 19. pii: 147469. doi: 10.2337/dc22-0764.
    PubMed     Abstract available


  680. SPANAKIS EK, Urrutia A, Galindo RJ, Vellanki P, et al
    Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.
    Diabetes Care. 2022 Aug 19. pii: 147466. doi: 10.2337/dc22-0716.
    PubMed     Abstract available


  681. GENG T, Wang Y, Lu Q, Zhang YB, et al
    Associations of New-onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes.
    Diabetes Care. 2022 Aug 19. pii: 147468. doi: 10.2337/dc22-0717.
    PubMed     Abstract available


  682. LIN X, Xiao Y, Tian Y, Cheng B, et al
    Can the Artificial Intelligence System for Urine Microalbuminuria Detection Monitor the Progression of Diabetic Kidney Disease in the Clinical Laboratory?
    Diabetes Care. 2022 Aug 19. pii: 147470. doi: 10.2337/dc22-0966.
    PubMed    


  683. HALMINEN J, Sattar N, Rawshani A, Eliasson B, et al
    Range of Risk Factor Levels, Risk Control, and Temporal Trends for Nephropathy and End-stage Kidney Disease in Patients With Type 1 and Type 2 Diabetes.
    Diabetes Care. 2022 Aug 19. pii: 147465. doi: 10.2337/dc22-0926.
    PubMed     Abstract available


  684. MARKER AM, Patton SR, Clements MA, Egan AE, et al
    Adjusted Cutoff Scores Increase Sensitivity of Depression Screening Measures in Adolescents With Type 1 Diabetes.
    Diabetes Care. 2022 Aug 19. pii: 147471. doi: 10.2337/dc22-0275.
    PubMed     Abstract available


  685. LIAW J, Harhay M, Setoguchi S, Gerhard T, et al
    Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006-2020.
    Diabetes Care. 2022 Aug 19. pii: 147460. doi: 10.2337/dc22-0224.
    PubMed     Abstract available


  686. LLAURADO G, Amigo N, Fuertes-Martin R, Romero A, et al
    Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes.
    Diabetes Care. 2022 Aug 19. pii: 147461. doi: 10.2337/dc22-0331.
    PubMed     Abstract available


  687. ANJANA RM, Srinivasan S, Sudha V, Joshi SR, et al
    Macronutrient Recommendations for Remission and Prevention of Diabetes in Asian Indians Based on a Data-Driven Optimization Model: The ICMR-INDIAB National Study.
    Diabetes Care. 2022 Aug 18. pii: 147462. doi: 10.2337/dc22-0627.
    PubMed     Abstract available


  688. JANUSZEWSKI AS, Velayutham V, Benitez-Aguirre PZ, Craig ME, et al
    Optimal Frequency of Retinopathy Screening in Adolescents With Type 1 Diabetes-Markov Modeling Approach Based on 30 Years of Data.
    Diabetes Care. 2022 Aug 17. pii: 147379. doi: 10.2337/dc22-0071.
    PubMed     Abstract available


  689. GERARD AO, Laurain A, Favre G, Drici MD, et al
    Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?
    Diabetes Care. 2022 Aug 16. pii: 147453. doi: 10.2337/dc22-0921.
    PubMed    


  690. FRYKBERG RG, Vileikyte L, Boulton AJM, Armstrong DG, et al
    The At-Risk Diabetic Foot: Time to Focus on Prevention.
    Diabetes Care. 2022 Aug 15. pii: 147451. doi: 10.2337/dc22-1111.
    PubMed    


  691. RODRIGUEZ HP, Fulton BD, Phillips AZ, Rubio K, et al
    Effect of State-Led Delivery System and Payment Reforms on Population-Level Detection and Management of Diabetes.
    Diabetes Care. 2022 Aug 15. pii: 147450. doi: 10.2337/dc21-2425.
    PubMed     Abstract available


  692. MARAN A, Morieri ML, Falaguasta D, Avogaro A, et al
    The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes.
    Diabetes Care. 2022 Aug 15. pii: 147446. doi: 10.2337/dc22-0980.
    PubMed     Abstract available


  693. CHAMINE I, Hwang J, Valenzuela S, Marino M, et al
    Acute and Chronic Diabetes-Related Complications Among Patients With Diabetes Receiving Care in Community Health Centers.
    Diabetes Care. 2022 Aug 15. pii: 147448. doi: 10.2337/dc22-0420.
    PubMed    


  694. ROSSING P, Anker SD, Filippatos G, Pitt B, et al
    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
    Diabetes Care. 2022 Aug 15. pii: 147449. doi: 10.2337/dc22-0294.
    PubMed     Abstract available


  695. TANG EHM, Mak IL, Tse ETY, Wan EYF, et al
    Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study.
    Diabetes Care. 2022 Aug 12. pii: 147443. doi: 10.2337/dc22-0387.
    PubMed     Abstract available


  696. LACHIN JM, Bebu I, Gao X, Nathan DM, et al
    Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial.
    Diabetes Care. 2022 Aug 12. pii: 147444. doi: 10.2337/dc21-2298.
    PubMed     Abstract available


  697. RAUTIO E, Gadler F, Gudbjornsdottir S, Franzen S, et al
    Erratum. Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population. Diabetes Care 2020;44:2853-2858.
    Diabetes Care. 2022 Aug 10. pii: 147384. doi: 10.2337.
    PubMed     Abstract available


  698. KIM RG, Deng J, Reaso JN, Grenert JP, et al
    Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy.
    Diabetes Care. 2022 Aug 10. pii: 147415. doi: 10.2337/dc22-0556.
    PubMed     Abstract available


  699. KHUNTI K, Feldman EL, Laiteerapong N, Parker W, et al
    The Impact of the COVID-19 Pandemic on Ethnic Minority Groups With Diabetes.
    Diabetes Care. 2022 Aug 9. pii: 147383. doi: 10.2337/dc21-2495.
    PubMed     Abstract available


  700. KEINER ES, Slaughter JC, Datye KA, Cherrington AD, et al
    COVID-19 Exacerbates Insulin Resistance During Diabetic Ketoacidosis in Pediatric Patients With Type 1 Diabetes.
    Diabetes Care. 2022 Aug 9. pii: 147406. doi: 10.2337/dc22-0396.
    PubMed     Abstract available


  701. SERES-NORIEGA T, Gimenez M, Perea V, Boswell L, et al
    Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk.
    Diabetes Care. 2022 Aug 9. pii: 147404. doi: 10.2337/dc22-0118.
    PubMed     Abstract available


  702. LI FR, Hukportie DN, Yang J, Yang HH, et al
    Microvascular Burden and Incident Heart Failure Among Middle-Aged and Older Adults With Type 1 or Type 2 Diabetes.
    Diabetes Care. 2022 Aug 9. pii: 147411. doi: 10.2337/dc22-0177.
    PubMed     Abstract available


  703. SASAKI N, Maeda R, Ozono R, Yoshimura K, et al
    Early-Phase Changes in Serum Free Fatty Acid Levels After Glucose Intake Are Associated With Type 2 Diabetes Incidence: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases.
    Diabetes Care. 2022 Aug 9. pii: 147410. doi: 10.2337/dc21-2554.
    PubMed     Abstract available


  704. BENNING TJ, Heien HC, McCoy RG
    Evolution of Clinical Complexity, Treatment Burden, Health Care Use, and Diabetes-Related Outcomes Among Commercial and Medicare Advantage Plan Beneficiaries With Diabetes in the U.S., 2006-2018.
    Diabetes Care. 2022 Aug 4. pii: 147378. doi: 10.2337/dc21-2623.
    PubMed     Abstract available


  705. LIU S, Leone M, Ludvigsson JF, Lichtenstein P, et al
    Association and Familial Coaggregation of Childhood-Onset Type 1 Diabetes With Depression, Anxiety, and Stress-Related Disorders: A Population-Based Cohort Study.
    Diabetes Care. 2022 Aug 1. pii: 147256. doi: 10.2337/dc21-1347.
    PubMed     Abstract available


  706. LEE JJ, Khan TA, McGlynn N, Malik VS, et al
    Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies.
    Diabetes Care. 2022;45:1917-1930.
    PubMed     Abstract available


  707. FERRANNINI E, Baldi S, Scozzaro T, Tsimihodimos V, et al
    Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS).
    Diabetes Care. 2022;45:1893-1899.
    PubMed     Abstract available


  708. MYERS LA, Swanson KM, Glasgow AE, McCoy RG, et al
    Management and Outcomes of Severe Hypoglycemia Treated by Emergency Medical Services in the U.S. Upper Midwest.
    Diabetes Care. 2022;45:1788-1798.
    PubMed     Abstract available


  709. WANG T, Li M, Zeng T, Hu R, et al
    Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study.
    Diabetes Care. 2022;45:1863-1872.
    PubMed     Abstract available


  710. SHAH HS, Moreno LO, Morieri ML, Tang Y, et al
    Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies.
    Diabetes Care. 2022;45:1882-1892.
    PubMed     Abstract available


    July 2022
  711. TAKESHITA Y, Honda M, Harada K, Kita Y, et al
    Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial.
    Diabetes Care. 2022 Jul 27. pii: 147324. doi: 10.2337/dc21-2049.
    PubMed     Abstract available


  712. MARTIN CL, Trapani VR, Backlund JC, Lee P, et al
    Physical Function in Middle-aged and Older Adults With Type 1 Diabetes: Long-term Follow-up of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Diabetes Care. 2022 Jul 26. pii: 147290. doi: 10.2337/dc21-2119.
    PubMed     Abstract available


  713. CELLI A, Barnouin Y, Jiang B, Blevins D, et al
    Lifestyle Intervention Strategy to Treat Diabetes in Older Adults: A Randomized Controlled Trial.
    Diabetes Care. 2022 Jul 26. pii: 147289. doi: 10.2337/dc22-0338.
    PubMed     Abstract available


  714. MCKEIGUE PM, McGurnaghan S, Blackbourn L, Bath LE, et al
    Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland.
    Diabetes Care. 2022 Jul 26. pii: 147219. doi: 10.2337/dc22-0385.
    PubMed     Abstract available


  715. VERHULST CEM, Fabricius TW, Nefs G, Kessels RPC, et al
    Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without Diabetes.
    Diabetes Care. 2022 Jul 25. pii: 147287. doi: 10.2337/dc21-2502.
    PubMed     Abstract available


  716. GYLDENKERNE C, Kahlert J, Olesen KKW, Thrane PG, et al
    Twenty-Year Temporal Trends in Risk of Ischemic Stroke in Incident Type 2 Diabetes: A Danish Population-Based Cohort Study.
    Diabetes Care. 2022 Jul 25. pii: 147286. doi: 10.2337/dc22-0440.
    PubMed     Abstract available


  717. PRADHAN R, Yin H, Yu OHY, Azoulay L, et al
    Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes.
    Diabetes Care. 2022 Jul 22. pii: 147257. doi: 10.2337/dc22-0712.
    PubMed     Abstract available


  718. DELLA PEPA G, Brancato V, Costabile G, Salamone D, et al
    An Isoenergetic Multifactorial Diet Reduces Pancreatic Fat and Increases Postprandial Insulin Response in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
    Diabetes Care. 2022 Jul 21. pii: 147254. doi: 10.2337/dc22-0605.
    PubMed     Abstract available


  719. KLEIN KR, Pate V, Assimon MM, Sturmer T, et al
    Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid Diabetes.
    Diabetes Care. 2022 Jul 21. pii: 147253. doi: 10.2337/dc22-0659.
    PubMed    


  720. GRAMS ME, Brunskill NJ, Ballew SH, Sang Y, et al
    Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes Mellitus.
    Diabetes Care. 2022 Jul 20. pii: 147251. doi: 10.2337/dc22-0698.
    PubMed     Abstract available


  721. FICKWEILER W, Park H, Park K, Mitzner MG, et al
    Elevated Retinol Binding Protein 3 Concentrations Are Associated With Decreased Vitreous Inflammatory Cytokines, VEGF, and Progression of Diabetic Retinopathy.
    Diabetes Care. 2022 Jul 19. pii: 147248. doi: 10.2337/dc22-0165.
    PubMed     Abstract available


  722. CHANG HC, Kuo TT, Chen YY, Lin YJ, et al
    Sodium-Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study.
    Diabetes Care. 2022 Jul 15. pii: 147245. doi: 10.2337/dc22-0938.
    PubMed    


  723. PUROLA PKM, Ojamo MUI, Gissler M, Uusitalo HMT, et al
    Changes in Visual Impairment due to Diabetic Retinopathy During 1980-2019 Based on Nationwide Register Data.
    Diabetes Care. 2022 Jul 15. pii: 147246. doi: 10.2337/dc21-2369.
    PubMed     Abstract available


  724. FU L, Tai S, Sun J, Zhang N, et al
    Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort.
    Diabetes Care. 2022 Jul 14. pii: 147241. doi: 10.2337/dc21-2511.
    PubMed     Abstract available


  725. ROTONDI MA, Wong O, Riddell M, Perkins B, et al
    Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study.
    Diabetes Care. 2022 Jul 14. pii: 147242. doi: 10.2337/dc21-2341.
    PubMed     Abstract available


  726. KUO S, Yang CT, Herman WH, Lisabeth LD, et al
    National Trends in the Achievement of Recommended Strategies for Stroke Prevention in U.S. Adults With Type 2 Diabetes, 2001-2018.
    Diabetes Care. 2022 Jul 14. pii: 147243. doi: 10.2337/dc21-2283.
    PubMed     Abstract available


  727. GERSTEIN HC, Hess S, Claggett B, Dickstein K, et al
    Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study.
    Diabetes Care. 2022 Jul 11. pii: 147217. doi: 10.2337/dc22-0453.
    PubMed     Abstract available


  728. FANG M, Wang D, Coresh J, Selvin E, et al
    Undiagnosed Diabetes in U.S. Adults: Prevalence and Trends.
    Diabetes Care. 2022 Jul 11. pii: 147216. doi: 10.2337/dc22-0242.
    PubMed     Abstract available


  729. POSCH MG, Walther N, Ferrannini E, Powell DR, et al
    Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study.
    Diabetes Care. 2022 Jul 11. pii: 147215. doi: 10.2337/dc21-2166.
    PubMed     Abstract available


  730. EGAN AM, Vella A
    Tighten Your Belt! Banded Roux-en-Y Gastric Bypass for Diabetes Remission?
    Diabetes Care. 2022;45:1495-1497.
    PubMed    


  731. MORIERI ML
    Heart Failure Burden in Diabetes: Can Fenofibrate Provide Additional Hope?
    Diabetes Care. 2022;45:1500-1502.
    PubMed    


  732. RIDDLE MC, Bakris G, Blonde L, Boulton AJM, et al
    Editorial Cycles and Continuity of Diabetes Care.
    Diabetes Care. 2022;45:1493-1494.
    PubMed    


  733. RAHMA S, Woods J, Brown S, Nixon J, et al
    The Use of Point-of-Care Bacterial Autofluorescence Imaging in the Management of Diabetic Foot Ulcers: A Pilot Randomized Controlled Trial.
    Diabetes Care. 2022;45:1601-1609.
    PubMed     Abstract available


  734. ESSIEN UR, Tang Y, Figueroa JF, Litam TMA, et al
    Diabetes Care Among Older Adults Enrolled in Medicare Advantage Versus Traditional Medicare Fee-For-Service Plans: The Diabetes Collaborative Registry.
    Diabetes Care. 2022;45:1549-1557.
    PubMed     Abstract available


  735. POP-BUSUI R, Januzzi JL, Bruemmer D, Butalia S, et al
    Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association.
    Diabetes Care. 2022;45:1670-1690.
    PubMed     Abstract available


  736. DEL POZO-CRUZ J, Alvarez-Barbosa F, Gallardo-Gomez D, Del Pozo Cruz B, et al
    Optimal Number of Steps per Day to Prevent All-Cause Mortality in People With Prediabetes and Diabetes.
    Diabetes Care. 2022 Jul 7. pii: 147209. doi: 10.2337/dc22-0524.
    PubMed     Abstract available


  737. JEFFCOATE W, Game F
    The Charcot Foot Reflects a Response to Injury That Is Critically Distorted by Preexisting Nerve Damage: An Imperfect Storm.
    Diabetes Care. 2022;45:1691-1697.
    PubMed     Abstract available


  738. JEX N, Chowdhary A, Thirunavukarasu S, Procter H, et al
    Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy.
    Diabetes Care. 2022 Jul 5. pii: 147161. doi: 10.2337/dc22-0083.
    PubMed     Abstract available


  739. SACRE JW, Magliano DJ, Shaw JE
    Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor Therapy.
    Diabetes Care. 2022 Jul 1. pii: 147158. doi: 10.2337/dc21-1929.
    PubMed     Abstract available


    June 2022
  740. REID LA, Zheng S, Mendoza JA, Reboussin BA, et al
    Household Food Insecurity and Fear of Hypoglycemia in Adolescents and Young Adults With Diabetes and Parents of Youth With Diabetes.
    Diabetes Care. 2022 Jun 30. pii: 147157. doi: 10.2337/dc21-1807.
    PubMed     Abstract available


  741. FLOOD D, Geldsetzer P, Agoudavi K, Aryal KK, et al
    Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data.
    Diabetes Care. 2022 Jun 30. pii: 147155. doi: 10.2337/dc21-2342.
    PubMed     Abstract available


  742. VAN HECK JIP, Gacesa R, Stienstra R, Fu J, et al
    The Gut Microbiome Composition Is Altered in Long-Standing Type 1 Diabetes and Associates With Glycemic Control and Disease-Related Complications.
    Diabetes Care. 2022 Jun 29. pii: 147146. doi: 10.2337/dc21-2225.
    PubMed     Abstract available


  743. ZHANG H, Kleinberger JW, Maloney KA, Guan Y, et al
    Model for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine Program.
    Diabetes Care. 2022 Jun 28. pii: 147145. doi: 10.2337/dc21-1975.
    PubMed     Abstract available


  744. HOLMAN H, Muller F, Bhangu N, Kottutt J, et al
    Impact of Limited English Proficiency on the Diagnosis and Awareness of Diabetes: The National Health and Nutrition Examination Survey, 2003-2018.
    Diabetes Care. 2022 Jun 28. pii: 147144. doi: 10.2337/dc22-0594.
    PubMed    


  745. AUZANNEAU M, Rosenbauer J, Warncke K, Maier W, et al
    Frequency of Ketoacidosis at Diagnosis of Pediatric Type 1 Diabetes Associated With Socioeconomic Deprivation and Urbanization: Results From the German Multicenter DPV Registry.
    Diabetes Care. 2022 Jun 21. pii: 147117. doi: 10.2337/dc21-2227.
    PubMed     Abstract available


  746. LI J, Glenn AJ, Yang Q, Ding D, et al
    Dietary Protein Sources, Mediating Biomarkers, and Incidence of Type 2 Diabetes: Findings From the Women's Health Initiative and the U.K. Biobank.
    Diabetes Care. 2022 Jun 17. pii: 147100. doi: 10.2337/dc22-0368.
    PubMed     Abstract available


  747. PASQUA MR, Bidal-St-Aubin M, Berger C, Hu XW, et al
    Current Endocrinologist Practices in Skeletal Health Management of Patients With Diabetes: A Medical Record Review.
    Diabetes Care. 2022 Jun 17. pii: 147102. doi: 10.2337/dc22-0768.
    PubMed    


  748. NOOR N, Kamboj MK, Triolo T, Polsky S, et al
    Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative.
    Diabetes Care. 2022 Jun 16. pii: 147093. doi: 10.2337/dc22-0329.
    PubMed    


  749. MCINERNEY AM, Lindekilde N, Nouwen A, Schmitz N, et al
    Diabetes Distress, Depressive Symptoms, and Anxiety Symptoms in People With Type 2 Diabetes: A Network Analysis Approach to Understanding Comorbidity.
    Diabetes Care. 2022 Jun 15. pii: 147092. doi: 10.2337/dc21-2297.
    PubMed     Abstract available


  750. SHAO H, Guan D, Guo J, Jiao T, et al
    Projected Impact of the Medicare Part D Senior Savings Model (SSM) on Diabetes-Related Health and Economic Outcomes Among Insulin Users Covered by Medicare.
    Diabetes Care. 2022 Jun 14. pii: 147083. doi: 10.2337/dc21-2601.
    PubMed     Abstract available


  751. JACOBSON AM, Braffett BH, Erus G, Ryan CM, et al
    Brain Structure Among Middle-aged and Older Adults With Long-standing Type 1 Diabetes in the DCCT/EDIC Study.
    Diabetes Care. 2022 Jun 14. pii: 147082. doi: 10.2337/dc21-2438.
    PubMed     Abstract available


  752. PAUL SK, Shaw JE, Fenici P, Montvida O, et al
    Cardiorenal Complications in Young-Onset Type 2 Diabetes Between White and African Americans.
    Diabetes Care. 2022 Jun 14. pii: 147081. doi: 10.2337/dc21-2349.
    PubMed     Abstract available


  753. SCOTT EM, Murphy HR, Kristensen KH, Feig DS, et al
    Continuous Glucose Monitoring Metrics and Birth Weight: Informing Management of Type 1 Diabetes Throughout Pregnancy.
    Diabetes Care. 2022 Jun 13. pii: 147079. doi: 10.2337/dc22-0078.
    PubMed     Abstract available


  754. YOUNG SK, Atwood A, Allen L, Pauly N, et al
    The SNAP Cycle and Diabetes Management During a One-Time Change in Disbursement Schedule.
    Diabetes Care. 2022 Jun 9. pii: 147069. doi: 10.2337/dc21-2047.
    PubMed     Abstract available


  755. TAMBORLANE WV, Bishai R, Geller D, Shehadeh N, et al
    Once-Weekly Exenatide in Youth With Type 2 Diabetes.
    Diabetes Care. 2022 Jun 9. pii: 147070. doi: 10.2337/dc21-2275.
    PubMed     Abstract available


  756. KEROLA AM, Juonala M, Palomaki A, Semb AG, et al
    Case Fatality of Patients With Type 1 Diabetes After Myocardial Infarction.
    Diabetes Care. 2022 Jun 9. pii: 147067. doi: 10.2337/dc22-0042.
    PubMed     Abstract available


  757. SHERR JL, Bode BW, Forlenza GP, Laffel LM, et al
    Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial.
    Diabetes Care. 2022 Jun 9. pii: 147068. doi: 10.2337/dc21-2359.
    PubMed     Abstract available


  758. VELLANKI P, Cardona S, Galindo RJ, Urrutia MA, et al
    Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study.
    Diabetes Care. 2022 Jun 8. pii: 147066. doi: 10.2337/dc21-1606.
    PubMed     Abstract available


  759. FRIAS JP, Choi J, Rosenstock J, Popescu L, et al
    Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial.
    Diabetes Care. 2022 Jun 7. pii: 147061. doi: 10.2337/dc21-2656.
    PubMed     Abstract available


  760. FEIG DS, Zinman B, Asztalos E, Donovan LE, et al
    Determinants of Small for Gestational Age in Women With Type 2 Diabetes in Pregnancy: Who Should Receive Metformin?
    Diabetes Care. 2022 Jun 7. pii: 147062. doi: 10.2337/dc22-0013.
    PubMed     Abstract available


  761. SHAH AS, Isom S, D'Agostino R, Dolan LM, et al
    Longitudinal Changes in Arterial Stiffness and Heart Rate Variability in Youth-Onset Type 1 Versus Type 2 Diabetes: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2022 Jun 6. pii: 146998. doi: 10.2337/dc21-2426.
    PubMed     Abstract available


  762. BENDOR CD, Bardugo A, Rotem RS, Derazne E, et al
    Glucose Intolerance in Pregnancy and Offspring Obesity in Late Adolescence.
    Diabetes Care. 2022 Jun 4. pii: 146991. doi: 10.2337/dc21-2634.
    PubMed     Abstract available


  763. KOSKA J, Gerstein HC, Beisswenger PJ, Reaven PD, et al
    Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684-691.
    Diabetes Care. 2022;45:e111-e112.
    PubMed    


  764. BORDERIE G, Larroumet A, Baillet-Blanco L, Foussard N, et al
    Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684-691.
    Diabetes Care. 2022;45:e110.
    PubMed    


  765. SYLOW L, Grand MK, von Heymann A, Persson F, et al
    Incidence of New-Onset Type 2 Diabetes After Cancer: A Danish Cohort Study.
    Diabetes Care. 2022;45:e105-e106.
    PubMed    


    May 2022

  766. Addendum. 11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022: Diabetes Care 2022;45(Suppl. 1):S175-S184.
    Diabetes Care. 2022 May 31. pii: 147052. doi: 10.2337.
    PubMed    



  767. Addendum. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1):S144-S174.
    Diabetes Care. 2022 May 31. pii: 147053. doi: 10.2337.
    PubMed    


  768. LINDE S, Walker RJ, Campbell JA, Egede LE, et al
    Historic Residential Redlining and Present-day Diabetes Mortality and Years of Life Lost: The Persistence of Structural Racism.
    Diabetes Care. 2022 May 31. pii: 147051. doi: 10.2337/dc21-2563.
    PubMed     Abstract available


  769. NIZNIK JD, Zhao X, Slieanu F, Mor MK, et al
    Effect of Deintensifying Diabetes Medications on Negative Events in Older Veteran Nursing Home Residents.
    Diabetes Care. 2022 May 27. pii: 147046. doi: 10.2337/dc21-2116.
    PubMed     Abstract available


  770. ZHAO LP, Skyler J, Papadopoulos GK, Pugliese A, et al
    Association of HLA-DQ Heterodimer Residues -18beta and beta57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial-Type 1.
    Diabetes Care. 2022 May 27. pii: 147047. doi: 10.2337/dc21-1628.
    PubMed     Abstract available


  771. ZHAO J, Tostivint I, Xu L, Huang J, et al
    Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial.
    Diabetes Care. 2022 May 25. pii: 147005. doi: 10.2337/dc22-0607.
    PubMed    


  772. ZHANG J, Van Spall HGC, Wang Y, Thabane L, et al
    Enrollment of Black, Indigenous, and Other People of Color in Multicountry Randomized Controlled Trials of Diabetes Conducted in North America and Europe.
    Diabetes Care. 2022 May 25. pii: 147006. doi: 10.2337/dc22-0261.
    PubMed    


  773. EHRMANN D, Schmitt A, Priesterroth L, Kulzer B, et al
    Time With Diabetes Distress and Glycemia-Specific Distress: New Patient-Reported Outcome Measures for the Psychosocial Burden of Diabetes Using Ecological Momentary Assessment in an Observational Study.
    Diabetes Care. 2022 May 25. pii: 147004. doi: 10.2337/dc21-2339.
    PubMed     Abstract available


  774. SCHRADER S, Perfilyev A, Ahlqvist E, Groop L, et al
    Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns, Which Associate With Future Diabetic Complications.
    Diabetes Care. 2022 May 24. pii: 146986. doi: 10.2337/dc21-2489.
    PubMed     Abstract available


  775. ALLEN DW, Liew G, Cho YH, Pryke A, et al
    Thirty-Year Time Trends in Diabetic Retinopathy and Macular Edema in Youth With Type 1 Diabetes.
    Diabetes Care. 2022 May 20. pii: 146990. doi: 10.2337/dc21-1652.
    PubMed     Abstract available


  776. HALLER PM, Boeddinghaus J, Neumann JT, Sorensen NA, et al
    Erratum. Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With Diabetes. Diabetes Care 2020;43:460-467.
    Diabetes Care. 2022 May 20. pii: 146996. doi: 10.2337.
    PubMed     Abstract available


  777. DATTA R, Lucas JA, Marino M, Aceves B, et al
    Diabetes Screening and Monitoring Among Older Mexican-Origin Populations in the U.S.
    Diabetes Care. 2022 May 19. pii: 146995. doi: 10.2337/dc21-2483.
    PubMed     Abstract available


  778. POTIER L, Mohammedi K, Saulnier PJ, Fumeron F, et al
    Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 Diabetes.
    Diabetes Care. 2022 May 18. pii: 146987. doi: 10.2337/dc21-2638.
    PubMed     Abstract available


  779. MURPHY R, Plank LD, Clarke MG, Evennett NJ, et al
    Effect of Banded Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy on Diabetes Remission at 5 Years Among Patients With Obesity and Type 2 Diabetes: A Blinded Randomized Clinical Trial.
    Diabetes Care. 2022 May 12. pii: 146925. doi: 10.2337/dc21-2498.
    PubMed     Abstract available


  780. WU IW, Tsai TH, Lo CJ, Chou YJ, et al
    Discovery of a Biomarker Signature That Reveals a Molecular Mechanism Underlying Diabetic Kidney Disease via Organ Cross Talk.
    Diabetes Care. 2022 May 12. pii: 146922. doi: 10.2337/dc22-0145.
    PubMed    


  781. LONTCHI-YIMAGOU E, Dasgupta R, Anoop S, Kehlenbrink S, et al
    An Atypical Form of Diabetes Among Individuals With Low BMI.
    Diabetes Care. 2022 May 6. pii: 146920. doi: 10.2337/dc21-1957.
    PubMed     Abstract available


  782. TORNESE G, Carletti C, Giangreco M, Nistico D, et al
    Carbohydrate Tolerance Threshold for Unannounced Snacks in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System.
    Diabetes Care. 2022 May 6. pii: 146921. doi: 10.2337/dc21-2643.
    PubMed     Abstract available


  783. CORDERO C, Schneiderman N, Llabre MM, Teng Y, et al
    Diabetes Incidence Among Hispanic/Latino Adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Diabetes Care. 2022 May 4. pii: 146869. doi: 10.2337/dc21-1543.
    PubMed     Abstract available


  784. QIU Z, Chen X, Geng T, Wan Z, et al
    Associations of Serum Carotenoids With Risk of Cardiovascular Mortality Among Individuals With Type 2 Diabetes: Results From NHANES.
    Diabetes Care. 2022 May 3. pii: 146867. doi: 10.2337/dc21-2371.
    PubMed     Abstract available


  785. HIRABAYASHI N, Hata J, Furuta Y, Ohara T, et al
    Association Between Diabetes and Gray Matter Atrophy Patterns in a General Older Japanese Population: The Hisayama Study.
    Diabetes Care. 2022 May 2. pii: 146860. doi: 10.2337/dc21-1911.
    PubMed     Abstract available


  786. SCHMITTDIEL JA, Adams AS, Haire-Joshu D, Heisler M, et al
    Comment on Dunne et al. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care 2021;44:1734-1743.
    Diabetes Care. 2022;45:e97-e98.
    PubMed    


  787. DUNNE JL, Maizel JL, Posgai AL, Atkinson MA, et al
    Response to Comment on Dunne et al. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care 2021;44:1734-1743.
    Diabetes Care. 2022;45:e99.
    PubMed    


  788. MURPHY HR, Moses RG
    Pregnancy Outcomes of Young Women With Type 2 Diabetes: Poor Care and Inadequate Attention to Glycemia.
    Diabetes Care. 2022;45:1046-1048.
    PubMed    


  789. PRICE SAL
    Mental Health During Pregnancy and Postpartum in Mothers With Type 1 Diabetes.
    Diabetes Care. 2022;45:1027-1028.
    PubMed    


  790. JASER SS, Hilliard ME
    Preventing, Screening, and Treating Suicidality in Pediatric Type 1 Diabetes: Roles for Behavioral Health Care Professionals.
    Diabetes Care. 2022;45:1035-1037.
    PubMed    


  791. VIOLANTE-CUMPA JR, Sanchez-Gomez RA, Lavalle-Gonzalez FJ, Mancillas-Adame LG, et al
    Comment on Aminian et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care 2021;44:2552-2563.
    Diabetes Care. 2022;45:e100.
    PubMed    


  792. AMINIAN A, Nissen SE
    Response to Comment On Aminian et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care 2021;44:2552-2563.
    Diabetes Care. 2022;45:e101.
    PubMed    


  793. PILLA SJ, Shahidzadeh Yazdi Z, Taylor SI
    Individualized Glycemic Goals for Older Adults Are a Moving Target.
    Diabetes Care. 2022;45:1029-1031.
    PubMed    


  794. UEDA P, Svanstrom H, Hviid A, Eliasson B, et al
    Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Bladder and Renal Cancer: Scandinavian Cohort Study.
    Diabetes Care. 2022;45:e93-e96.
    PubMed    


  795. THIRUVENKATARAJAN V, Smithson-Tomas G, Jothin A, Meyer E, et al
    Sodium-Glucose Cotransporter 2 Inhibitor-Linked Pericolonoscopy Hyperketonemia: A Retrospective Study.
    Diabetes Care. 2022;45:e91-e92.
    PubMed    


  796. BUZIAU AM, Eussen SJPM, Kooi ME, van der Kallen CJH, et al
    Fructose Intake From Fruit Juice and Sugar-Sweetened Beverages Is Associated With Higher Intrahepatic Lipid Content: The Maastricht Study.
    Diabetes Care. 2022;45:1116-1123.
    PubMed     Abstract available


    April 2022
  797. VILLARD O, Breton MD, Rao S, Voelmle MK, et al
    Accuracy of a Factory-Calibrated Continuous Glucose Monitor in Individuals With Diabetes on Hemodialysis.
    Diabetes Care. 2022 Apr 29. pii: 145075. doi: 10.2337/dc22-0073.
    PubMed     Abstract available


  798. VAZEOU A, Tittel SR, Birkebaek NH, Kordonouri O, et al
    The Importance of Office Blood Pressure Measurement Frequency and Methodology in Evaluating the Prevalence of Hypertension in Children and Adolescents With Type 1 Diabetes: The SWEET International Database.
    Diabetes Care. 2022 Apr 27. pii: 145034. doi: 10.2337/dc21-2472.
    PubMed     Abstract available


  799. LAUGESEN C, Ranjan AG, Schmidt S, Norgaard K, et al
    Low-Dose Dasiglucagon Versus Oral Glucose for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes: A Phase 2, Randomized, Three-Arm Crossover Study.
    Diabetes Care. 2022 Apr 27. pii: 145035. doi: 10.2337/dc21-2304.
    PubMed     Abstract available


  800. TUTTLE KR, Levin A, Nangaku M, Kadowaki T, et al
    Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials.
    Diabetes Care. 2022 Apr 26. pii: 145036. doi: 10.2337/dc21-2034.
    PubMed     Abstract available


  801. KIM D, Alshuwaykh O, Sandhu KK, Dennis BB, et al
    Trends in All-Cause and Cause-Specific Mortality Among Individuals With Diabetes Before and During the COVID-19 Pandemic in the U.S.
    Diabetes Care. 2022 Apr 21. pii: 145033. doi: 10.2337/dc22-0348.
    PubMed    


  802. OKADA A, Hashimoto Y, Goto T, Yamaguchi S, et al
    A Machine Learning-Based Predictive Model to Identify Patients Who Failed to Attend a Follow-up Visit for Diabetes Care After Recommendations From a National Screening Program.
    Diabetes Care. 2022 Apr 18. pii: 144968. doi: 10.2337/dc21-1841.
    PubMed     Abstract available


  803. ALY HH, Fouda EM, Kotby AA, Magdy SM, et al
    Erratum. COVID-19-Related Multisystem Inflammatory Syndrome in Children Presenting With New-Onset Type 1 Diabetes in Severe Ketoacidosis: A Case Series. Diabetes Care 2022;45:983-989.
    Diabetes Care. 2022 Apr 14. pii: 145006. doi: 10.2337.
    PubMed     Abstract available


  804. TURBOW SD, Uppal TS, Haw JS, Chehal P, et al
    Trends and Demographic Disparities in Diabetes Hospital Admissions: Analyses of Serial Cross-Sectional National and State Data, 2008-2017.
    Diabetes Care. 2022 Apr 5. pii: 144979. doi: 10.2337/dc21-1837.
    PubMed     Abstract available


  805. DUNNE JL, Maizel JL, Posgai AL, Atkinson MA, et al
    Erratum. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care 2021;44:1734-1743.
    Diabetes Care. 2022 Apr 5. pii: 144980. doi: 10.2337.
    PubMed     Abstract available


  806. LIMONTE CP, Valo E, Drel V, Natarajan L, et al
    Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes.
    Diabetes Care. 2022 Apr 4. pii: 144976. doi: 10.2337/dc21-2204.
    PubMed     Abstract available


  807. CHEN Y, Jia H, Qian X, Wang J, et al
    Erratum. Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study. Diabetes Care 2022;44:666-673.
    Diabetes Care. 2022 Apr 1. pii: 144960. doi: 10.2337.
    PubMed    


  808. KHUNTI K, Aroda VR
    Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 Diabetes.
    Diabetes Care. 2022;45:766-768.
    PubMed    


  809. DAWED AY, Yee SW, Zhou K, van Leeuwen N, et al
    Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682.
    Diabetes Care. 2022;45:e82-e83.
    PubMed    


  810. BAILEY R, Calhoun P, Beck RW, Bergenstal RM, et al
    Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737.
    Diabetes Care. 2022;45:e85-e86.
    PubMed    


  811. HARDING JL, Wander PL, Zhang X, Li X, et al
    The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions.
    Diabetes Care. 2022;45:994-1006.
    PubMed     Abstract available


  812. DAVIDSON MB
    Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737.
    Diabetes Care. 2022;45:e84.
    PubMed    


  813. WANG K, Shi M, Yang A, Tomlinson B, et al
    Comment on Dawed et al. Genome-Wide Meta-Analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682.
    Diabetes Care. 2022;45:e80-e81.
    PubMed    


  814. MORZE J, Wittenbecher C, Schwingshackl L, Danielewicz A, et al
    Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies.
    Diabetes Care. 2022;45:1013-1024.
    PubMed     Abstract available


  815. LIU J, Richmond RC, Bowden J, Barry C, et al
    Assessing the Causal Role of Sleep Traits on Glycated Hemoglobin: A Mendelian Randomization Study.
    Diabetes Care. 2022;45:772-781.
    PubMed     Abstract available


  816. TANG H, Kimmel SE, Smith SM, Cusi K, et al
    Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials.
    Diabetes Care. 2022;45:1007-1012.
    PubMed     Abstract available


  817. CAHN A, Wiviott SD, Mosenzon O, Goodrich EL, et al
    Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58.
    Diabetes Care. 2022;45:938-946.
    PubMed     Abstract available


    March 2022
  818. RAMPHUL K, Joynauth J
    Erratum. An Update on the Incidence and Burden of Diabetic Ketoacidosis in the U.S. Diabetes Care 2020;43:e196-e197.
    Diabetes Care. 2022 Mar 31. pii: 144951. doi: 10.2337.
    PubMed    


  819. RAGHAVAN S, Warsavage T, Liu WG, Raffle K, et al
    Trends in Timing of and Glycemia at Initiation of Second-line Type 2 Diabetes Treatment in U.S. Adults.
    Diabetes Care. 2022 Mar 28. pii: 144954. doi: 10.2337/dc21-2492.
    PubMed     Abstract available


  820. KANNENKERIL D, Nolde JM, Kiuchi MG, Carnagarin R, et al
    Retinal Capillary Damage is Already Evident in Patients With Hypertension and Prediabetes and Associated With HbA1c Levels in the Nondiabetic Range.
    Diabetes Care. 2022 Mar 28. pii: 144953. doi: 10.2337/dc21-1569.
    PubMed     Abstract available


  821. KIRWAN JP, Courcoulas AP, Cummings DE, Goldfine AB, et al
    Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D).
    Diabetes Care. 2022 Mar 23. pii: 144854. doi: 10.2337/dc21-2441.
    PubMed     Abstract available


  822. FERREIRA JP, Vasques-Novoa F, Ferrao D, Saraiva F, et al
    Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD.
    Diabetes Care. 2022 Mar 23. pii: 144882. doi: 10.2337/dc21-1977.
    PubMed     Abstract available


  823. HOLMAN N, Wild SH, Khunti K, Knighton P, et al
    Incidence and Characteristics of Remission of Type 2 Diabetes in England: A Cohort Study Using the National Diabetes Audit.
    Diabetes Care. 2022 Mar 23. pii: 144853. doi: 10.2337/dc21-2136.
    PubMed     Abstract available


  824. WING RR, Bray GA, Cassidy-Begay M, Clark JM, et al
    Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study.
    Diabetes Care. 2022 Mar 21. pii: 144847. doi: 10.2337/dc21-1805.
    PubMed     Abstract available


  825. ORAM RA, Sharp SA, Pihoker C, Ferrat L, et al
    Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth.
    Diabetes Care. 2022 Mar 21. pii: 144843. doi: 10.2337/dc20-2872.
    PubMed     Abstract available


  826. OLESEN SS, Viggers R, Drewes AM, Vestergaard P, et al
    Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality in Postpancreatitis Diabetes Mellitus Versus Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
    Diabetes Care. 2022 Mar 21. pii: 144848. doi: 10.2337/dc21-2531.
    PubMed     Abstract available


  827. HERRING RA, Shojaee-Moradie F, Stevenage M, Parsons I, et al
    The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes.
    Diabetes Care. 2022 Mar 21. pii: 144845. doi: 10.2337/dc21-2043.
    PubMed     Abstract available


  828. WEEDA ER, Alnewais ME, Zecopoulos A, Haas S, et al
    Social Determinants of Health in U.S. Counties Where Guideline-Influencing Diabetes Studies Were Conducted.
    Diabetes Care. 2022 Mar 21. pii: 144842. doi: 10.2337/dc21-2105.
    PubMed    


  829. GAO M, Jebb SA, Aveyard P, Ambrosini GL, et al
    Associations Between Dietary Patterns and Incident Type 2 Diabetes: Prospective Cohort Study of 120,343 UK Biobank Participants.
    Diabetes Care. 2022 Mar 17. pii: 144841. doi: 10.2337/dc21-2258.
    PubMed     Abstract available


  830. WANG MT, Huang YL, Lai JH, Lee CH, et al
    Association Between Specificity of Sulfonylureas to Cardiac Mitochondrial KATP Channels and the Risk of Major Adverse Cardiovascular Events in Type 2 Diabetes.
    Diabetes Care. 2022 Mar 16. pii: 144833. doi: 10.2337/dc21-1779.
    PubMed     Abstract available


  831. WU YM, Huang J, Reed ME
    Association Between High-Deductible Health Plans and Engagement in Routine Medical Care for Type 2 Diabetes in a Privately Insured Population: A Propensity Score-Matched Study.
    Diabetes Care. 2022 Mar 15. pii: 144738. doi: 10.2337/dc21-1885.
    PubMed     Abstract available



  832. Longitudinal Association of Depressive Symptoms, Binge Eating, and Quality of Life With Cardiovascular Risk Factors in Young Adults With Youth-Onset Type 2 Diabetes: The TODAY2 Study.
    Diabetes Care. 2022 Mar 15. pii: 144828. doi: 10.2337/dc21-1995.
    PubMed     Abstract available


  833. MONE P, Lombardi A, Gambardella J, Pansini A, et al
    Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction.
    Diabetes Care. 2022 Mar 14. pii: 144737. doi: 10.2337/dc21-2434.
    PubMed     Abstract available


  834. OTTOSSON F, Smith E, Ericson U, Brunkwall L, et al
    Metabolome-Defined Obesity and the Risk of Future Type 2 Diabetes and Mortality.
    Diabetes Care. 2022 Mar 14. pii: 144736. doi: 10.2337/dc21-2402.
    PubMed     Abstract available


  835. WANG X, Cheng FTF, Lam TYT, Liu Y, et al
    Stress Hyperglycemia Is Associated With an Increased Risk of Subsequent Development of Diabetes Among Bacteremic and Nonbacteremic Patients.
    Diabetes Care. 2022 Mar 11. pii: 144731. doi: 10.2337/dc21-1682.
    PubMed     Abstract available


  836. YANG YS, Chen HH, Huang CN, Hsu CY, et al
    GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease.
    Diabetes Care. 2022 Mar 11. pii: 144733. doi: 10.2337/dc21-1993.
    PubMed     Abstract available


  837. PARK CS, Choi YJ, Rhee TM, Lee HJ, et al
    U-Shaped Associations Between Body Weight Changes and Major Cardiovascular Events in Type 2 Diabetes Mellitus: A Longitudinal Follow-up Study of Over 1.5 Million Nationwide Cohort.
    Diabetes Care. 2022 Mar 9. pii: 144699. doi: 10.2337/dc21-2299.
    PubMed     Abstract available


  838. WESTERINK J, Matthiessen KS, Nuhoho S, Fainberg U, et al
    Estimated Life-Years Gained Free of New or Recurrent Major Cardiovascular Events With the Addition of Semaglutide to Standard of Care in People With Type 2 Diabetes and High Cardiovascular Risk.
    Diabetes Care. 2022 Mar 9. pii: 144726. doi: 10.2337/dc21-1138.
    PubMed     Abstract available


  839. CHAN KS, Wan EYF, Chin WY, Yu EYT, et al
    Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients With Diabetes: A Retrospective Cohort Study.
    Diabetes Care. 2022 Mar 9. pii: 144698. doi: 10.2337/dc21-1217.
    PubMed     Abstract available


  840. CHENG H, Zhang Z, Zhang B, Zhang W, et al
    Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study.
    Diabetes Care. 2022 Mar 9. pii: 144697. doi: 10.2337/dc21-2064.
    PubMed     Abstract available


  841. HARTMANN-BOYCE J, Rees K, Perring JC, Kerneis SA, et al
    Erratum. Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews. Diabetes Care 2021;44:2790-2811.
    Diabetes Care. 2022 Mar 9. pii: 144639. doi: 10.2337.
    PubMed    


  842. MARCOUX S, Cote-Corriveau G, Healy-Profitos J, Auger N, et al
    Varying Impact of Gestational Diabetes Mellitus on Incidence of Childhood Cancers: An Age-Stratified Retrospective Cohort Study.
    Diabetes Care. 2022 Mar 9. pii: 144696. doi: 10.2337/dc21-2107.
    PubMed     Abstract available


  843. RETNAKARAN R, Ye C, Hanley AJ, Connelly PW, et al
    Treating Gestational Diabetes Reduces Birth Weight but Does Not Affect Infant Adiposity Across the 1st Year of Life.
    Diabetes Care. 2022 Mar 8. pii: 144700. doi: 10.2337/dc21-2640.
    PubMed     Abstract available



  844. Erratum. 10. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1):S144-S174.
    Diabetes Care. 2022 Mar 7. pii: 144642. doi: 10.2337.
    PubMed    


  845. KAMP YJMOD, Ligt M, Dautzenberg B, Kornips E, et al
    Erratum. Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial. Diabetes Care 2021;44:1334-1343.
    Diabetes Care. 2022 Mar 3. pii: 144630. doi: 10.2337.
    PubMed    


  846. KILPATRICK ES, Butler AE, Ostlundh L, Atkin SL, et al
    Erratum. Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis. Diabetes Care 2022;45:267-272.
    Diabetes Care. 2022 Mar 3. pii: 144629. doi: 10.2337.
    PubMed    


  847. CHEN X, Affinati AH, Lee Y, Turcu AF, et al
    Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes.
    Diabetes Care. 2022 Mar 3. pii: 144640. doi: 10.2337/dc21-2213.
    PubMed     Abstract available


  848. GREGORY JM, Slaughter JC, Duffus SH, Smith TJ, et al
    Erratum. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532.
    Diabetes Care. 2022 Mar 2. pii: 144623. doi: 10.2337.
    PubMed    


  849. ALATRACH M, Agyin C, Solis-Herrera C, Lavryneko O, et al
    Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose.
    Diabetes Care. 2022 Mar 2. pii: 144631. doi: 10.2337/dc21-1798.
    PubMed     Abstract available


  850. OOSTERWIJK MM, Groothof D, Navis G, Bakker SJL, et al
    Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35-41.
    Diabetes Care. 2022;45:e69.
    PubMed    


  851. FAHRMANN ER, Driscoll HK
    Response to Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During approximately 30 Years of Follow-up in the DCCT/EDIC Stud
    Diabetes Care. 2022;45:e65-e66.
    PubMed    


  852. QUINN LM, Thayakaran R, Thomas N, Nirantharakumar K, et al
    Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230.
    Diabetes Care. 2022;45:e70-e71.
    PubMed    


  853. RIGALLEAU V, Larroumet A, Mohammedi K, Baillet-Blanco L, et al
    Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518-2526.
    Diabetes Care. 2022;45:e60.
    PubMed    


  854. GONZALEZ-CLEMENTE JM, Llaurado G, Romero A, Gimenez-Palop O, et al
    Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During approximately 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes
    Diabetes Care. 2022;45:e63-e64.
    PubMed    


  855. HEYMAN SN, Raz I, Abassi Z
    Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35-41.
    Diabetes Care. 2022;45:e67-e68.
    PubMed    


  856. RIGALLEAU V, Barbet-Massin MA, Larroumet A, Mohammedi K, et al
    Comment on Sjoholm et al. Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-term Results From the Swedish Obese Subjects Study. Diabetes Care 2022;45:444-450.
    Diabetes Care. 2022;45:e72.
    PubMed    


  857. LOPEZ J, Gange WS, Lung K, Xu BY, et al
    Response to Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518-2526.
    Diabetes Care. 2022;45:e61-e62.
    PubMed    


  858. SJOHOLM K, Carlsson LMS, Peltonen M, Taube M, et al
    Response to Comment on Sjoholm et al. Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-term Results From the Swedish Obese Subjects Study. Diabetes Care 2022;45:444-450.
    Diabetes Care. 2022;45:e73.
    PubMed    


  859. DAVIS J, Fischl AH, Beck J, Browning L, et al
    Erratum. 2022 National Standards for Diabetes Self-Management Education and Support. Diabetes Care 2022;45:484-494.
    Diabetes Care. 2022 Mar 1. pii: 144622. doi: 10.2337.
    PubMed    


  860. TOBI EW, Juvinao-Quintero DL, Ronkainen J, Ott R, et al
    Maternal Glycemic Dysregulation During Pregnancy and Neonatal Blood DNA Methylation: Meta-analyses of Epigenome-Wide Association Studies.
    Diabetes Care. 2022;45:614-623.
    PubMed     Abstract available


  861. HAWLEY CE, Lauffenburger JC, Paik JM, Wexler DJ, et al
    Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries.
    Diabetes Care. 2022;45:604-613.
    PubMed     Abstract available


  862. JAKICIC JM, Berkowitz RI, Bolin P, Bray GA, et al
    Association Between Change in Accelerometer-Measured and Self-Reported Physical Activity and Cardiovascular Disease in the Look AHEAD Trial.
    Diabetes Care. 2022;45:742-749.
    PubMed     Abstract available


    February 2022
  863. LEE N, Park SJ, Kang D, Jeon JY, et al
    Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study.
    Diabetes Care. 2022 Feb 28. pii: 144609. doi: 10.2337/dc21-1659.
    PubMed     Abstract available


  864. ZHANG P, Guo D, Xu B, Huang C, et al
    Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study.
    Diabetes Care. 2022 Feb 28. pii: 144610. doi: 10.2337/dc21-2193.
    PubMed     Abstract available


  865. COBRY EC, Bisio A, Wadwa RP, Breton MD, et al
    Improvements in Parental Sleep, Fear of Hypoglycemia, and Diabetes Distress With Use of an Advanced Hybrid Closed Loop System.
    Diabetes Care. 2022 Feb 24. pii: 144606. doi: 10.2337/dc21-1778.
    PubMed     Abstract available


  866. YOO JE, Han K, Kim B, Park SH, et al
    Changes in Physical Activity and the Risk of Dementia in Patients With New-Onset Type 2 Diabetes: A Nationwide Cohort Study.
    Diabetes Care. 2022 Feb 22. pii: 144601. doi: 10.2337/dc21-1597.
    PubMed     Abstract available


  867. ALGEFFARI M, Hussain S, Almogbel T, Alsharidah M, et al
    Home Use of Mini-Dose Glucagon As a Novel Treatment for Hypoglycemia Following Repeated, Prolonged Fasts in Type 1 Diabetes During Ramadan.
    Diabetes Care. 2022 Feb 17. pii: 144592. doi: 10.2337/dc21-1655.
    PubMed     Abstract available


  868. FERKET BS, Hunink MGM, Masharani U, Max W, et al
    Lifetime Cardiovascular Disease Risk by Coronary Artery Calcium Score in Individuals With and Without Diabetes: An Analysis From the Multi-Ethnic Study of Atherosclerosis.
    Diabetes Care. 2022 Feb 15. pii: 144564. doi: 10.2337/dc21-1607.
    PubMed     Abstract available


  869. MAGEE MJ, Khakharia A, Gandhi NR, Day CL, et al
    Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection.
    Diabetes Care. 2022 Feb 15. pii: 144563. doi: 10.2337/dc21-1687.
    PubMed     Abstract available


  870. CHEN Y, Jia H, Qian X, Wang J, et al
    Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study.
    Diabetes Care. 2022 Feb 14. pii: 139264. doi: 10.2337/dc21-1520.
    PubMed     Abstract available


  871. KARL FM, Winkler C, Ziegler AG, Laxy M, et al
    Costs of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, Germany.
    Diabetes Care. 2022 Feb 14. pii: 141056. doi: 10.2337/dc21-1648.
    PubMed     Abstract available


  872. PARVIAINEN A, Harkonen T, Ilonen J, But A, et al
    Heterogeneity of Type 1 Diabetes at Diagnosis Supports Existence of Age-Related Endotypes.
    Diabetes Care. 2022 Feb 11. pii: 144559. doi: 10.2337/dc21-1251.
    PubMed     Abstract available


  873. MOSS AC, Roberts AJ, Yi-Frazier JP, Read KL, et al
    Identifying Suicidal Risk in Adolescents and Young Adults With Type 1 Diabetes: Are Depression Screeners Sufficient?
    Diabetes Care. 2022 Feb 11. pii: 144558. doi: 10.2337/dc21-1553.
    PubMed     Abstract available


  874. DAWWAS GK, Flory JH, Hennessy S, Leonard CE, et al
    Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis.
    Diabetes Care. 2022 Feb 11. pii: 144557. doi: 10.2337/dc21-2177.
    PubMed     Abstract available


  875. LAI HTM, Imamura F, Korat AVA, Murphy RA, et al
    Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE).
    Diabetes Care. 2022 Feb 10. pii: 144555. doi: 10.2337/dc21-1756.
    PubMed     Abstract available


  876. SUOMI T, Kalim UU, Rasool O, Laiho A, et al
    Type 1 Diabetes in Children With Genetic Risk May Be Predicted Very Early With a Blood miRNA.
    Diabetes Care. 2022 Feb 8. pii: 144532. doi: 10.2337/dc21-2120.
    PubMed    


  877. PRADA M, Wittenbecher C, Eichelmann F, Wernitz A, et al
    Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort.
    Diabetes Care. 2022 Feb 7. pii: 144531. doi: 10.2337/dc21-1897.
    PubMed     Abstract available


  878. OIKONOMOU EK, Suchard MA, McGuire DK, Khera R, et al
    Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes.
    Diabetes Care. 2022 Feb 4. pii: 144528. doi: 10.2337/dc21-1765.
    PubMed     Abstract available


  879. ALY HH, Fouda EM, Kotby AA, Magdy SM, et al
    COVID-19-Related Multisystem Inflammatory Syndrome in Children Presenting With New-Onset Type 1 Diabetes in Severe Ketoacidosis: A Case Series.
    Diabetes Care. 2022 Feb 3. pii: 144527. doi: 10.2337/dc21-1094.
    PubMed     Abstract available


  880. GANCHEVA S, Kahl S, Pesta D, Mastrototaro L, et al
    Impaired Hepatic Mitochondrial Capacity in Nonalcoholic Steatohepatitis Associated With Type 2 Diabetes.
    Diabetes Care. 2022 Feb 3. pii: 144526. doi: 10.2337/dc21-1758.
    PubMed     Abstract available


  881. HALL M, Oakey H, Penno MAS, McGorm K, et al
    Mental Health During Late Pregnancy and Postpartum in Mothers With and Without Type 1 Diabetes: The ENDIA Study.
    Diabetes Care. 2022 Feb 2. pii: 141062. doi: 10.2337/dc21-2335.
    PubMed     Abstract available


  882. GAZZARUSO C, Coppola A, Gallotti P, Terruzzi I, et al
    Comment on Khunti et al. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care 2021;44:2645-2655.
    Diabetes Care. 2022;45:e45.
    PubMed    


  883. IPP E, Kumar M
    Response to Comment on Ipp and Kumar. A Clinical Conundrum: Intensifying Glucose Control in the Presence of Advanced Diabetic Retinopathy. Diabetes Care 2021;44:2192-2193.
    Diabetes Care. 2022;45:e40.
    PubMed    


  884. FELDMAN-BILLARD S, Paques M
    Comment on Lee et al. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. Diabetes Care 2021;44:2419-2426.
    Diabetes Care. 2022;45:e37.
    PubMed    


  885. MEEK CL, Oram RA, McDonald TJ, Feig DS, et al
    Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834.
    Diabetes Care. 2022;45:e43-e44.
    PubMed    


  886. RIGALLEAU V, Larroumet A, Mohammedi K, Baillet-Blanco L, et al
    Comment on Ipp and Kumar. A Clinical Conundrum: Intensifying Glucose Control in the Presence of Advanced Diabetic Retinopathy. Diabetes Care 2021;44:2192-2193.
    Diabetes Care. 2022;45:e39.
    PubMed    


  887. IVANISEVIC M, Djelmis J
    Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834.
    Diabetes Care. 2022;45:e41-e42.
    PubMed    


  888. LEE MK, Han K, Kwon HS
    Response to Comment on Lee et al. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. Diabetes Care 2021; 44:2419-2426.
    Diabetes Care. 2022;45:e38.
    PubMed    


  889. KILPATRICK ES, Butler AE, Ostlundh L, Atkin SL, et al
    Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis.
    Diabetes Care. 2022;45:267-272.
    PubMed     Abstract available


  890. DAVIS J, Fischl AH, Beck J, Browning L, et al
    2022 National Standards for Diabetes Self-Management Education and Support.
    Diabetes Care. 2022;45:484-494.
    PubMed    


  891. NOLAN JJ, Kahkoska AR, Semnani-Azad Z, Hivert MF, et al
    ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Diabetes.
    Diabetes Care. 2022;45:261-266.
    PubMed    


  892. GARDUNO AC, LaCroix AZ, LaMonte MJ, Dunstan DW, et al
    Associations of Daily Steps and Step Intensity With Incident Diabetes in a Prospective Cohort Study of Older Women: The OPACH Study.
    Diabetes Care. 2022;45:339-347.
    PubMed     Abstract available


  893. THORPE LE, Adhikari S, Lopez P, Kanchi R, et al
    Neighborhood Socioeconomic Environment and Risk of Type 2 Diabetes: Associations and Mediation Through Food Environment Pathways in Three Independent Study Samples.
    Diabetes Care. 2022 Feb 1. pii: 141053. doi: 10.2337/dc21-1693.
    PubMed     Abstract available


  894. PRADHAN R, Yin H, Yu O, Azoulay L, et al
    Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes.
    Diabetes Care. 2022 Feb 1. pii: 141054. doi: 10.2337/dc21-1953.
    PubMed     Abstract available


  895. DIAZ-SANTANA MV, O'Brien KM, Park YM, Sandler DP, et al
    Persistence of Risk for Type 2 Diabetes After Gestational Diabetes Mellitus.
    Diabetes Care. 2022 Feb 1. pii: 141055. doi: 10.2337/dc21-1430.
    PubMed     Abstract available


  896. SCHLOGL H, Stumvoll M
    The Brains Behind SGLT2 Inhibition.
    Diabetes Care. 2022;45:273-275.
    PubMed    


  897. CARUSO I, Cignarelli A, Laviola L, Giorgino F, et al
    GLP-1 Receptor Agonists for Cardiovascular Protection: A Matter of Time.
    Diabetes Care. 2022;45:e30-e31.
    PubMed    


  898. XIA PF, Tian YX, Geng TT, Li Y, et al
    Trends in Prevalence and Awareness of Prediabetes Among Adults in the U.S., 2005-2020.
    Diabetes Care. 2022;45:e21-e23.
    PubMed    


  899. KULLMANN S, Hummel J, Wagner R, Dannecker C, et al
    Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial.
    Diabetes Care. 2022;45:398-406.
    PubMed     Abstract available


    January 2022
  900. WRIGHT AK, Carr MJ, Kontopantelis E, Leelarathna L, et al
    Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes.
    Diabetes Care. 2022 Jan 31. pii: 141051. doi: 10.2337/dc21-1113.
    PubMed     Abstract available


  901. RUUSKANEN MO, Erawijantari PP, Havulinna AS, Liu Y, et al
    Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults.
    Diabetes Care. 2022 Jan 31. pii: 141052. doi: 10.2337/dc21-2358.
    PubMed     Abstract available


  902. YE X, Yu R, Jiang F, Hou X, et al
    Osteocalcin and Risks of Incident Diabetes and Diabetic Kidney Disease: A 4.6-Year Prospective Cohort Study.
    Diabetes Care. 2022 Jan 28. pii: 141038. doi: 10.2337/dc21-2113.
    PubMed     Abstract available


  903. ZHUANG P, Liu X, Li Y, Li H, et al
    Circulating Fatty Acids and Genetic Predisposition to Type 2 Diabetes: Gene-Nutrient Interaction Analysis.
    Diabetes Care. 2022 Jan 28. pii: 141037. doi: 10.2337/dc21-2048.
    PubMed     Abstract available


  904. DICORPO D, LeClair J, Cole JB, Sarnowski C, et al
    Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 individuals Across 13 Cohorts.
    Diabetes Care. 2022 Jan 27. pii: 141024. doi: 10.2337/dc21-1395.
    PubMed     Abstract available


  905. WANDER PL, Lowy E, Beste LA, Tulloch-Palomino L, et al
    The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection.
    Diabetes Care. 2022 Jan 27. pii: 141025. doi: 10.2337/dc21-1686.
    PubMed     Abstract available


  906. MORTON JI, Lazzarini PA, Shaw JE, Magliano DJ, et al
    Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010-2019.
    Diabetes Care. 2022 Jan 27. pii: 141021. doi: 10.2337/dc21-2268.
    PubMed     Abstract available


  907. CHENG F, Luk AO, Shi M, Huang C, et al
    Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization Analysis.
    Diabetes Care. 2022 Jan 27. pii: 141023. doi: 10.2337/dc21-1609.
    PubMed     Abstract available


  908. CHEN JL, Krupp GR, Lo JY
    The COVID-19 Pandemic and Changes in Health Care Utilization Among Patients With Type 2 Diabetes.
    Diabetes Care. 2022 Jan 27. pii: 141022. doi: 10.2337/dc21-2248.
    PubMed    


  909. CELIS-MORALES CA, Franzen S, Eeg-Olofsson K, Naucler E, et al
    Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register.
    Diabetes Care. 2022 Jan 25. pii: 141015. doi: 10.2337/dc21-0601.
    PubMed     Abstract available


  910. MUNSHI M, Slyne C, Adam A, Davis D, et al
    Impact of Diabetes Duration on Functional and Clinical Status in Older Adults With Type 1 Diabetes.
    Diabetes Care. 2022 Jan 25. pii: 141008. doi: 10.2337/dc21-2000.
    PubMed     Abstract available


  911. GUBITOSI-KLUG RA, Braffett BH, Bebu I, Johnson ML, et al
    Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study.
    Diabetes Care. 2022 Jan 25. pii: 141005. doi: 10.2337/dc21-0629.
    PubMed     Abstract available


  912. WANG M, Huang J, Wu T, Qi L, et al
    Arterial Stiffness, Genetic Risk, and Type 2 Diabetes: A Prospective Cohort Study.
    Diabetes Care. 2022 Jan 25. pii: 141007. doi: 10.2337/dc21-1921.
    PubMed     Abstract available


  913. LE P, Ayers G, Misra-Hebert AD, Herzig SJ, et al
    Adherence to the ADA's Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001-2018.
    Diabetes Care. 2022 Jan 25. pii: 141006. doi: 10.2337/dc21-1507.
    PubMed     Abstract available


  914. GUPTA K, Rajagopal R, King F, Simmons D, et al
    Erratum. Complications of Antenatal Corticosteroids in Infants Born by Early Term Scheduled Cesarean Section. Diabetes Care 2020;43:906-908.
    Diabetes Care. 2022 Jan 21. pii: 140934. doi: 10.2337.
    PubMed    


  915. ROSSING P, Burgess E, Agarwal R, Anker SD, et al
    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
    Diabetes Care. 2022 Jan 21. pii: 140949. doi: 10.2337/dc21-1944.
    PubMed     Abstract available


  916. PANG L, Colclough KC, Shepherd MH, McLean J, et al
    Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.K.
    Diabetes Care. 2022 Jan 21. pii: 140936. doi: 10.2337/dc21-2056.
    PubMed     Abstract available


  917. PALANCA A, van Nes F, Pardo F, Ampudia Blasco FJ, et al
    Real-world Evidence of Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience.
    Diabetes Care. 2022 Jan 21. pii: 140935. doi: 10.2337/dc21-1584.
    PubMed     Abstract available


  918. KOSKA J, Gerstein HC, Beisswenger PJ, Reaven PD, et al
    Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes.
    Diabetes Care. 2022 Jan 20. pii: 140922. doi: 10.2337/dc21-2196.
    PubMed     Abstract available


  919. VASBINDER A, Anderson E, Shadid H, Berlin H, et al
    Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19.
    Diabetes Care. 2022 Jan 19. pii: 140930. doi: 10.2337/dc21-2102.
    PubMed     Abstract available


  920. PREVOST MS, Rabasa-Lhoret R, Talbo MK, Yardley JE, et al
    Gender Differences in Strategies to Prevent Physical Activity-Related Hypoglycemia in Patients With Type 1 Diabetes: A BETTER Study.
    Diabetes Care. 2022 Jan 19. pii: 140932. doi: 10.2337/dc21-1899.
    PubMed    


  921. SHILO S, Godneva A, Rachmiel M, Korem T, et al
    The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic Control.
    Diabetes Care. 2022 Jan 19. pii: 140931. doi: 10.2337/dc21-1656.
    PubMed     Abstract available


  922. TALLON EM, Redondo MJ, Shyu CR, Liu D, et al
    Contrast Pattern Mining With the T1D Exchange Clinic Registry Reveals Complex Phenotypic Factors and Comorbidity Patterns Associated With Familial Versus Sporadic Type 1 Diabetes.
    Diabetes Care. 2022 Jan 19. pii: 140928. doi: 10.2337/dc21-2239.
    PubMed    


  923. LINDEKILDE N, Scheuer SH, Diaz LJ, Rubin KH, et al
    Risk of Developing Type 2 Diabetes in Individuals With a Psychiatric Disorder: A Nationwide Register-Based Cohort Study.
    Diabetes Care. 2022 Jan 19. pii: 139335. doi: 10.2337/dc21-1864.
    PubMed     Abstract available


  924. KWAN AYM, Gerstein HC, Basile J, Xavier D, et al
    HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial.
    Diabetes Care. 2022 Jan 19. pii: 140923. doi: 10.2337/dc21-1160.
    PubMed     Abstract available


  925. KADDIS JS, Perry DJ, Vu AN, Rich SS, et al
    Improving the Prediction of Type 1 Diabetes Across Ancestries.
    Diabetes Care. 2022 Jan 17. pii: 139387. doi: 10.2337/dc21-1254.
    PubMed    


  926. SHAKA H
    Economic Disparities Among Pediatric Diabetic Ketoacidosis Readmissions in the U.S.
    Diabetes Care. 2022 Jan 17. pii: 139384. doi: 10.2337/dc21-1776.
    PubMed    


  927. KAMRATH C, Rosenbauer J, Eckert AJ, Siedler K, et al
    Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry.
    Diabetes Care. 2022 Jan 17. pii: 139385. doi: 10.2337/dc21-0969.
    PubMed     Abstract available


  928. MORDI IR, Trucco E, Syed MG, MacGillivray T, et al
    Prediction of Major Adverse Cardiovascular Events From Retinal, Clinical, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort Study.
    Diabetes Care. 2022 Jan 17. pii: 139386. doi: 10.2337/dc21-1124.
    PubMed     Abstract available


  929. KOLKAILAH AA, Wiviott SD, Raz I, Murphy SA, et al
    Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58.
    Diabetes Care. 2022 Jan 12. pii: 139334. doi: 10.2337/dc21-1668.
    PubMed    


  930. HAYNES SC, Kompala T, Tancredi DJ, Neinstein AB, et al
    Factors Associated With Discontinuation of Subspecialty Diabetes Care During the COVID-19 Pandemic: A Multisite Retrospective Cohort Study.
    Diabetes Care. 2022 Jan 12. pii: 139332. doi: 10.2337/dc21-1360.
    PubMed    


  931. SHAO H, Li P, Guo J, Fonseca V, et al
    Socioeconomic Factors Play a More Important Role than Clinical Needs in the Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in People With Type 2 Diabetes.
    Diabetes Care. 2022 Jan 12. pii: 139336. doi: 10.2337/dc21-1800.
    PubMed    


  932. LITHOVIUS R, Antikainen AA, Mutter S, Valo E, et al
    Genetic Risk Score Enhances Coronary Artery Disease Risk Prediction in Individuals With Type 1 Diabetes.
    Diabetes Care. 2022 Jan 12. pii: 139339. doi: 10.2337/dc21-0974.
    PubMed     Abstract available


  933. JACOBSEN LM, Vehik K, Veijola R, Warncke K, et al
    Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study.
    Diabetes Care. 2022 Jan 12. pii: 139338. doi: 10.2337/dc21-0422.
    PubMed     Abstract available


  934. MACLEAN RH, Jacob P, Choudhary P, Heller SR, et al
    Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II.
    Diabetes Care. 2022 Jan 12. pii: 139337. doi: 10.2337/dc21-1120.
    PubMed     Abstract available


  935. TRIEF PM, Uschner D, Tung M, Marcus MD, et al
    Diabetes Distress in Young Adults With Youth-Onset Type 2 Diabetes: TODAY2 Study Results.
    Diabetes Care. 2022 Jan 11. pii: 139265. doi: 10.2337/dc21-1689.
    PubMed     Abstract available


  936. FANG Y, Zhang C, Shi H, Wei W, et al
    Erratum. Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control Study. Diabetes Care 2021;44:2738-2746.
    Diabetes Care. 2022 Jan 10. pii: 139249. doi: 10.2337.
    PubMed    


  937. NATHAN DM, Buse JB, Kahn SE, Krause-Steinrauf H, et al
    Erratum. Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2013;36:2254-2261.
    Diabetes Care. 2022 Jan 10. pii: 139248. doi: 10.2337.
    PubMed    


  938. CHAMPAKANATH A, Akturk HK, Alonso GT, Snell-Bergeon JK, et al
    Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study.
    Diabetes Care. 2022 Jan 10. pii: 139120. doi: 10.2337/dc21-2004.
    PubMed     Abstract available


  939. TAHA MB, Valero-Elizondo J, Yahya T, Caraballo C, et al
    Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013-2018.
    Diabetes Care. 2022 Jan 10. pii: 139257. doi: 10.2337/dc21-1757.
    PubMed     Abstract available


  940. GARAULET M, Lopez-Minguez J, Dashti HS, Vetter C, et al
    Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial.
    Diabetes Care. 2022 Jan 10. pii: 139258. doi: 10.2337/dc21-1314.
    PubMed     Abstract available


  941. LIN YK, Richardson CR, Dobrin I, DeJonckheere MJ, et al
    Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies.
    Diabetes Care. 2022 Jan 10. pii: 139256. doi: 10.2337/dc21-1285.
    PubMed     Abstract available


  942. MALIK FS, Sauder KA, Isom S, Reboussin BA, et al
    Trends in Glycemic Control Among Youth and Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2022 Jan 7. pii: 139219. doi: 10.2337/dc21-0507.
    PubMed     Abstract available


  943. PERKINS BA, Bebu I, Gao X, Karger AB, et al
    Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes.
    Diabetes Care. 2022 Jan 6. pii: 139193. doi: 10.2337/dc21-1883.
    PubMed     Abstract available


  944. MAHTTA D, Ramsey DJ, Lee MT, Chen L, et al
    Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.
    Diabetes Care. 2022 Jan 6. pii: 139194. doi: 10.2337/dc21-1815.
    PubMed     Abstract available


  945. CHIKOWORE T, Ekoru K, Vujkovi M, Gill D, et al
    Polygenic Prediction of Type 2 Diabetes in Africa.
    Diabetes Care. 2022 Jan 6. pii: 139195. doi: 10.2337/dc21-0365.
    PubMed     Abstract available


  946. BOYKO EJ, Zelnick LR, Braffett BH, Pop-Busui R, et al
    Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Diabetes Care. 2022 Jan 6. pii: 139191. doi: 10.2337/dc21-1816.
    PubMed     Abstract available


  947. LOOKER HC, Pyle L, Vigers T, Severn C, et al
    Structural Lesions on Kidney Biopsy in Youth-Onset and Adult-Onset Type 2 Diabetes.
    Diabetes Care. 2022 Jan 6. pii: 139190. doi: 10.2337/dc21-1688.
    PubMed     Abstract available


  948. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  949. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  950. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    Summary of Revisions: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed    



  951. 17. Diabetes Advocacy: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  952. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  953. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  954. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  955. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  956. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    7. Diabetes Technology: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  957. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  958. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    6. Glycemic Targets: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  959. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  960. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    14. Children and Adolescents: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  961. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available



  962. Disclosures: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed    


  963. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    13. Older Adults: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  964. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  965. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available


  966. DRAZNIN B, Aroda VR, Bakris G, Benson G, et al
    10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed     Abstract available



  967. Introduction: Standards of Medical Care in Diabetes-2022.
    Diabetes Care. 2022;45.
    PubMed    


  968. YEN FS, Wei JC
    Comment on Shih et al. Increased Incidence of Pediatric Type 1 Diabetes With Novel Association With Coxsackievirus A Species in Young Children but Declined Incidence in Adolescents in Taiwan. Diabetes Care 2021;44:1579-1585.
    Diabetes Care. 2022;45:e10.
    PubMed    


  969. MEERASA A, Dash S
    Weighing in on Type 2 Diabetes Remission.
    Diabetes Care. 2022;45:28-30.
    PubMed    


  970. PARENTE EB, Dahlstrom EH, Harjutsalo V, Inkeri J, et al
    Response to Comment on Parente et al. The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes. Diabetes Care 2021;44:1706-1713.
    Diabetes Care. 2022;45:e8-e9.
    PubMed    


  971. THIRUVENKATARAJAN V, Meyer EJ, Jesudason D
    Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126.
    Diabetes Care. 2022;45:e15-e16.
    PubMed    


  972. DE VRIES M, Kaasjager KHAH, de Valk HW
    Comment on Parente et al. The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes. Diabetes Care 2021;44:1706-1713.
    Diabetes Care. 2022;45:e7.
    PubMed    


  973. MINK J, Thakkar R, Jeddah D
    Comment on Stempniewicz et al. Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations. Diabetes Care 2021;44:2000-2009.
    Diabetes Care. 2022;45:e19-e20.
    PubMed    


  974. HAMBLIN PS, Wong R, Ekinci EI, Sztal-Mazer S, et al
    Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126.
    Diabetes Care. 2022;45:e17-e18.
    PubMed    


  975. WENG J, Zhou Z, Guo L
    Comment on Liu et al. Incidence of Type 1 Diabetes May Be Underestimated in the Chinese Population: Evidence From 21.7 Million People Between 2007 and 2017. Diabetes Care 2021;44:2503-2509.
    Diabetes Care. 2022;45:e12.
    PubMed    


  976. SHIH WL, Tung YC, Chang LY
    Response to Comment on Shih et al. Increased Incidence of Pediatric Type 1 Diabetes With Novel Association With Coxsackievirus A Species in Young Children but Declined Incidence in Adolescents in Taiwan. Diabetes Care 2021;44:1579-1585.
    Diabetes Care. 2022;45:e11.
    PubMed    


  977. LIU C, Yang JK
    Response to Comment on Liu et al. Incidence of Type 1 Diabetes May Be Underestimated in the Chinese Population: Evidence From 21.7 Million People Between 2007 and 2017. Diabetes Care 2021;44:2503-2509.
    Diabetes Care. 2022;45:e13-e14.
    PubMed    


  978. RAMON J, Llaurado G, Guerri R, Climent E, et al
    Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality.
    Diabetes Care. 2022;45:255-258.
    PubMed     Abstract available


  979. HARRISON VS, Khan MH, Chamberlain CE, Harlan DM, et al
    The Noble and Often Nobel Role Played by Insulin-Focused Research in Modern Medicine.
    Diabetes Care. 2022;45:23-27.
    PubMed     Abstract available


  980. WARREN RA, Carew AS, Andreou P, Herman C, et al
    Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial.
    Diabetes Care. 2022;45:241-250.
    PubMed     Abstract available


    December 2021

  981. Erratum. 11. Chronic kidney disease and risk management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1):S175-S184.
    Diabetes Care. 2021 Dec 29. pii: 139179. doi: 10.2337.
    PubMed    


  982. MARTIN S, Sorokin EP, Thomas EL, Sattar N, et al
    Estimating the Effect of Liver and Pancreas Volume and Fat Content on Risk of Diabetes: A Mendelian Randomization Study.
    Diabetes Care. 2021 Dec 22. pii: 139118. doi: 10.2337/dc21-1262.
    PubMed     Abstract available


  983. STECK AK, Dong F, Geno Rasmussen C, Bautista K, et al
    CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study.
    Diabetes Care. 2021 Dec 8. pii: dc21-0602. doi: 10.2337/dc21-0602.
    PubMed     Abstract available



  984. Pregnancy Outcomes in Young Women With Youth-Onset Type 2 Diabetes Followed in the TODAY Study.
    Diabetes Care. 2021 Dec 8. pii: dc21-1071. doi: 10.2337/dc21-1071.
    PubMed     Abstract available


  985. AKTURK HK, Snell-Bergeon J, Kinney GL, Champakanath A, et al
    Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes.
    Diabetes Care. 2021 Dec 8. pii: dc21-1730. doi: 10.2337/dc21-1730.
    PubMed     Abstract available


  986. YANG J, Zhang C, Chavarro JE, Rich-Edwards JW, et al
    Lifestyle Changes and Long-Term Weight Gain in Women With and Without a History of Gestational Diabetes Mellitus: A Prospective Study of 54,062 Women in the Nurses' Health Study II.
    Diabetes Care. 2021 Dec 8. pii: dc21-1692. doi: 10.2337/dc21-1692.
    PubMed     Abstract available


  987. PREISS D, Spata E, Holman RR, Coleman RL, et al
    Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials.
    Diabetes Care. 2021 Dec 7. pii: dc21-1439. doi: 10.2337/dc21-1439.
    PubMed    


  988. HERZOG K, Andersson T, Grill V, Hammar N, et al
    Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS Cohort.
    Diabetes Care. 2021 Dec 7. pii: dc21-1238. doi: 10.2337/dc21-1238.
    PubMed     Abstract available


  989. LIN TK, Lin YH, Jong GP
    Erratum. Comment on Choi et al. Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study. Diabetes Care 2021;44:1393-1401.
    Diabetes Care. 2021 Dec 7. pii: 139197. doi: 10.2337.
    PubMed    


  990. JOHNSON SR, Holmes-Walker DJ, Chee M, Earnest A, et al
    Universal Subsidized Continuous Glucose Monitoring Funding for Young People With Type 1 Diabetes: Uptake and Outcomes Over 2 Years, a Population-Based Study.
    Diabetes Care. 2021 Dec 6. pii: dc21-1666. doi: 10.2337/dc21-1666.
    PubMed     Abstract available


  991. WANG S, Wang Y, Wan X, Guo J, et al
    Cobalamin Intake and Related Biomarkers: Examining Associations With Mortality Risk Among Adults With Type 2 Diabetes in NHANES.
    Diabetes Care. 2021 Dec 3. pii: dc21-1674. doi: 10.2337/dc21-1674.
    PubMed     Abstract available


  992. HAN H, Cao Y, Feng C, Zheng Y, et al
    Association of a Healthy Lifestyle With All-Cause and Cause-Specific Mortality Among Individuals With Type 2 Diabetes: A Prospective Study in UK Biobank.
    Diabetes Care. 2021 Dec 2. pii: dc21-1512. doi: 10.2337/dc21-1512.
    PubMed     Abstract available


  993. PRASAD M, Mark V, Ligon C, Dutia R, et al
    Role of the Gut in the Temporal Changes of beta-Cell Function After Gastric Bypass in Individuals With and Without Diabetes Remission.
    Diabetes Care. 2021 Dec 2. pii: dc21-1270. doi: 10.2337/dc21-1270.
    PubMed     Abstract available


  994. MOHAMMEDI K, Abouleka Y, Carpentier C, Potier L, et al
    Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes.
    Diabetes Care. 2021 Dec 1. pii: dc21-0973. doi: 10.2337/dc21-0973.
    PubMed     Abstract available


  995. NATHAN BM, Redondo MJ, Ismail H, Jacobsen L, et al
    Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes.
    Diabetes Care. 2021 Dec 1. pii: dc21-0944. doi: 10.2337/dc21-0944.
    PubMed     Abstract available


  996. KUMARENDRAN B, O'Reilly MW, Subramanian A, Sumilo D, et al
    Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study.
    Diabetes Care. 2021;44:2758-2766.
    PubMed     Abstract available


  997. YAJNIK CS, Bandopadhyay S, Bhalerao A, Bhat DS, et al
    Poor In Utero Growth, and Reduced beta-Cell Compensation and High Fasting Glucose From Childhood, Are Harbingers of Glucose Intolerance in Young Indians.
    Diabetes Care. 2021;44:2747-2757.
    PubMed     Abstract available


  998. DAWED AY, Yee SW, Zhou K, van Leeuwen N, et al
    Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.
    Diabetes Care. 2021;44:2673-2682.
    PubMed     Abstract available


    November 2021
  999. ABERER F, Moser O, Aziz F, Sourij C, et al
    Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study.
    Diabetes Care. 2021 Nov 30. pii: dc21-1563. doi: 10.2337/dc21-1563.
    PubMed    


  1000. BRAGG F, Kartsonaki C, Guo Y, Holmes M, et al
    Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults.
    Diabetes Care. 2021 Nov 30. pii: dc21-1415. doi: 10.2337/dc21-1415.
    PubMed     Abstract available


  1001. ROSENBAUM JL, Melhorn SJ, Schoen S, Webb MF, et al
    Evidence That Hypothalamic Gliosis Is Related to Impaired Glucose Homeostasis in Adults With Obesity.
    Diabetes Care. 2021 Nov 30. pii: dc21-1535. doi: 10.2337/dc21-1535.
    PubMed     Abstract available


  1002. MCAULEY SA, Trawley S, Vogrin S, Ward GM, et al
    Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.
    Diabetes Care. 2021 Nov 29. pii: dc21-1667. doi: 10.2337/dc21-1667.
    PubMed     Abstract available


  1003. PETERSEN EA, Stauss TG, Scowcroft JA, Brooks ES, et al
    Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial.
    Diabetes Care. 2021 Nov 29. pii: dc21-1813. doi: 10.2337/dc21-1813.
    PubMed    


  1004. PETERSEN GB, Byberg S, Vistisen D, Fangel MV, et al
    Factors Associated With Nonattendance in a Nationwide Screening Program for Diabetic Retinopathy: A Register-Based Cohort Study.
    Diabetes Care. 2021 Nov 23. pii: dc21-1380. doi: 10.2337/dc21-1380.
    PubMed     Abstract available


  1005. MALIK FS, Liese AD, Reboussin BA, Sauder KA, et al
    Prevalence and Predictors of Household Food Insecurity and Supplemental Nutrition Assistance Program Use in Youth and Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2021 Nov 19. pii: dc21-0790. doi: 10.2337/dc21-0790.
    PubMed     Abstract available


  1006. SJOHOLM K, Carlsson LMS, Svensson PA, Andersson-Assarsson JC, et al
    Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-Term Results From the Swedish Obese Subjects Study.
    Diabetes Care. 2021 Nov 19. pii: dc21-1335. doi: 10.2337/dc21-1335.
    PubMed     Abstract available


  1007. BISIO A, Anderson S, Norlander L, O'Malley G, et al
    Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study.
    Diabetes Care. 2021 Nov 18. pii: dc21-0838. doi: 10.2337/dc21-0838.
    PubMed     Abstract available


  1008. PALDUS B, Morrison D, Zaharieva DP, Lee MH, et al
    A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes.
    Diabetes Care. 2021 Nov 17. pii: dc21-1593. doi: 10.2337/dc21-1593.
    PubMed     Abstract available


  1009. WU P, Moon JY, Daghlas I, Franco G, et al
    Obesity Partially Mediates the Diabetogenic Effect of Lowering LDL Cholesterol.
    Diabetes Care. 2021 Nov 17. pii: dc21-1284. doi: 10.2337/dc21-1284.
    PubMed     Abstract available


  1010. CEFALU WT, Andersen DK, Arreaza-Rubin G, Pin CL, et al
    Heterogeneity of Diabetes: beta-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of He
    Diabetes Care. 2021 Nov 15. pii: dci21-0051. doi: 10.2337/dci21-0051.
    PubMed     Abstract available


  1011. CHAMBERLAIN RC, Fleetwood K, Wild SH, Colhoun HM, et al
    Foot Ulcer and Risk of Lower Limb Amputation or Death in People With Diabetes: A National Population-Based Retrospective Cohort Study.
    Diabetes Care. 2021 Nov 15. pii: dc21-1596. doi: 10.2337/dc21-1596.
    PubMed     Abstract available


  1012. MILLER RG, Orchard TJ, Costacou T
    30-Year Cardiovascular Disease in Type 1 Diabetes: Risk and Risk Factors Differ by Long-Term Patterns of Glycemic Control.
    Diabetes Care. 2021 Nov 15. pii: dc21-1381. doi: 10.2337/dc21-1381.
    PubMed     Abstract available


  1013. YU Y, Soohoo M, Sorensen HT, Li J, et al
    Gestational Diabetes Mellitus and the Risks of Overall and Type-Specific Cardiovascular Diseases: A Population- and Sibling-Matched Cohort Study.
    Diabetes Care. 2021 Nov 11. pii: dc21-1018. doi: 10.2337/dc21-1018.
    PubMed     Abstract available


  1014. NG K, Stavropoulos H, Anand V, Veijola R, et al
    Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children.
    Diabetes Care. 2021 Nov 10. pii: dc21-0878. doi: 10.2337/dc21-0878.
    PubMed     Abstract available


  1015. YAZDANPANAH N, Yazdanpanah M, Wang Y, Forgetta V, et al
    Clinically Relevant Circulating Protein Biomarkers for Type 1 Diabetes: Evidence From a Two-Sample Mendelian Randomization Study.
    Diabetes Care. 2021 Nov 10. pii: dc21-1049. doi: 10.2337/dc21-1049.
    PubMed     Abstract available


  1016. CHAO AM, Wadden TA, Clark JM, Hayden KM, et al
    Changes in the Prevalence of Symptoms of Depression, Loneliness, and Insomnia in U.S. Older Adults With Type 2 Diabetes During the COVID-19 Pandemic: The Look AHEAD Study.
    Diabetes Care. 2021 Nov 9. pii: dc21-1179. doi: 10.2337/dc21-1179.
    PubMed     Abstract available


  1017. XU T, Clark AJ, Pentti J, Rugulies R, et al
    Characteristics of Workplace Psychosocial Resources and Risk of Diabetes: A Prospective Cohort Study.
    Diabetes Care. 2021 Nov 5. pii: dc20-2943. doi: 10.2337/dc20-2943.
    PubMed     Abstract available


  1018. MYERS BA, Klingensmith R, de Groot M
    Emotional Correlates of the COVID-19 Pandemic in Individuals With and Without Diabetes.
    Diabetes Care. 2021 Nov 5. pii: dc21-0769. doi: 10.2337/dc21-0769.
    PubMed     Abstract available


  1019. GALINDO RJ, Ali MK, Funni SA, Dodge AB, et al
    Hypoglycemic and Hyperglycemic Crises Among U.S. Adults With Diabetes and End-stage Kidney Disease: Population-Based Study, 2013-2017.
    Diabetes Care. 2021 Nov 5. pii: dc21-1579. doi: 10.2337/dc21-1579.
    PubMed     Abstract available


  1020. MCINNES N, Hall S, Hramiak I, Sigal RJ, et al
    Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial.
    Diabetes Care. 2021 Nov 2. pii: dc21-0278. doi: 10.2337/dc21-0278.
    PubMed     Abstract available


  1021. POP-BUSUI R, Braffett BH, Wessells H, Herman WH, et al
    Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study.
    Diabetes Care. 2021 Nov 2. pii: dc21-1276. doi: 10.2337/dc21-1276.
    PubMed     Abstract available


  1022. BALDUCCI S, Haxhi J, Sacchetti M, Orlando G, et al
    Relationships of Changes in Physical Activity and Sedentary Behavior With Changes in Physical Fitness and Cardiometabolic Risk Profile in Individuals With Type 2 Diabetes: The Italian Diabetes and Exercise Study 2 (IDES_2).
    Diabetes Care. 2021 Nov 2. pii: dc21-1505. doi: 10.2337/dc21-1505.
    PubMed     Abstract available


  1023. KAHKOSKA AR, Pokaprakarn T, Alexander GR, Crume TL, et al
    The Impact of Racial and Ethnic Health Disparities in Diabetes Management on Clinical Outcomes: A Reinforcement Learning Analysis of Health Inequity Among Youth and Young Adults in the SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2021 Nov 2. pii: dc21-0496. doi: 10.2337/dc21-0496.
    PubMed     Abstract available


  1024. MEZUK B, Allen JO
    Rethinking the Goals of Diabetes Prevention Programs.
    Diabetes Care. 2021;44:2457-2459.
    PubMed    


  1025. PAOLISSO P, Bergamaschi L, Rambaldi P, Gatta G, et al
    Response to Comment on Paolisso et al. Impact of Admission Hyperglycemia on Heart Failure Events and Mortality in Patients With Takotsubo Syndrome at Long-term Follow-up: Data From HIGH-GLUCOTAKO Investigators. Diabetes Care 2021;44:2158-2161.
    Diabetes Care. 2021;44:e201-e202.
    PubMed    


  1026. MADIAS JE
    Comment on Paolisso et al. Impact of Admission Hyperglycemia on Heart Failure Events and Mortality in Patients With Takotsubo Syndrome at Long-term Follow-up: Data From HIGH-GLUCOTAKO Investigators. Diabetes Care 2021;44:2158-2161.
    Diabetes Care. 2021;44:e200.
    PubMed    


  1027. CHOI YJ, Han KD, Lee SR, Choi EK, et al
    Response to Comment on Choi et al. Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: a Nationwide Population-Based Study. Diabetes Care 2021;44:1393-1401.
    Diabetes Care. 2021;44:e199.
    PubMed    


  1028. LIN TK, Lin YH, Jong GP
    Comment on Choi et al. Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study. Diabetes Care 2021;44:1393-1401.
    Diabetes Care. 2021;44:e198.
    PubMed    


  1029. ROSENSTOCK J
    Response to Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Rando
    Diabetes Care. 2021;44:e196-e197.
    PubMed    


  1030. MARATHE CS, Jones KL, Rayner CK, Wu T, et al
    Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial.
    Diabetes Care. 2021;44:e194-e195.
    PubMed    


  1031. SINGH P, Adderley NJ, Hazlehurst J, Price M, et al
    Prognostic Models for Predicting Remission of Diabetes Following Bariatric Surgery: A Systematic Review and Meta-analysis.
    Diabetes Care. 2021;44:2626-2641.
    PubMed     Abstract available


  1032. SHAW JE
    Paul Zimmet: A Voice for Diabetes.
    Diabetes Care. 2021;44:2460-2463.
    PubMed    


  1033. LESLIE RD, Evans-Molina C, Freund-Brown J, Buzzetti R, et al
    Adult-Onset Type 1 Diabetes: Current Understanding and Challenges.
    Diabetes Care. 2021;44:2449-2456.
    PubMed     Abstract available


  1034. NAGASU H, Yano Y, Kanegae H, Heerspink HJL, et al
    Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database.
    Diabetes Care. 2021;44:2542-2551.
    PubMed     Abstract available


  1035. ESTRELLA J, Wiley V, Simmons D, Hng TM, et al
    Effect of Maternal Metformin Treatment in Pregnancy on Neonatal Metabolism: Evidence From Newborn Metabolic Screening.
    Diabetes Care. 2021;44:2536-2541.
    PubMed     Abstract available


    October 2021
  1036. SHARMA A, Zheng Y, Ezekowitz JA, Westerhout CM, et al
    Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.
    Diabetes Care. 2021 Oct 29. pii: dc20-2806. doi: 10.2337/dc20-2806.
    PubMed     Abstract available


  1037. BALINTESCU A, Lind M, Franko MA, Oldner A, et al
    Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes.
    Diabetes Care. 2021 Oct 29. pii: dc21-1050. doi: 10.2337/dc21-1050.
    PubMed     Abstract available


  1038. BEVIER WC, Castorino KN, Axelrod C, Haroush G, et al
    Travelling Across Time Zones With Type 1 Diabetes: A Pilot Study Comparing Insulin Degludec With Insulin Glargine U100.
    Diabetes Care. 2021 Oct 29. pii: dc21-1524. doi: 10.2337/dc21-1524.
    PubMed     Abstract available



  1039. Risk Factors for Diabetic Peripheral Neuropathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study.
    Diabetes Care. 2021 Oct 29. pii: dc21-1074. doi: 10.2337/dc21-1074.
    PubMed     Abstract available


  1040. SHILO S, Godneva A, Rachmiel M, Korem T, et al
    Prediction of Personal Glycemic Responses to Food for Individuals With Type 1 Diabetes Through Integration of Clinical and Microbial Data.
    Diabetes Care. 2021 Oct 28. pii: dc21-1048. doi: 10.2337/dc21-1048.
    PubMed     Abstract available


  1041. HARTMANN-BOYCE J, Rees K, Perring JC, Kerneis SA, et al
    Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: a Systematic Review of Reviews.
    Diabetes Care. 2021 Oct 28. pii: dc21-0930. doi: 10.2337/dc21-0930.
    PubMed     Abstract available


  1042. OOSTERWIJK MM, Groothof D, Navis G, Bakker SJL, et al
    High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort.
    Diabetes Care. 2021 Oct 28. pii: dc21-1211. doi: 10.2337/dc21-1211.
    PubMed     Abstract available


  1043. MIAO G, Zhang Y, Huo Z, Zeng W, et al
    Longitudinal Plasma Lipidome and Risk of Type 2 Diabetes in a Large Sample of American Indians With Normal Fasting Glucose: The Strong Heart Family Study.
    Diabetes Care. 2021 Oct 26. pii: dc21-0451. doi: 10.2337/dc21-0451.
    PubMed     Abstract available


  1044. LEE CG, Heckman-Stoddard B, Dabelea D, Gadde KM, et al
    Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.
    Diabetes Care. 2021 Oct 25. pii: dc21-1046. doi: 10.2337/dc21-1046.
    PubMed     Abstract available


  1045. DEHN-HINDENBERG A, Sassmann H, Berndt V, Biester T, et al
    Long-Term Occupational Consequences for Families of Children With Type 1 Diabetes: The Mothers Take the Burden.
    Diabetes Care. 2021 Oct 25. pii: dc21-0740. doi: 10.2337/dc21-0740.
    PubMed     Abstract available


  1046. BANKER KK, Liew D, Ademi Z, Owen AJ, et al
    The Impact of Diabetes on Productivity in India.
    Diabetes Care. 2021 Oct 21. pii: dc21-0922. doi: 10.2337/dc21-0922.
    PubMed     Abstract available


  1047. NIP ASY, Lodish M
    Trend of Diabetes-Related Hospital Admissions During the Transition Period From Adolescence to Adulthood in the State of California.
    Diabetes Care. 2021 Oct 21. pii: dc21-0555. doi: 10.2337/dc21-0555.
    PubMed     Abstract available


  1048. NGUETA G, Nouthe B, Kengne AP
    Trends and Factors Associated With Very High Glycemia and Noninitiation of Insulin Therapy in U.S. Adults With Type 2 Diabetes, 1999-2018.
    Diabetes Care. 2021 Oct 21. pii: dc21-1226. doi: 10.2337/dc21-1226.
    PubMed    


  1049. NUBE VL, White JM, Brewer K, Veldhoen D, et al
    A Randomized Trial Comparing Weekly With Every Second Week Sharp Debridement in People With Diabetes-Related Foot Ulcers Shows Similar Healing Outcomes: Potential Benefit to Resource Utilization.
    Diabetes Care. 2021 Oct 21. pii: dc21-1454. doi: 10.2337/dc21-1454.
    PubMed    


  1050. YAHYAVI SK, Snorgaard O, Knop FK, Schou M, et al
    Prediabetes Defined by First Measured HbA1c Predicts Higher Cardiovascular Risk Compared With HbA1c in the Diabetes Range: A Cohort Study of Nationwide Registries.
    Diabetes Care. 2021 Oct 21. pii: dc21-1062. doi: 10.2337/dc21-1062.
    PubMed     Abstract available


  1051. LI S, Yu H, Zhang P, Tu Y, et al
    The Nonlinear Relationship Between Psoas Cross-sectional Area and BMI: A New Observation and Its Insights into Diabetes Remission After Roux-en-Y Gastric Bypass.
    Diabetes Care. 2021 Oct 13. pii: dc20-2907. doi: 10.2337/dc20-2907.
    PubMed     Abstract available


  1052. TOSCHI E, Michals A, Adam A, Davis D, et al
    Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes.
    Diabetes Care. 2021 Oct 11. pii: dc21-1373. doi: 10.2337/dc21-1373.
    PubMed     Abstract available


  1053. KHUNTI K, Del Prato S, Mathieu C, Kahn SE, et al
    COVID-19, Hyperglycemia, and New-Onset Diabetes.
    Diabetes Care. 2021 Oct 8. pii: dc21-1318. doi: 10.2337/dc21-1318.
    PubMed     Abstract available


  1054. ALESSI J, de Oliveira GB, Erthal IN, Teixeira JB, et al
    Diabetes and Obesity Bias: Are We Intensifying the Pharmacological Treatment in Patients With and Without Obesity With Equity?
    Diabetes Care. 2021 Oct 8. pii: dc21-1294. doi: 10.2337/dc21-1294.
    PubMed    


  1055. FANG Y, Zhang C, Shi H, Wei W, et al
    Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control Study.
    Diabetes Care. 2021 Oct 7. pii: dc20-2975. doi: 10.2337/dc20-2975.
    PubMed     Abstract available


  1056. WANDER PL, Lowy E, Beste LA, Tulloch-Palomino L, et al
    Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19.
    Diabetes Care. 2021 Oct 6. pii: dc21-1351. doi: 10.2337/dc21-1351.
    PubMed     Abstract available


  1057. STAM SP, Sokooti S, Eisenga MF, van der Veen A, et al
    Androgens and Development of Posttransplantation Diabetes Mellitus in Male Kidney Transplant Recipients: A Post Hoc Analysis of a Prospective Study.
    Diabetes Care. 2021 Oct 5. pii: dc21-0237. doi: 10.2337/dc21-0237.
    PubMed     Abstract available


  1058. KHATANA SAM, Illenberger N, Werner RM, Groeneveld PW, et al
    Changes in Supplemental Nutrition Assistance Program Policies and Diabetes Prevalence: Analysis of Behavioral Risk Factor Surveillance System Data From 2004 to 2014.
    Diabetes Care. 2021 Oct 4. pii: dc21-1203. doi: 10.2337/dc21-1203.
    PubMed     Abstract available


  1059. LAWRENCE JM, Reynolds K, Saydah SH, Mottl A, et al
    Demographic Correlates of Short-Term Mortality Among Youth and Young Adults With Youth-Onset Diabetes Diagnosed From 2002 to 2015: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2021 Oct 4. pii: dc21-0728. doi: 10.2337/dc21-0728.
    PubMed     Abstract available


    September 2021
  1060. HOLT RIG, DeVries JH, Hess-Fischl A, Hirsch IB, et al
    The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetes Care. 2021 Sep 30. pii: dci21-0043. doi: 10.2337/dci21-0043.
    PubMed     Abstract available


  1061. WHARAM JF, Wallace J, Argetsinger S, Zhang F, et al
    Diabetes Microvascular Disease Diagnosis and Treatment After High-Deductible Health Plan Enrollment.
    Diabetes Care. 2021 Sep 29. pii: dc21-0407. doi: 10.2337/dc21-0407.
    PubMed     Abstract available


  1062. ALEPPO G, Beck RW, Bailey R, Ruedy KJ, et al
    The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin.
    Diabetes Care. 2021 Sep 29. pii: dc21-1304. doi: 10.2337/dc21-1304.
    PubMed     Abstract available


  1063. VAN GENNIP ACE, Stehouwer CDA, van Boxtel MPJ, Verhey FRJ, et al
    Association of Type 2 Diabetes, According to the Number of Risk Factors Within Target Range, With Structural Brain Abnormalities, Cognitive Performance, and Risk of Dementia.
    Diabetes Care. 2021 Sep 29. pii: dc21-0149. doi: 10.2337/dc21-0149.
    PubMed     Abstract available


  1064. BIZZOTTO R, Trico D, Natali A, Gastaldelli A, et al
    New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms.
    Diabetes Care. 2021;44:2115-2123.
    PubMed     Abstract available


  1065. ALFEGO D, Ennis J, Gillespie B, Lewis MJ, et al
    Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database.
    Diabetes Care. 2021;44:2025-2032.
    PubMed     Abstract available


  1066. BEN-YACOV O, Godneva A, Rein M, Shilo S, et al
    Personalized Postprandial Glucose Response-Targeting Diet Versus Mediterranean Diet for Glycemic Control in Prediabetes.
    Diabetes Care. 2021;44:1980-1991.
    PubMed     Abstract available


  1067. KAHN SE, Edelstein SL, Arslanian SA, Barengolts E, et al
    Effect of Medical and Surgical Interventions on alpha-Cell Function in Dysglycemic Youth and Adults in the RISE Study.
    Diabetes Care. 2021;44:1948-1960.
    PubMed     Abstract available


  1068. KAHN SE, Mather KJ, Arslanian SA, Barengolts E, et al
    Hyperglucagonemia Does Not Explain the beta-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study.
    Diabetes Care. 2021;44:1961-1969.
    PubMed     Abstract available


    August 2021
  1069. MOSENZON O, Wiviott SD, Heerspink HJL, Dwyer JP, et al
    The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.
    Diabetes Care. 2021;44:1805-1815.
    PubMed     Abstract available


  1070. PERSSON F, Rossing P, Vart P, Chertow GM, et al
    Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial.
    Diabetes Care. 2021;44:1894-1897.
    PubMed     Abstract available


  1071. HIERSCH L, Shah BR, Berger H, Geary M, et al
    Oral Glucose Tolerance Test Results in Pregnancy Can Be Used to Individualize the Risk of Future Maternal Type 2 Diabetes Mellitus in Women With Gestational Diabetes Mellitus.
    Diabetes Care. 2021;44:1860-1867.
    PubMed     Abstract available


  1072. SANDOVAL DA, Alonso LC, Gannon M, Sander M, et al
    Career Advancement for Women in Diabetes-Related Research: Developing and Retaining Female Talent.
    Diabetes Care. 2021;44:1744-1747.
    PubMed    


  1073. DUNNE JL, Maizel JL, Posgai AL, Atkinson MA, et al
    The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence.
    Diabetes Care. 2021;44:1734-1743.
    PubMed     Abstract available


  1074. MUNOZ CE, Weinstock RS, Brown TD, Gabbay RA, et al
    Women and the American Diabetes Association.
    Diabetes Care. 2021;44:1748-1749.
    PubMed    


    July 2021
  1075. KAHKOSKA AR, Abrahamsen TJ, Alexander GC, Bennett TD, et al
    Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.
    Diabetes Care. 2021;44:1564-1572.
    PubMed     Abstract available


  1076. JULLA JB, Jacquemier P, Fagherazzi G, Vidal-Trecan T, et al
    Is the Consensual Threshold for Defining High Glucose Variability Implementable in Clinical Practice?
    Diabetes Care. 2021;44:1722-1725.
    PubMed     Abstract available


  1077. ADAM TC, Drummen M, Macdonald I, Jalo E, et al
    Association of Psychobehavioral Variables With HOMA-IR and BMI Differs for Men and Women With Prediabetes in the PREVIEW Lifestyle Intervention.
    Diabetes Care. 2021;44:1491-1498.
    PubMed     Abstract available


  1078. HAYASHI A, Shimizu N, Suzuki A, Matoba K, et al
    Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia.
    Diabetes Care. 2021;44:1647-1656.
    PubMed     Abstract available


  1079. CHEN NS, Boughton CK, Hartnell S, Fuchs J, et al
    User Engagement With the CamAPS FX Hybrid Closed-Loop App According to Age and User Characteristics.
    Diabetes Care. 2021;44:e148-e150.
    PubMed    


  1080. HERMAN WH, Joiner K, Hurst T, McEwen LN, et al
    The Effectiveness of a Proactive, Three-Level Strategy to Identify People With Prediabetes in a Large Workforce With Employer-Sponsored Health Insurance.
    Diabetes Care. 2021;44:1532-1539.
    PubMed     Abstract available


  1081. SEMNANI-AZAD Z, Connelly PW, Bazinet RP, Retnakaran R, et al
    Adipose Tissue Insulin Resistance Is Longitudinally Associated With Adipose Tissue Dysfunction, Circulating Lipids, and Dysglycemia: The PROMISE Cohort.
    Diabetes Care. 2021;44:1682-1691.
    PubMed     Abstract available


  1082. LINGVAY I, Buse JB, Franek E, Hansen MV, et al
    A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100.
    Diabetes Care. 2021;44:1595-1603.
    PubMed     Abstract available


    June 2021
  1083. SCOCCIMARRO D, Cipani G, Dicembrini I, Mannucci E, et al
    Cigarette Smoking as a Predictor of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Genital Infections: A Retrospective Cohort Study.
    Diabetes Care. 2021;44:e127-e128.
    PubMed    


  1084. GIUGLIANO D, Longo M, Caruso P, Di Fraia R, et al
    Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial.
    Diabetes Care. 2021;44:1353-1360.
    PubMed     Abstract available


  1085. ZHAO M, Song L, Sun L, Wang M, et al
    Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study.
    Diabetes Care. 2021;44:1426-1432.
    PubMed     Abstract available


  1086. PIEBER TR, Aronson R, Hovelmann U, Willard J, et al
    Dasiglucagon-A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial.
    Diabetes Care. 2021;44:1361-1367.
    PubMed     Abstract available


    January 2021

  1087. 16. Diabetes Advocacy: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1088. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1089. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1090. 13. Children and Adolescents: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1091. 12. Older Adults: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1092. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1093. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1094. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1095. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1096. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1097. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1098. 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1099. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1100. 3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1101. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available



  1102. 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2021.
    Diabetes Care. 2021;44.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.